id	sid	tid	token	lemma	pos
gsrj-19	1	1	gsr	gsr	PROPN
gsrj-19	1	2	journal	journal	PROPN
gsrj-19	1	3	georgetown	georgetown	PROPN
gsrj-19	1	4	scientific	scientific	PROPN
gsrj-19	1	5	research	research	PROPN
gsrj-19	1	6	journal	journal	PROPN
gsrj-19	1	7	volume	volume	NOUN
gsrj-19	1	8	1	1	NUM
gsrj-19	1	9	|	|	NOUN
gsrj-19	1	10	edition	edition	NOUN
gsrj-19	1	11	2	2	NUM
gsrj-19	1	12	july	july	PROPN
gsrj-19	1	13	31	31	NUM
gsrj-19	1	14	,	,	PUNCT
gsrj-19	1	15	2021	2021	NUM
gsrj-19	1	16	danya	danya	PROPN
gsrj-19	1	17	adams	adams	PROPN
gsrj-19	1	18	issn	issn	PROPN
gsrj-19	1	19	2767	2767	NUM
gsrj-19	1	20	-	-	PUNCT
gsrj-19	1	21	6420	6420	NUM
gsrj-19	1	22	gpr40	gpr40	PROPN
gsrj-19	1	23	and	and	CCONJ
gsrj-19	1	24	postsynaptic	postsynaptic	ADJ
gsrj-19	1	25	nmda	nmda	ADJ
gsrj-19	1	26	receptors	receptor	NOUN
gsrj-19	1	27	:	:	PUNCT
gsrj-19	1	28	a	a	DET
gsrj-19	1	29	pair	pair	NOUN
gsrj-19	1	30	against	against	ADP
gsrj-19	1	31	epilepsy	epilepsy	NOUN
gsrj-19	1	32	vidya	vidya	NOUN
gsrj-19	1	33	mullangi	mullangi	VERB
gsrj-19	1	34	,	,	PUNCT
gsrj-19	1	35	*	*	PUNCT
gsrj-19	1	36	nikita	nikita	PROPN
gsrj-19	1	37	shah	shah	PROPN
gsrj-19	1	38	,	,	PUNCT
gsrj-19	1	39	*	*	PUNCT
gsrj-19	1	40	hyunwook	hyunwook	PROPN
gsrj-19	1	41	nam	nam	PROPN
gsrj-19	1	42	,	,	PUNCT
gsrj-19	1	43	*	*	PROPN
gsrj-19	1	44	alexa	alexa	PROPN
gsrj-19	1	45	asch	asch	PROPN
gsrj-19	1	46	,	,	PUNCT
gsrj-19	1	47	*	*	PUNCT
gsrj-19	1	48	lauren	lauren	PROPN
gsrj-19	1	49	cox	cox	PROPN
gsrj-19	1	50	,	,	PUNCT
gsrj-19	1	51	clarisa	clarisa	VERB
gsrj-19	1	52	mendoza	mendoza	PROPN
gsrj-19	1	53	*	*	PUNCT
gsrj-19	1	54	indicates	indicate	VERB
gsrj-19	1	55	equal	equal	ADJ
gsrj-19	1	56	contribution	contribution	NOUN
gsrj-19	1	57	volume	volume	NOUN
gsrj-19	1	58	one	one	NUM
gsrj-19	1	59	edition	edition	NOUN
gsrj-19	1	60	two	two	NUM
gsrj-19	1	61	spring	spring	NOUN
gsrj-19	1	62	2021	2021	NUM
gsrj-19	1	63	georgetown	georgetown	PROPN
gsrj-19	1	64	scientific	scientific	PROPN
gsrj-19	1	65	research	research	PROPN
gsrj-19	1	66	journal	journal	PROPN
gsrj-19	1	67	19	19	NUM
gsrj-19	1	68	georgetown	georgetown	PROPN
gsrj-19	1	69	scientific	scientific	PROPN
gsrj-19	1	70	research	research	PROPN
gsrj-19	1	71	journal	journal	NOUN
gsrj-19	1	72	gpr40	gpr40	PROPN
gsrj-19	1	73	and	and	CCONJ
gsrj-19	1	74	postsynaptic	postsynaptic	ADJ
gsrj-19	1	75	nmda	nmda	ADJ
gsrj-19	1	76	receptors	receptor	NOUN
gsrj-19	1	77	:	:	PUNCT
gsrj-19	1	78	a	a	DET
gsrj-19	1	79	pair	pair	NOUN
gsrj-19	1	80	against	against	ADP
gsrj-19	1	81	epilepsy	epilepsy	NOUN
gsrj-19	1	82	vidya	vidya	NOUN
gsrj-19	1	83	mullangi	mullangi	VERB
gsrj-19	1	84	*	*	PROPN
gsrj-19	1	85	,	,	PUNCT
gsrj-19	1	86	nikita	nikita	PROPN
gsrj-19	1	87	shah	shah	PROPN
gsrj-19	1	88	*	*	PROPN
gsrj-19	1	89	,	,	PUNCT
gsrj-19	1	90	hyunwook	hyunwook	PROPN
gsrj-19	1	91	nam	nam	PROPN
gsrj-19	1	92	*	*	PROPN
gsrj-19	1	93	,	,	PUNCT
gsrj-19	1	94	alexa	alexa	PROPN
gsrj-19	1	95	asch	asch	PROPN
gsrj-19	1	96	*	*	PROPN
gsrj-19	1	97	,	,	PUNCT
gsrj-19	1	98	lauren	lauren	PROPN
gsrj-19	1	99	cox	cox	PROPN
gsrj-19	1	100	,	,	PUNCT
gsrj-19	1	101	clarisa	clarisa	VERB
gsrj-19	1	102	mendoza	mendoza	PROPN
gsrj-19	1	103	*	*	PUNCT
gsrj-19	1	104	indicates	indicate	VERB
gsrj-19	1	105	equal	equal	ADJ
gsrj-19	1	106	contribution	contribution	NOUN
gsrj-19	1	107	department	department	NOUN
gsrj-19	1	108	of	of	ADP
gsrj-19	1	109	biology	biology	NOUN
gsrj-19	1	110	,	,	PUNCT
gsrj-19	1	111	georgetown	georgetown	PROPN
gsrj-19	1	112	university	university	PROPN
gsrj-19	1	113	,	,	PUNCT
gsrj-19	1	114	washington	washington	PROPN
gsrj-19	1	115	d.c	d.c	PROPN
gsrj-19	1	116	.	.	PUNCT
gsrj-19	2	1	e	e	X
gsrj-19	2	2	-	-	NOUN
gsrj-19	2	3	mail	mail	NOUN
gsrj-19	2	4	:	:	PUNCT
gsrj-19	2	5	vm491@georgetown.edu	vm491@georgetown.edu	PROPN
gsrj-19	2	6	,	,	PUNCT
gsrj-19	2	7	ns1217@georgetown.edu	ns1217@georgetown.edu	PROPN
gsrj-19	2	8	,	,	PUNCT
gsrj-19	2	9	hn210@georgetown.edu	hn210@georgetown.edu	X
gsrj-19	2	10	,	,	PUNCT
gsrj-19	2	11	aa2142@georgetown.edu	aa2142@georgetown.edu	PROPN
gsrj-19	2	12	,	,	PUNCT
gsrj-19	2	13	lec122@georgetown.edu	lec122@georgetown.edu	PROPN
gsrj-19	2	14	,	,	PUNCT
gsrj-19	2	15	cem328@georgetown.edu	cem328@georgetown.edu	X
gsrj-19	2	16	https://doi.org/10.48091/gsr.v1i2.19	https://doi.org/10.48091/gsr.v1i2.19	PROPN
gsrj-19	2	17	abstract	abstract	ADJ
gsrj-19	2	18	epilepsy	epilepsy	NOUN
gsrj-19	2	19	is	be	AUX
gsrj-19	2	20	a	a	DET
gsrj-19	2	21	chronic	chronic	ADJ
gsrj-19	2	22	neurological	neurological	ADJ
gsrj-19	2	23	condition	condition	NOUN
gsrj-19	2	24	characterized	characterize	VERB
gsrj-19	2	25	by	by	ADP
gsrj-19	2	26	abnormal	abnormal	ADJ
gsrj-19	2	27	brain	brain	NOUN
gsrj-19	2	28	activity	activity	NOUN
gsrj-19	2	29	,	,	PUNCT
gsrj-19	2	30	unusual	unusual	ADJ
gsrj-19	2	31	behavior	behavior	NOUN
gsrj-19	2	32	,	,	PUNCT
gsrj-19	2	33	and	and	CCONJ
gsrj-19	2	34	loss	loss	NOUN
gsrj-19	2	35	of	of	ADP
gsrj-19	2	36	awareness	awareness	NOUN
gsrj-19	2	37	.	.	PUNCT
gsrj-19	3	1	one	one	NUM
gsrj-19	3	2	of	of	ADP
gsrj-19	3	3	the	the	DET
gsrj-19	3	4	most	most	ADV
gsrj-19	3	5	common	common	ADJ
gsrj-19	3	6	features	feature	NOUN
gsrj-19	3	7	is	be	AUX
gsrj-19	3	8	the	the	DET
gsrj-19	3	9	spontaneous	spontaneous	ADJ
gsrj-19	3	10	recurrence	recurrence	NOUN
gsrj-19	3	11	of	of	ADP
gsrj-19	3	12	unprovoked	unprovoked	ADJ
gsrj-19	3	13	seizures	seizure	NOUN
gsrj-19	3	14	that	that	PRON
gsrj-19	3	15	mainly	mainly	ADV
gsrj-19	3	16	affect	affect	VERB
gsrj-19	3	17	the	the	DET
gsrj-19	3	18	hippocampus	hippocampus	NOUN
gsrj-19	3	19	and	and	CCONJ
gsrj-19	3	20	cortical	cortical	ADJ
gsrj-19	3	21	regions	region	NOUN
gsrj-19	3	22	of	of	ADP
gsrj-19	3	23	the	the	DET
gsrj-19	3	24	brain	brain	NOUN
gsrj-19	3	25	.	.	PUNCT
gsrj-19	4	1	although	although	SCONJ
gsrj-19	4	2	the	the	DET
gsrj-19	4	3	exact	exact	ADJ
gsrj-19	4	4	cause	cause	NOUN
gsrj-19	4	5	of	of	ADP
gsrj-19	4	6	epilepsy	epilepsy	NOUN
gsrj-19	4	7	is	be	AUX
gsrj-19	4	8	still	still	ADV
gsrj-19	4	9	unknown	unknown	ADJ
gsrj-19	4	10	,	,	PUNCT
gsrj-19	4	11	a	a	DET
gsrj-19	4	12	mix	mix	NOUN
gsrj-19	4	13	of	of	ADP
gsrj-19	4	14	genetic	genetic	ADJ
gsrj-19	4	15	,	,	PUNCT
gsrj-19	4	16	neurological	neurological	ADJ
gsrj-19	4	17	,	,	PUNCT
gsrj-19	4	18	and	and	CCONJ
gsrj-19	4	19	environmental	environmental	ADJ
gsrj-19	4	20	factors	factor	NOUN
gsrj-19	4	21	play	play	VERB
gsrj-19	4	22	a	a	DET
gsrj-19	4	23	role	role	NOUN
gsrj-19	4	24	.	.	PUNCT
gsrj-19	5	1	a	a	DET
gsrj-19	5	2	novel	novel	ADJ
gsrj-19	5	3	study	study	NOUN
gsrj-19	5	4	by	by	ADP
gsrj-19	5	5	yang	yang	PROPN
gsrj-19	5	6	et	et	PROPN
gsrj-19	5	7	al	al	PROPN
gsrj-19	5	8	.	.	PROPN
gsrj-19	5	9	explores	explore	VERB
gsrj-19	5	10	the	the	DET
gsrj-19	5	11	metabotropic	metabotropic	NOUN
gsrj-19	5	12	receptor	receptor	NOUN
gsrj-19	5	13	gpr40	gpr40	PROPN
gsrj-19	5	14	which	which	PRON
gsrj-19	5	15	is	be	AUX
gsrj-19	5	16	suspected	suspect	VERB
gsrj-19	5	17	to	to	PART
gsrj-19	5	18	be	be	AUX
gsrj-19	5	19	involved	involve	VERB
gsrj-19	5	20	in	in	ADP
gsrj-19	5	21	the	the	DET
gsrj-19	5	22	regulation	regulation	NOUN
gsrj-19	5	23	of	of	ADP
gsrj-19	5	24	epileptic	epileptic	ADJ
gsrj-19	5	25	seizures	seizure	NOUN
gsrj-19	5	26	,	,	PUNCT
gsrj-19	5	27	specifically	specifically	ADV
gsrj-19	5	28	through	through	ADP
gsrj-19	5	29	its	its	PRON
gsrj-19	5	30	modulatory	modulatory	ADJ
gsrj-19	5	31	role	role	NOUN
gsrj-19	5	32	on	on	ADP
gsrj-19	5	33	nmda	nmda	ADJ
gsrj-19	5	34	receptors	receptor	NOUN
gsrj-19	5	35	in	in	ADP
gsrj-19	5	36	the	the	DET
gsrj-19	5	37	central	central	ADJ
gsrj-19	5	38	nervous	nervous	ADJ
gsrj-19	5	39	system	system	NOUN
gsrj-19	5	40	.	.	PUNCT
gsrj-19	6	1	their	their	PRON
gsrj-19	6	2	findings	finding	NOUN
gsrj-19	6	3	suggest	suggest	VERB
gsrj-19	6	4	that	that	SCONJ
gsrj-19	6	5	gpr40	gpr40	PROPN
gsrj-19	6	6	induces	induce	VERB
gsrj-19	6	7	nmda	nmda	ADJ
gsrj-19	6	8	receptor	receptor	NOUN
gsrj-19	6	9	endocytosis	endocytosis	NOUN
gsrj-19	6	10	via	via	ADP
gsrj-19	6	11	direct	direct	ADJ
gsrj-19	6	12	interaction	interaction	NOUN
gsrj-19	6	13	with	with	ADP
gsrj-19	6	14	nr2a	nr2a	PROPN
gsrj-19	6	15	and	and	CCONJ
gsrj-19	6	16	nr2b	nr2b	NUM
gsrj-19	6	17	subunits	subunit	NOUN
gsrj-19	6	18	of	of	ADP
gsrj-19	6	19	postsynaptic	postsynaptic	ADJ
gsrj-19	6	20	nmda	nmda	ADJ
gsrj-19	6	21	receptors	receptor	NOUN
gsrj-19	6	22	.	.	PUNCT
gsrj-19	7	1	through	through	ADP
gsrj-19	7	2	this	this	DET
gsrj-19	7	3	mechanism	mechanism	NOUN
gsrj-19	7	4	,	,	PUNCT
gsrj-19	7	5	nmda	nmda	ADJ
gsrj-19	7	6	-	-	PUNCT
gsrj-19	7	7	mediated	mediate	VERB
gsrj-19	7	8	postsynaptic	postsynaptic	ADJ
gsrj-19	7	9	currents	current	NOUN
gsrj-19	7	10	are	be	AUX
gsrj-19	7	11	altered	alter	VERB
gsrj-19	7	12	,	,	PUNCT
gsrj-19	7	13	resulting	result	VERB
gsrj-19	7	14	in	in	ADP
gsrj-19	7	15	reduced	reduce	VERB
gsrj-19	7	16	seizure	seizure	NOUN
gsrj-19	7	17	-	-	PUNCT
gsrj-19	7	18	like	like	ADJ
gsrj-19	7	19	activity	activity	NOUN
gsrj-19	7	20	.	.	PUNCT
gsrj-19	8	1	this	this	DET
gsrj-19	8	2	review	review	NOUN
gsrj-19	8	3	article	article	NOUN
gsrj-19	8	4	discusses	discuss	VERB
gsrj-19	8	5	these	these	DET
gsrj-19	8	6	novel	novel	ADJ
gsrj-19	8	7	findings	finding	NOUN
gsrj-19	8	8	which	which	PRON
gsrj-19	8	9	not	not	PART
gsrj-19	8	10	only	only	ADV
gsrj-19	8	11	shed	shed	VERB
gsrj-19	8	12	light	light	NOUN
gsrj-19	8	13	on	on	ADP
gsrj-19	8	14	the	the	DET
gsrj-19	8	15	potential	potential	ADJ
gsrj-19	8	16	molecular	molecular	ADJ
gsrj-19	8	17	mechanisms	mechanism	NOUN
gsrj-19	8	18	of	of	ADP
gsrj-19	8	19	epilepsy	epilepsy	NOUN
gsrj-19	8	20	but	but	CCONJ
gsrj-19	8	21	also	also	ADV
gsrj-19	8	22	push	push	VERB
gsrj-19	8	23	the	the	DET
gsrj-19	8	24	scientific	scientific	ADJ
gsrj-19	8	25	community	community	NOUN
gsrj-19	8	26	closer	close	ADV
gsrj-19	8	27	to	to	ADP
gsrj-19	8	28	developing	develop	VERB
gsrj-19	8	29	a	a	DET
gsrj-19	8	30	treatment	treatment	NOUN
gsrj-19	8	31	for	for	ADP
gsrj-19	8	32	this	this	DET
gsrj-19	8	33	disorder	disorder	NOUN
gsrj-19	8	34	.	.	PUNCT
gsrj-19	9	1	keywords	keyword	NOUN
gsrj-19	9	2	:	:	PUNCT
gsrj-19	9	3	epilepsy	epilepsy	PROPN
gsrj-19	9	4	,	,	PUNCT
gsrj-19	9	5	gpr40	gpr40	PROPN
gsrj-19	9	6	,	,	PUNCT
gsrj-19	9	7	seizures	seizure	NOUN
gsrj-19	9	8	,	,	PUNCT
gsrj-19	9	9	nmda	nmda	ADJ
gsrj-19	9	10	receptors	receptor	NOUN
gsrj-19	9	11	,	,	PUNCT
gsrj-19	9	12	nr2a	nr2a	NOUN
gsrj-19	9	13	and	and	CCONJ
gsrj-19	9	14	nr2b	nr2b	NUM
gsrj-19	9	15	subunits	subunit	NOUN
gsrj-19	9	16	,	,	PUNCT
gsrj-19	9	17	excitatory	excitatory	ADJ
gsrj-19	9	18	postsynaptic	postsynaptic	ADJ
gsrj-19	9	19	currents	current	NOUN
gsrj-19	9	20	,	,	PUNCT
gsrj-19	9	21	cortex	cortex	NOUN
gsrj-19	9	22	,	,	PUNCT
gsrj-19	9	23	and	and	CCONJ
gsrj-19	9	24	hippocampus	hippocampus	NOUN
gsrj-19	9	25	1	1	NUM
gsrj-19	9	26	.	.	PUNCT
gsrj-19	10	1	introduction	introduction	NOUN
gsrj-19	10	2	epilepsy	epilepsy	NOUN
gsrj-19	10	3	is	be	AUX
gsrj-19	10	4	a	a	DET
gsrj-19	10	5	chronic	chronic	ADJ
gsrj-19	10	6	neurological	neurological	ADJ
gsrj-19	10	7	condition	condition	NOUN
gsrj-19	10	8	that	that	PRON
gsrj-19	10	9	affects	affect	VERB
gsrj-19	10	10	an	an	DET
gsrj-19	10	11	estimated	estimate	VERB
gsrj-19	10	12	one	one	NUM
gsrj-19	10	13	to	to	PART
gsrj-19	10	14	three	three	NUM
gsrj-19	10	15	percent	percent	NOUN
gsrj-19	10	16	of	of	ADP
gsrj-19	10	17	the	the	DET
gsrj-19	10	18	population	population	NOUN
gsrj-19	10	19	;	;	PUNCT
gsrj-19	10	20	it	it	PRON
gsrj-19	10	21	is	be	AUX
gsrj-19	10	22	characterized	characterize	VERB
gsrj-19	10	23	by	by	ADP
gsrj-19	10	24	the	the	DET
gsrj-19	10	25	spontaneous	spontaneous	ADJ
gsrj-19	10	26	recurrence	recurrence	NOUN
gsrj-19	10	27	of	of	ADP
gsrj-19	10	28	unprovoked	unprovoked	ADJ
gsrj-19	10	29	seizures	seizure	NOUN
gsrj-19	10	30	,	,	PUNCT
gsrj-19	10	31	seizures	seizure	NOUN
gsrj-19	10	32	that	that	PRON
gsrj-19	10	33	occur	occur	VERB
gsrj-19	10	34	without	without	ADP
gsrj-19	10	35	apparent	apparent	ADJ
gsrj-19	10	36	triggers.1	triggers.1	PROPN
gsrj-19	10	37	epilepsy	epilepsy	NOUN
gsrj-19	10	38	can	can	AUX
gsrj-19	10	39	also	also	ADV
gsrj-19	10	40	be	be	AUX
gsrj-19	10	41	characterized	characterize	VERB
gsrj-19	10	42	by	by	ADP
gsrj-19	10	43	abnormal	abnormal	ADJ
gsrj-19	10	44	brain	brain	NOUN
gsrj-19	10	45	activity	activity	NOUN
gsrj-19	10	46	,	,	PUNCT
gsrj-19	10	47	unusual	unusual	ADJ
gsrj-19	10	48	behavior	behavior	NOUN
gsrj-19	10	49	or	or	CCONJ
gsrj-19	10	50	sensations	sensation	NOUN
gsrj-19	10	51	,	,	PUNCT
gsrj-19	10	52	and	and	CCONJ
gsrj-19	10	53	even	even	ADV
gsrj-19	10	54	a	a	DET
gsrj-19	10	55	loss	loss	NOUN
gsrj-19	10	56	of	of	ADP
gsrj-19	10	57	awareness	awareness	NOUN
gsrj-19	10	58	,	,	PUNCT
gsrj-19	10	59	though	though	SCONJ
gsrj-19	10	60	these	these	PRON
gsrj-19	10	61	are	be	AUX
gsrj-19	10	62	often	often	ADV
gsrj-19	10	63	common	common	ADJ
gsrj-19	10	64	characteristics	characteristic	NOUN
gsrj-19	10	65	of	of	ADP
gsrj-19	10	66	other	other	ADJ
gsrj-19	10	67	neurological	neurological	ADJ
gsrj-19	10	68	disorders	disorder	NOUN
gsrj-19	10	69	as	as	SCONJ
gsrj-19	10	70	well.2	well.2	PROPN
gsrj-19	10	71	other	other	ADJ
gsrj-19	10	72	general	general	ADJ
gsrj-19	10	73	symptoms	symptom	NOUN
gsrj-19	10	74	of	of	ADP
gsrj-19	10	75	epilepsy	epilepsy	NOUN
gsrj-19	10	76	may	may	AUX
gsrj-19	10	77	include	include	VERB
gsrj-19	10	78	temporary	temporary	ADJ
gsrj-19	10	79	confusion	confusion	NOUN
gsrj-19	10	80	,	,	PUNCT
gsrj-19	10	81	uncontrollable	uncontrollable	ADJ
gsrj-19	10	82	motor	motor	NOUN
gsrj-19	10	83	function	function	NOUN
gsrj-19	10	84	,	,	PUNCT
gsrj-19	10	85	loss	loss	NOUN
gsrj-19	10	86	of	of	ADP
gsrj-19	10	87	consciousness	consciousness	NOUN
gsrj-19	10	88	,	,	PUNCT
gsrj-19	10	89	and	and	CCONJ
gsrj-19	10	90	even	even	ADV
gsrj-19	10	91	psychological	psychological	ADJ
gsrj-19	10	92	symptoms	symptom	NOUN
gsrj-19	10	93	,	,	PUNCT
gsrj-19	10	94	such	such	ADJ
gsrj-19	10	95	as	as	ADP
gsrj-19	10	96	anxiety	anxiety	NOUN
gsrj-19	10	97	,	,	PUNCT
gsrj-19	10	98	fear	fear	NOUN
gsrj-19	10	99	,	,	PUNCT
gsrj-19	10	100	or	or	CCONJ
gsrj-19	10	101	deja	deja	X
gsrj-19	10	102	vu.2	vu.2	PROPN
gsrj-19	10	103	the	the	DET
gsrj-19	10	104	exact	exact	ADJ
gsrj-19	10	105	cause	cause	NOUN
gsrj-19	10	106	of	of	ADP
gsrj-19	10	107	epilepsy	epilepsy	NOUN
gsrj-19	10	108	has	have	AUX
gsrj-19	10	109	not	not	PART
gsrj-19	10	110	yet	yet	ADV
gsrj-19	10	111	been	be	AUX
gsrj-19	10	112	determined	determine	VERB
gsrj-19	10	113	.	.	PUNCT
gsrj-19	11	1	however	however	ADV
gsrj-19	11	2	,	,	PUNCT
gsrj-19	11	3	the	the	DET
gsrj-19	11	4	neurological	neurological	ADJ
gsrj-19	11	5	disorder	disorder	NOUN
gsrj-19	11	6	has	have	AUX
gsrj-19	11	7	been	be	AUX
gsrj-19	11	8	connected	connect	VERB
gsrj-19	11	9	to	to	ADP
gsrj-19	11	10	a	a	DET
gsrj-19	11	11	variety	variety	NOUN
gsrj-19	11	12	of	of	ADP
gsrj-19	11	13	factors.2	factors.2	PROPN
gsrj-19	11	14	the	the	DET
gsrj-19	11	15	onset	onset	NOUN
gsrj-19	11	16	of	of	ADP
gsrj-19	11	17	epilepsy	epilepsy	NOUN
gsrj-19	11	18	has	have	AUX
gsrj-19	11	19	been	be	AUX
gsrj-19	11	20	associated	associate	VERB
gsrj-19	11	21	with	with	ADP
gsrj-19	11	22	several	several	ADJ
gsrj-19	11	23	developmental	developmental	ADJ
gsrj-19	11	24	disorders	disorder	NOUN
gsrj-19	11	25	including	include	VERB
gsrj-19	11	26	autism	autism	NOUN
gsrj-19	11	27	and	and	CCONJ
gsrj-19	11	28	neurofibromatosis	neurofibromatosis	NOUN
gsrj-19	11	29	.	.	PUNCT
gsrj-19	12	1	it	it	PRON
gsrj-19	12	2	has	have	AUX
gsrj-19	12	3	also	also	ADV
gsrj-19	12	4	been	be	AUX
gsrj-19	12	5	associated	associate	VERB
gsrj-19	12	6	with	with	ADP
gsrj-19	12	7	infectious	infectious	ADJ
gsrj-19	12	8	diseases	disease	NOUN
gsrj-19	12	9	such	such	ADJ
gsrj-19	12	10	as	as	ADP
gsrj-19	12	11	meningitis	meningitis	NOUN
gsrj-19	12	12	,	,	PUNCT
gsrj-19	12	13	acquired	acquire	VERB
gsrj-19	12	14	immunodeficiency	immunodeficiency	NOUN
gsrj-19	12	15	syndrome	syndrome	NOUN
gsrj-19	12	16	,	,	PUNCT
gsrj-19	12	17	and	and	CCONJ
gsrj-19	12	18	viral	viral	ADJ
gsrj-19	12	19	encephalitis	encephalitis	NOUN
gsrj-19	12	20	.	.	PUNCT
gsrj-19	13	1	brain	brain	NOUN
gsrj-19	13	2	trauma	trauma	NOUN
gsrj-19	13	3	caused	cause	VERB
gsrj-19	13	4	by	by	ADP
gsrj-19	13	5	stroke	stroke	NOUN
gsrj-19	13	6	or	or	CCONJ
gsrj-19	13	7	brain	brain	NOUN
gsrj-19	13	8	tumors	tumor	NOUN
gsrj-19	13	9	can	can	AUX
gsrj-19	13	10	also	also	ADV
gsrj-19	13	11	lead	lead	VERB
gsrj-19	13	12	to	to	ADP
gsrj-19	13	13	the	the	DET
gsrj-19	13	14	onset	onset	NOUN
gsrj-19	13	15	of	of	ADP
gsrj-19	13	16	epilepsy	epilepsy	NOUN
gsrj-19	13	17	;	;	PUNCT
gsrj-19	13	18	in	in	ADP
gsrj-19	13	19	fact	fact	NOUN
gsrj-19	13	20	,	,	PUNCT
gsrj-19	13	21	stroke	stroke	NOUN
gsrj-19	13	22	is	be	AUX
gsrj-19	13	23	known	know	VERB
gsrj-19	13	24	to	to	PART
gsrj-19	13	25	be	be	AUX
gsrj-19	13	26	a	a	DET
gsrj-19	13	27	common	common	ADJ
gsrj-19	13	28	cause	cause	NOUN
gsrj-19	13	29	of	of	ADP
gsrj-19	13	30	epilepsy	epilepsy	NOUN
gsrj-19	13	31	in	in	ADP
gsrj-19	13	32	individuals	individual	NOUN
gsrj-19	13	33	over	over	ADP
gsrj-19	13	34	thirty	thirty	NUM
gsrj-19	13	35	-	-	PUNCT
gsrj-19	13	36	five	five	NUM
gsrj-19	13	37	years	year	NOUN
gsrj-19	13	38	old.2	old.2	PROPN
gsrj-19	13	39	20	20	NUM
gsrj-19	13	40	georgetown	georgetown	PROPN
gsrj-19	13	41	scientific	scientific	PROPN
gsrj-19	13	42	research	research	NOUN
gsrj-19	13	43	journal	journal	PROPN
gsrj-19	13	44	additionally	additionally	ADV
gsrj-19	13	45	,	,	PUNCT
gsrj-19	13	46	head	head	NOUN
gsrj-19	13	47	trauma	trauma	NOUN
gsrj-19	13	48	and	and	CCONJ
gsrj-19	13	49	traumatic	traumatic	ADJ
gsrj-19	13	50	brain	brain	NOUN
gsrj-19	13	51	injury	injury	NOUN
gsrj-19	13	52	can	can	AUX
gsrj-19	13	53	play	play	VERB
gsrj-19	13	54	a	a	DET
gsrj-19	13	55	role	role	NOUN
gsrj-19	13	56	in	in	ADP
gsrj-19	13	57	the	the	DET
gsrj-19	13	58	development	development	NOUN
gsrj-19	13	59	of	of	ADP
gsrj-19	13	60	epilepsy	epilepsy	NOUN
gsrj-19	13	61	.	.	PUNCT
gsrj-19	14	1	lastly	lastly	ADV
gsrj-19	14	2	,	,	PUNCT
gsrj-19	14	3	research	research	NOUN
gsrj-19	14	4	has	have	AUX
gsrj-19	14	5	supported	support	VERB
gsrj-19	14	6	links	link	NOUN
gsrj-19	14	7	between	between	ADP
gsrj-19	14	8	epilepsy	epilepsy	NOUN
gsrj-19	14	9	and	and	CCONJ
gsrj-19	14	10	specific	specific	ADJ
gsrj-19	14	11	genes	gene	NOUN
gsrj-19	14	12	in	in	ADP
gsrj-19	14	13	the	the	DET
gsrj-19	14	14	human	human	ADJ
gsrj-19	14	15	genome	genome	NOUN
gsrj-19	14	16	.	.	PUNCT
gsrj-19	15	1	some	some	DET
gsrj-19	15	2	genes	gene	NOUN
gsrj-19	15	3	may	may	AUX
gsrj-19	15	4	contribute	contribute	VERB
gsrj-19	15	5	to	to	ADP
gsrj-19	15	6	making	make	VERB
gsrj-19	15	7	an	an	DET
gsrj-19	15	8	individual	individual	NOUN
gsrj-19	15	9	more	more	ADV
gsrj-19	15	10	susceptible	susceptible	ADJ
gsrj-19	15	11	to	to	ADP
gsrj-19	15	12	environmental	environmental	ADJ
gsrj-19	15	13	conditions	condition	NOUN
gsrj-19	15	14	that	that	PRON
gsrj-19	15	15	might	might	AUX
gsrj-19	15	16	trigger	trigger	VERB
gsrj-19	15	17	seizures	seizure	NOUN
gsrj-19	15	18	,	,	PUNCT
gsrj-19	15	19	making	make	VERB
gsrj-19	15	20	genetic	genetic	ADJ
gsrj-19	15	21	influence	influence	NOUN
gsrj-19	15	22	another	another	DET
gsrj-19	15	23	factor	factor	NOUN
gsrj-19	15	24	in	in	ADP
gsrj-19	15	25	the	the	DET
gsrj-19	15	26	development	development	NOUN
gsrj-19	15	27	of	of	ADP
gsrj-19	15	28	epilepsy.2	epilepsy.2	VERB
gsrj-19	15	29	the	the	DET
gsrj-19	15	30	relationship	relationship	NOUN
gsrj-19	15	31	between	between	ADP
gsrj-19	15	32	genetic	genetic	ADJ
gsrj-19	15	33	influence	influence	NOUN
gsrj-19	15	34	,	,	PUNCT
gsrj-19	15	35	gene	gene	NOUN
gsrj-19	15	36	expression	expression	NOUN
gsrj-19	15	37	,	,	PUNCT
gsrj-19	15	38	and	and	CCONJ
gsrj-19	15	39	protein	protein	NOUN
gsrj-19	15	40	synthesis	synthesis	NOUN
gsrj-19	15	41	has	have	AUX
gsrj-19	15	42	shed	shed	VERB
gsrj-19	15	43	light	light	NOUN
gsrj-19	15	44	on	on	ADP
gsrj-19	15	45	a	a	DET
gsrj-19	15	46	new	new	ADJ
gsrj-19	15	47	protein	protein	NOUN
gsrj-19	15	48	,	,	PUNCT
gsrj-19	15	49	g	g	NOUN
gsrj-19	15	50	-	-	PUNCT
gsrj-19	15	51	protein	protein	NOUN
gsrj-19	15	52	coupled	couple	VERB
gsrj-19	15	53	receptor	receptor	NOUN
gsrj-19	15	54	40	40	NUM
gsrj-19	15	55	(	(	PUNCT
gsrj-19	15	56	gpr40	gpr40	PROPN
gsrj-19	15	57	)	)	PUNCT
gsrj-19	15	58	,	,	PUNCT
gsrj-19	15	59	that	that	PRON
gsrj-19	15	60	is	be	AUX
gsrj-19	15	61	involved	involve	VERB
gsrj-19	15	62	in	in	ADP
gsrj-19	15	63	the	the	DET
gsrj-19	15	64	regulation	regulation	NOUN
gsrj-19	15	65	of	of	ADP
gsrj-19	15	66	epileptic	epileptic	ADJ
gsrj-19	15	67	seizures	seizure	NOUN
gsrj-19	15	68	,	,	PUNCT
gsrj-19	15	69	specifically	specifically	ADV
gsrj-19	15	70	through	through	ADP
gsrj-19	15	71	its	its	PRON
gsrj-19	15	72	role	role	NOUN
gsrj-19	15	73	in	in	ADP
gsrj-19	15	74	regulating	regulate	VERB
gsrj-19	15	75	nmda	nmda	ADJ
gsrj-19	15	76	receptors	receptor	NOUN
gsrj-19	15	77	in	in	ADP
gsrj-19	15	78	the	the	DET
gsrj-19	15	79	central	central	ADJ
gsrj-19	15	80	nervous	nervous	ADJ
gsrj-19	15	81	system.3	system.3	NOUN
gsrj-19	15	82	the	the	DET
gsrj-19	15	83	novel	novel	ADJ
gsrj-19	15	84	study	study	NOUN
gsrj-19	15	85	conducted	conduct	VERB
gsrj-19	15	86	by	by	ADP
gsrj-19	15	87	yang	yang	PROPN
gsrj-19	15	88	et	et	PROPN
gsrj-19	15	89	al	al	PROPN
gsrj-19	15	90	,	,	PUNCT
gsrj-19	15	91	“	"	PUNCT
gsrj-19	15	92	gpr40	gpr40	PROPN
gsrj-19	15	93	modulates	modulate	NOUN
gsrj-19	15	94	epileptic	epileptic	ADJ
gsrj-19	15	95	seizure	seizure	NOUN
gsrj-19	15	96	and	and	CCONJ
gsrj-19	15	97	nmda	nmda	ADJ
gsrj-19	15	98	receptor	receptor	NOUN
gsrj-19	15	99	function	function	NOUN
gsrj-19	15	100	,	,	PUNCT
gsrj-19	15	101	”	"	PUNCT
gsrj-19	15	102	investigated	investigate	VERB
gsrj-19	15	103	the	the	DET
gsrj-19	15	104	impact	impact	NOUN
gsrj-19	15	105	of	of	ADP
gsrj-19	15	106	gpr40	gpr40	PROPN
gsrj-19	15	107	on	on	ADP
gsrj-19	15	108	epileptic	epileptic	ADJ
gsrj-19	15	109	brains	brain	NOUN
gsrj-19	15	110	,	,	PUNCT
gsrj-19	15	111	and	and	CCONJ
gsrj-19	15	112	more	more	ADV
gsrj-19	15	113	specifically	specifically	ADV
gsrj-19	15	114	,	,	PUNCT
gsrj-19	15	115	how	how	SCONJ
gsrj-19	15	116	expression	expression	NOUN
gsrj-19	15	117	of	of	ADP
gsrj-19	15	118	gpr40	gpr40	PROPN
gsrj-19	15	119	affected	affect	VERB
gsrj-19	15	120	nmda	nmda	ADJ
gsrj-19	15	121	receptor	receptor	NOUN
gsrj-19	15	122	function	function	NOUN
gsrj-19	15	123	and	and	CCONJ
gsrj-19	15	124	nmda	nmda	ADJ
gsrj-19	15	125	receptor	receptor	NOUN
gsrj-19	15	126	-	-	PUNCT
gsrj-19	15	127	mediated	mediate	VERB
gsrj-19	15	128	synaptic	synaptic	ADJ
gsrj-19	15	129	transmission	transmission	NOUN
gsrj-19	15	130	.	.	PUNCT
gsrj-19	16	1	this	this	DET
gsrj-19	16	2	study	study	NOUN
gsrj-19	16	3	determined	determine	VERB
gsrj-19	16	4	the	the	DET
gsrj-19	16	5	specific	specific	ADJ
gsrj-19	16	6	localization	localization	NOUN
gsrj-19	16	7	of	of	ADP
gsrj-19	16	8	gpr40	gpr40	PROPN
gsrj-19	16	9	in	in	ADP
gsrj-19	16	10	the	the	DET
gsrj-19	16	11	brain	brain	NOUN
gsrj-19	16	12	and	and	CCONJ
gsrj-19	16	13	central	central	ADJ
gsrj-19	16	14	nervous	nervous	ADJ
gsrj-19	16	15	system	system	NOUN
gsrj-19	16	16	,	,	PUNCT
gsrj-19	16	17	how	how	SCONJ
gsrj-19	16	18	the	the	DET
gsrj-19	16	19	upregulation	upregulation	NOUN
gsrj-19	16	20	of	of	ADP
gsrj-19	16	21	the	the	DET
gsrj-19	16	22	receptor	receptor	NOUN
gsrj-19	16	23	affects	affect	VERB
gsrj-19	16	24	epileptic	epileptic	ADJ
gsrj-19	16	25	seizures	seizure	NOUN
gsrj-19	16	26	,	,	PUNCT
gsrj-19	16	27	and	and	CCONJ
gsrj-19	16	28	how	how	SCONJ
gsrj-19	16	29	nmda	nmda	ADJ
gsrj-19	16	30	receptor	receptor	NOUN
gsrj-19	16	31	mediated	mediate	VERB
gsrj-19	16	32	synaptic	synaptic	ADJ
gsrj-19	16	33	transmission	transmission	NOUN
gsrj-19	16	34	function	function	NOUN
gsrj-19	16	35	is	be	AUX
gsrj-19	16	36	affected	affect	VERB
gsrj-19	16	37	,	,	PUNCT
gsrj-19	16	38	through	through	ADP
gsrj-19	16	39	regulation	regulation	NOUN
gsrj-19	16	40	of	of	ADP
gsrj-19	16	41	specific	specific	ADJ
gsrj-19	16	42	subunits	subunit	NOUN
gsrj-19	16	43	of	of	ADP
gsrj-19	16	44	the	the	DET
gsrj-19	16	45	nmda	nmda	ADJ
gsrj-19	16	46	receptor	receptor	NOUN
gsrj-19	16	47	on	on	ADP
gsrj-19	16	48	the	the	DET
gsrj-19	16	49	postsynaptic	postsynaptic	ADJ
gsrj-19	16	50	neuron.3	neuron.3	NOUN
gsrj-19	16	51	various	various	ADJ
gsrj-19	16	52	antiepileptic	antiepileptic	ADJ
gsrj-19	16	53	drugs	drug	NOUN
gsrj-19	16	54	(	(	PUNCT
gsrj-19	16	55	aeds	aed	NOUN
gsrj-19	16	56	)	)	PUNCT
gsrj-19	16	57	have	have	AUX
gsrj-19	16	58	been	be	AUX
gsrj-19	16	59	synthesized	synthesize	VERB
gsrj-19	16	60	to	to	ADP
gsrj-19	16	61	combat	combat	NOUN
gsrj-19	16	62	seizure	seizure	NOUN
gsrj-19	16	63	activity	activity	NOUN
gsrj-19	16	64	in	in	ADP
gsrj-19	16	65	epileptic	epileptic	ADJ
gsrj-19	16	66	individuals	individual	NOUN
gsrj-19	16	67	.	.	PUNCT
gsrj-19	17	1	a	a	PRON
gsrj-19	17	2	meta	meta	ADJ
gsrj-19	17	3	-	-	PUNCT
gsrj-19	17	4	analysis	analysis	NOUN
gsrj-19	17	5	reviewing	review	VERB
gsrj-19	17	6	the	the	DET
gsrj-19	17	7	efficacy	efficacy	NOUN
gsrj-19	17	8	of	of	ADP
gsrj-19	17	9	11	11	NUM
gsrj-19	17	10	antiepileptic	antiepileptic	ADJ
gsrj-19	17	11	drugs	drug	NOUN
gsrj-19	17	12	administered	administer	VERB
gsrj-19	17	13	to	to	ADP
gsrj-19	17	14	over	over	ADP
gsrj-19	17	15	900	900	NUM
gsrj-19	17	16	patients	patient	NOUN
gsrj-19	17	17	revealed	reveal	VERB
gsrj-19	17	18	that	that	SCONJ
gsrj-19	17	19	pregabalin	pregabalin	NOUN
gsrj-19	17	20	,	,	PUNCT
gsrj-19	17	21	tiagabine	tiagabine	NOUN
gsrj-19	17	22	,	,	PUNCT
gsrj-19	17	23	and	and	CCONJ
gsrj-19	17	24	vigabatrin	vigabatrin	NOUN
gsrj-19	17	25	yielded	yield	VERB
gsrj-19	17	26	the	the	DET
gsrj-19	17	27	most	most	ADV
gsrj-19	17	28	significant	significant	ADJ
gsrj-19	17	29	reductions	reduction	NOUN
gsrj-19	17	30	in	in	ADP
gsrj-19	17	31	seizures	seizure	NOUN
gsrj-19	17	32	(	(	PUNCT
gsrj-19	17	33	>	>	X
gsrj-19	17	34	50%).5	50%).5	NUM
gsrj-19	17	35	however	however	ADV
gsrj-19	17	36	,	,	PUNCT
gsrj-19	17	37	similar	similar	ADJ
gsrj-19	17	38	meta	meta	ADJ
gsrj-19	17	39	-	-	PUNCT
gsrj-19	17	40	studies	study	NOUN
gsrj-19	17	41	have	have	AUX
gsrj-19	17	42	revealed	reveal	VERB
gsrj-19	17	43	alternative	alternative	ADJ
gsrj-19	17	44	drugs	drug	NOUN
gsrj-19	17	45	as	as	ADP
gsrj-19	17	46	the	the	DET
gsrj-19	17	47	most	most	ADV
gsrj-19	17	48	effective	effective	ADJ
gsrj-19	17	49	,	,	PUNCT
gsrj-19	17	50	taking	take	VERB
gsrj-19	17	51	factors	factor	NOUN
gsrj-19	17	52	such	such	ADJ
gsrj-19	17	53	as	as	ADP
gsrj-19	17	54	adverse	adverse	ADJ
gsrj-19	17	55	side	side	NOUN
gsrj-19	17	56	effects	effect	NOUN
gsrj-19	17	57	and	and	CCONJ
gsrj-19	17	58	tolerability	tolerability	NOUN
gsrj-19	17	59	of	of	ADP
gsrj-19	17	60	the	the	DET
gsrj-19	17	61	drugs	drug	NOUN
gsrj-19	17	62	into	into	ADP
gsrj-19	17	63	account	account	NOUN
gsrj-19	17	64	.	.	PUNCT
gsrj-19	18	1	while	while	SCONJ
gsrj-19	18	2	many	many	ADJ
gsrj-19	18	3	of	of	ADP
gsrj-19	18	4	these	these	DET
gsrj-19	18	5	aeds	aed	NOUN
gsrj-19	18	6	have	have	VERB
gsrj-19	18	7	adequate	adequate	ADJ
gsrj-19	18	8	efficacy	efficacy	NOUN
gsrj-19	18	9	,	,	PUNCT
gsrj-19	18	10	30	30	NUM
gsrj-19	18	11	%	%	NOUN
gsrj-19	18	12	of	of	ADP
gsrj-19	18	13	patients	patient	NOUN
gsrj-19	18	14	using	use	VERB
gsrj-19	18	15	these	these	DET
gsrj-19	18	16	drugs	drug	NOUN
gsrj-19	18	17	continue	continue	VERB
gsrj-19	18	18	to	to	PART
gsrj-19	18	19	experience	experience	VERB
gsrj-19	18	20	some	some	DET
gsrj-19	18	21	side	side	NOUN
gsrj-19	18	22	effects	effect	NOUN
gsrj-19	18	23	of	of	ADP
gsrj-19	18	24	the	the	DET
gsrj-19	18	25	treatment	treatment	NOUN
gsrj-19	18	26	,	,	PUNCT
gsrj-19	18	27	including	include	VERB
gsrj-19	18	28	insomnia	insomnia	NOUN
gsrj-19	18	29	,	,	PUNCT
gsrj-19	18	30	depression	depression	NOUN
gsrj-19	18	31	,	,	PUNCT
gsrj-19	18	32	and	and	CCONJ
gsrj-19	18	33	dizziness.3	dizziness.3	VERB
gsrj-19	18	34	these	these	DET
gsrj-19	18	35	antiepileptic	antiepileptic	ADJ
gsrj-19	18	36	drugs	drug	NOUN
gsrj-19	18	37	target	target	VERB
gsrj-19	18	38	neurotransmission	neurotransmission	NOUN
gsrj-19	18	39	,	,	PUNCT
gsrj-19	18	40	specifically	specifically	ADV
gsrj-19	18	41	to	to	PART
gsrj-19	18	42	maintain	maintain	VERB
gsrj-19	18	43	the	the	DET
gsrj-19	18	44	balance	balance	NOUN
gsrj-19	18	45	of	of	ADP
gsrj-19	18	46	excitatory	excitatory	NOUN
gsrj-19	18	47	and	and	CCONJ
gsrj-19	18	48	inhibitory	inhibitory	ADJ
gsrj-19	18	49	neurotransmission	neurotransmission	NOUN
gsrj-19	18	50	that	that	PRON
gsrj-19	18	51	is	be	AUX
gsrj-19	18	52	normally	normally	ADV
gsrj-19	18	53	disrupted	disrupt	VERB
gsrj-19	18	54	in	in	ADP
gsrj-19	18	55	epileptic	epileptic	ADJ
gsrj-19	18	56	brains.3	brains.3	PROPN
gsrj-19	18	57	for	for	ADP
gsrj-19	18	58	the	the	DET
gsrj-19	18	59	development	development	NOUN
gsrj-19	18	60	of	of	ADP
gsrj-19	18	61	a	a	DET
gsrj-19	18	62	more	more	ADV
gsrj-19	18	63	effective	effective	ADJ
gsrj-19	18	64	antiepileptic	antiepileptic	ADJ
gsrj-19	18	65	drug	drug	NOUN
gsrj-19	18	66	that	that	PRON
gsrj-19	18	67	can	can	AUX
gsrj-19	18	68	both	both	PRON
gsrj-19	18	69	treat	treat	VERB
gsrj-19	18	70	and	and	CCONJ
gsrj-19	18	71	limit	limit	VERB
gsrj-19	18	72	the	the	DET
gsrj-19	18	73	side	side	NOUN
gsrj-19	18	74	effects	effect	NOUN
gsrj-19	18	75	of	of	ADP
gsrj-19	18	76	epileptic	epileptic	ADJ
gsrj-19	18	77	seizures	seizure	NOUN
gsrj-19	18	78	,	,	PUNCT
gsrj-19	18	79	many	many	ADJ
gsrj-19	18	80	factors	factor	NOUN
gsrj-19	18	81	must	must	AUX
gsrj-19	18	82	be	be	AUX
gsrj-19	18	83	taken	take	VERB
gsrj-19	18	84	into	into	ADP
gsrj-19	18	85	account	account	NOUN
gsrj-19	18	86	,	,	PUNCT
gsrj-19	18	87	including	include	VERB
gsrj-19	18	88	the	the	DET
gsrj-19	18	89	neurological	neurological	ADJ
gsrj-19	18	90	root	root	NOUN
gsrj-19	18	91	of	of	ADP
gsrj-19	18	92	the	the	DET
gsrj-19	18	93	disorder	disorder	NOUN
gsrj-19	18	94	.	.	PUNCT
gsrj-19	19	1	the	the	DET
gsrj-19	19	2	investigation	investigation	NOUN
gsrj-19	19	3	conducted	conduct	VERB
gsrj-19	19	4	by	by	ADP
gsrj-19	19	5	yang	yang	PROPN
gsrj-19	19	6	et	et	PROPN
gsrj-19	19	7	al	al	PROPN
gsrj-19	19	8	.	.	PROPN
gsrj-19	19	9	aims	aim	VERB
gsrj-19	19	10	to	to	PART
gsrj-19	19	11	obtain	obtain	VERB
gsrj-19	19	12	a	a	DET
gsrj-19	19	13	deeper	deep	ADJ
gsrj-19	19	14	understanding	understanding	NOUN
gsrj-19	19	15	of	of	ADP
gsrj-19	19	16	the	the	DET
gsrj-19	19	17	root	root	NOUN
gsrj-19	19	18	cause	cause	NOUN
gsrj-19	19	19	of	of	ADP
gsrj-19	19	20	epileptic	epileptic	ADJ
gsrj-19	19	21	seizures	seizure	NOUN
gsrj-19	19	22	and	and	CCONJ
gsrj-19	19	23	the	the	DET
gsrj-19	19	24	onset	onset	NOUN
gsrj-19	19	25	of	of	ADP
gsrj-19	19	26	epilepsy.3	epilepsy.3	NOUN
gsrj-19	19	27	these	these	DET
gsrj-19	19	28	studies	study	NOUN
gsrj-19	19	29	may	may	AUX
gsrj-19	19	30	contribute	contribute	VERB
gsrj-19	19	31	to	to	ADP
gsrj-19	19	32	the	the	DET
gsrj-19	19	33	future	future	ADJ
gsrj-19	19	34	development	development	NOUN
gsrj-19	19	35	of	of	ADP
gsrj-19	19	36	a	a	DET
gsrj-19	19	37	more	more	ADV
gsrj-19	19	38	effective	effective	ADJ
gsrj-19	19	39	cure	cure	NOUN
gsrj-19	19	40	for	for	ADP
gsrj-19	19	41	this	this	DET
gsrj-19	19	42	chronic	chronic	ADJ
gsrj-19	19	43	neurological	neurological	ADJ
gsrj-19	19	44	condition	condition	NOUN
gsrj-19	19	45	.	.	PUNCT
gsrj-19	20	1	as	as	SCONJ
gsrj-19	20	2	aforementioned	aforementione	VERB
gsrj-19	20	3	,	,	PUNCT
gsrj-19	20	4	epilepsy	epilepsy	PROPN
gsrj-19	20	5	is	be	AUX
gsrj-19	20	6	characterized	characterize	VERB
gsrj-19	20	7	by	by	ADP
gsrj-19	20	8	excessive	excessive	ADJ
gsrj-19	20	9	and	and	CCONJ
gsrj-19	20	10	abnormal	abnormal	ADJ
gsrj-19	20	11	neuronal	neuronal	ADJ
gsrj-19	20	12	activity	activity	NOUN
gsrj-19	20	13	.	.	PUNCT
gsrj-19	21	1	the	the	DET
gsrj-19	21	2	precise	precise	ADJ
gsrj-19	21	3	mechanism	mechanism	NOUN
gsrj-19	21	4	is	be	AUX
gsrj-19	21	5	yet	yet	ADV
gsrj-19	21	6	to	to	PART
gsrj-19	21	7	be	be	AUX
gsrj-19	21	8	discovered	discover	VERB
gsrj-19	21	9	as	as	SCONJ
gsrj-19	21	10	epilepsy	epilepsy	NOUN
gsrj-19	21	11	is	be	AUX
gsrj-19	21	12	known	know	VERB
gsrj-19	21	13	to	to	PART
gsrj-19	21	14	have	have	VERB
gsrj-19	21	15	multiple	multiple	ADJ
gsrj-19	21	16	pathophysiological	pathophysiological	ADJ
gsrj-19	21	17	causes	cause	NOUN
gsrj-19	21	18	including	include	VERB
gsrj-19	21	19	genetic	genetic	ADJ
gsrj-19	21	20	mutation	mutation	NOUN
gsrj-19	21	21	,	,	PUNCT
gsrj-19	21	22	traumatic	traumatic	ADJ
gsrj-19	21	23	brain	brain	NOUN
gsrj-19	21	24	injury	injury	NOUN
gsrj-19	21	25	,	,	PUNCT
gsrj-19	21	26	and	and	CCONJ
gsrj-19	21	27	exposure	exposure	NOUN
gsrj-19	21	28	to	to	ADP
gsrj-19	21	29	toxins	toxin	NOUN
gsrj-19	21	30	.	.	PUNCT
gsrj-19	22	1	however	however	ADV
gsrj-19	22	2	,	,	PUNCT
gsrj-19	22	3	the	the	DET
gsrj-19	22	4	imbalance	imbalance	NOUN
gsrj-19	22	5	of	of	ADP
gsrj-19	22	6	excitatory	excitatory	NOUN
gsrj-19	22	7	and	and	CCONJ
gsrj-19	22	8	inhibitory	inhibitory	ADJ
gsrj-19	22	9	neurotransmitters	neurotransmitter	NOUN
gsrj-19	22	10	is	be	AUX
gsrj-19	22	11	understood	understand	VERB
gsrj-19	22	12	as	as	ADP
gsrj-19	22	13	the	the	DET
gsrj-19	22	14	most	most	ADV
gsrj-19	22	15	common	common	ADJ
gsrj-19	22	16	mechanism	mechanism	NOUN
gsrj-19	22	17	of	of	ADP
gsrj-19	22	18	various	various	ADJ
gsrj-19	22	19	epileptic	epileptic	ADJ
gsrj-19	22	20	seizures.6	seizures.6	NOUN
gsrj-19	22	21	to	to	PART
gsrj-19	22	22	elaborate	elaborate	VERB
gsrj-19	22	23	,	,	PUNCT
gsrj-19	22	24	seizures	seizure	NOUN
gsrj-19	22	25	are	be	AUX
gsrj-19	22	26	often	often	ADV
gsrj-19	22	27	the	the	DET
gsrj-19	22	28	result	result	NOUN
gsrj-19	22	29	of	of	ADP
gsrj-19	22	30	sudden	sudden	ADJ
gsrj-19	22	31	synchronized	synchronize	VERB
gsrj-19	22	32	neuronal	neuronal	ADJ
gsrj-19	22	33	signaling	signaling	NOUN
gsrj-19	22	34	and	and	CCONJ
gsrj-19	22	35	changes	change	NOUN
gsrj-19	22	36	in	in	ADP
gsrj-19	22	37	inhibitory	inhibitory	ADJ
gsrj-19	22	38	and	and	CCONJ
gsrj-19	22	39	excitatory	excitatory	ADJ
gsrj-19	22	40	stimulation	stimulation	NOUN
gsrj-19	22	41	.	.	PUNCT
gsrj-19	23	1	many	many	ADJ
gsrj-19	23	2	neurotransmitters	neurotransmitter	NOUN
gsrj-19	23	3	and	and	CCONJ
gsrj-19	23	4	hormones	hormone	NOUN
gsrj-19	23	5	such	such	ADJ
gsrj-19	23	6	as	as	ADP
gsrj-19	23	7	serotonin	serotonin	NOUN
gsrj-19	23	8	,	,	PUNCT
gsrj-19	23	9	norepinephrine	norepinephrine	NOUN
gsrj-19	23	10	,	,	PUNCT
gsrj-19	23	11	histamine	histamine	NOUN
gsrj-19	23	12	,	,	PUNCT
gsrj-19	23	13	are	be	AUX
gsrj-19	23	14	involved	involve	VERB
gsrj-19	23	15	in	in	ADP
gsrj-19	23	16	epilepsy.7	epilepsy.7	NOUN
gsrj-19	23	17	gamma	gamma	NOUN
gsrj-19	23	18	-	-	PUNCT
gsrj-19	23	19	aminobutyric	aminobutyric	ADJ
gsrj-19	23	20	acid	acid	NOUN
gsrj-19	23	21	(	(	PUNCT
gsrj-19	23	22	gaba	gaba	PROPN
gsrj-19	23	23	)	)	PUNCT
gsrj-19	23	24	and	and	CCONJ
gsrj-19	23	25	nicotinic	nicotinic	ADJ
gsrj-19	23	26	acetylcholine	acetylcholine	NOUN
gsrj-19	23	27	(	(	PUNCT
gsrj-19	23	28	ach	ach	NOUN
gsrj-19	23	29	)	)	PUNCT
gsrj-19	23	30	receptors	receptor	NOUN
gsrj-19	23	31	,	,	PUNCT
gsrj-19	23	32	in	in	ADP
gsrj-19	23	33	particular	particular	ADJ
gsrj-19	23	34	,	,	PUNCT
gsrj-19	23	35	have	have	AUX
gsrj-19	23	36	been	be	AUX
gsrj-19	23	37	implicated	implicate	VERB
gsrj-19	23	38	.	.	PUNCT
gsrj-19	24	1	mutations	mutation	NOUN
gsrj-19	24	2	in	in	ADP
gsrj-19	24	3	gaba	gaba	NOUN
gsrj-19	24	4	receptors	receptor	NOUN
gsrj-19	24	5	have	have	AUX
gsrj-19	24	6	been	be	AUX
gsrj-19	24	7	shown	show	VERB
gsrj-19	24	8	to	to	PART
gsrj-19	24	9	cause	cause	VERB
gsrj-19	24	10	er	er	INTJ
gsrj-19	24	11	stress	stress	NOUN
gsrj-19	24	12	and	and	CCONJ
gsrj-19	24	13	ion	ion	NOUN
gsrj-19	24	14	imbalance	imbalance	NOUN
gsrj-19	24	15	,	,	PUNCT
gsrj-19	24	16	contributing	contribute	VERB
gsrj-19	24	17	to	to	ADP
gsrj-19	24	18	epileptogenesis	epileptogenesis	NOUN
gsrj-19	24	19	.	.	PUNCT
gsrj-19	25	1	additionally	additionally	ADV
gsrj-19	25	2	,	,	PUNCT
gsrj-19	25	3	dysfunctional	dysfunctional	ADJ
gsrj-19	25	4	acetylcholine	acetylcholine	NOUN
gsrj-19	25	5	signaling	signaling	NOUN
gsrj-19	25	6	has	have	AUX
gsrj-19	25	7	been	be	AUX
gsrj-19	25	8	shown	show	VERB
gsrj-19	25	9	to	to	PART
gsrj-19	25	10	aggravate	aggravate	VERB
gsrj-19	25	11	inflammation	inflammation	NOUN
gsrj-19	25	12	,	,	PUNCT
gsrj-19	25	13	a	a	DET
gsrj-19	25	14	key	key	ADJ
gsrj-19	25	15	feature	feature	NOUN
gsrj-19	25	16	of	of	ADP
gsrj-19	25	17	epilepsy.7	epilepsy.7	NOUN
gsrj-19	25	18	although	although	SCONJ
gsrj-19	25	19	epilepsy	epilepsy	NOUN
gsrj-19	25	20	can	can	AUX
gsrj-19	25	21	occur	occur	VERB
gsrj-19	25	22	in	in	ADP
gsrj-19	25	23	any	any	DET
gsrj-19	25	24	region	region	NOUN
gsrj-19	25	25	of	of	ADP
gsrj-19	25	26	the	the	DET
gsrj-19	25	27	brain	brain	NOUN
gsrj-19	25	28	,	,	PUNCT
gsrj-19	25	29	it	it	PRON
gsrj-19	25	30	is	be	AUX
gsrj-19	25	31	known	know	VERB
gsrj-19	25	32	to	to	PART
gsrj-19	25	33	affect	affect	VERB
gsrj-19	25	34	the	the	DET
gsrj-19	25	35	frontal	frontal	ADJ
gsrj-19	25	36	lobe	lobe	NOUN
gsrj-19	25	37	and	and	CCONJ
gsrj-19	25	38	the	the	DET
gsrj-19	25	39	temporal	temporal	ADJ
gsrj-19	25	40	lobe	lobe	VERB
gsrj-19	25	41	most	most	ADV
gsrj-19	25	42	commonly	commonly	ADV
gsrj-19	25	43	,	,	PUNCT
gsrj-19	25	44	particularly	particularly	ADV
gsrj-19	25	45	the	the	DET
gsrj-19	25	46	hippocampus.8	hippocampus.8	PROPN
gsrj-19	25	47	therefore	therefore	ADV
gsrj-19	25	48	,	,	PUNCT
gsrj-19	25	49	studying	study	VERB
gsrj-19	25	50	the	the	DET
gsrj-19	25	51	regulatory	regulatory	ADJ
gsrj-19	25	52	mechanisms	mechanism	NOUN
gsrj-19	25	53	of	of	ADP
gsrj-19	25	54	neurotransmitters	neurotransmitter	NOUN
gsrj-19	25	55	in	in	ADP
gsrj-19	25	56	cortical	cortical	ADJ
gsrj-19	25	57	and	and	CCONJ
gsrj-19	25	58	hippocampal	hippocampal	ADJ
gsrj-19	25	59	regions	region	NOUN
gsrj-19	25	60	of	of	ADP
gsrj-19	25	61	the	the	DET
gsrj-19	25	62	brain	brain	NOUN
gsrj-19	25	63	is	be	AUX
gsrj-19	25	64	important	important	ADJ
gsrj-19	25	65	in	in	ADP
gsrj-19	25	66	furthering	further	VERB
gsrj-19	25	67	our	our	PRON
gsrj-19	25	68	understanding	understanding	NOUN
gsrj-19	25	69	of	of	ADP
gsrj-19	25	70	epilepsy	epilepsy	NOUN
gsrj-19	25	71	.	.	PUNCT
gsrj-19	26	1	interestingly	interestingly	ADV
gsrj-19	26	2	,	,	PUNCT
gsrj-19	26	3	recent	recent	ADJ
gsrj-19	26	4	studies	study	NOUN
gsrj-19	26	5	have	have	AUX
gsrj-19	26	6	found	find	VERB
gsrj-19	26	7	that	that	SCONJ
gsrj-19	26	8	gpr40	gpr40	PROPN
gsrj-19	26	9	plays	play	VERB
gsrj-19	26	10	a	a	DET
gsrj-19	26	11	role	role	NOUN
gsrj-19	26	12	in	in	ADP
gsrj-19	26	13	modulating	modulate	VERB
gsrj-19	26	14	synaptic	synaptic	ADJ
gsrj-19	26	15	transmission	transmission	NOUN
gsrj-19	26	16	,	,	PUNCT
gsrj-19	26	17	especially	especially	ADV
gsrj-19	26	18	in	in	ADP
gsrj-19	26	19	the	the	DET
gsrj-19	26	20	cortex	cortex	NOUN
gsrj-19	26	21	and	and	CCONJ
gsrj-19	26	22	hippocampus.3	hippocampus.3	PROPN
gsrj-19	26	23	therefore	therefore	ADV
gsrj-19	26	24	,	,	PUNCT
gsrj-19	26	25	the	the	DET
gsrj-19	26	26	yang	yang	PROPN
gsrj-19	26	27	et	et	PROPN
gsrj-19	26	28	al	al	PROPN
gsrj-19	26	29	.	.	PROPN
gsrj-19	26	30	study	study	PROPN
gsrj-19	26	31	21	21	NUM
gsrj-19	26	32	georgetown	georgetown	PROPN
gsrj-19	26	33	scientific	scientific	PROPN
gsrj-19	26	34	research	research	NOUN
gsrj-19	26	35	journal	journal	NOUN
gsrj-19	26	36	was	be	AUX
gsrj-19	26	37	set	set	VERB
gsrj-19	26	38	out	out	ADP
gsrj-19	26	39	to	to	PART
gsrj-19	26	40	investigate	investigate	VERB
gsrj-19	26	41	the	the	DET
gsrj-19	26	42	role	role	NOUN
gsrj-19	26	43	of	of	ADP
gsrj-19	26	44	gpr40	gpr40	PROPN
gsrj-19	26	45	in	in	ADP
gsrj-19	26	46	epileptic	epileptic	ADJ
gsrj-19	26	47	seizure.3	seizure.3	ADP
gsrj-19	26	48	2	2	NUM
gsrj-19	26	49	.	.	PUNCT
gsrj-19	26	50	description	description	NOUN
gsrj-19	26	51	of	of	ADP
gsrj-19	26	52	gpr40	gpr40	PROPN
gsrj-19	26	53	involvement	involvement	NOUN
gsrj-19	26	54	in	in	ADP
gsrj-19	26	55	regions	region	NOUN
gsrj-19	26	56	of	of	ADP
gsrj-19	26	57	the	the	DET
gsrj-19	26	58	brain	brain	NOUN
gsrj-19	26	59	while	while	SCONJ
gsrj-19	26	60	previous	previous	ADJ
gsrj-19	26	61	studies	study	NOUN
gsrj-19	26	62	have	have	AUX
gsrj-19	26	63	shown	show	VERB
gsrj-19	26	64	that	that	SCONJ
gsrj-19	26	65	gpr40	gpr40	PROPN
gsrj-19	26	66	is	be	AUX
gsrj-19	26	67	expressed	express	VERB
gsrj-19	26	68	in	in	ADP
gsrj-19	26	69	the	the	DET
gsrj-19	26	70	cortex	cortex	NOUN
gsrj-19	26	71	and	and	CCONJ
gsrj-19	26	72	hippocampus	hippocampus	NOUN
gsrj-19	26	73	,	,	PUNCT
gsrj-19	26	74	the	the	DET
gsrj-19	26	75	precise	precise	ADJ
gsrj-19	26	76	distribution	distribution	NOUN
gsrj-19	26	77	and	and	CCONJ
gsrj-19	26	78	expression	expression	NOUN
gsrj-19	26	79	levels	level	NOUN
gsrj-19	26	80	are	be	AUX
gsrj-19	26	81	poorly	poorly	ADV
gsrj-19	26	82	understood.9	understood.9	ADP
gsrj-19	26	83	the	the	DET
gsrj-19	26	84	novel	novel	ADJ
gsrj-19	26	85	study	study	NOUN
gsrj-19	26	86	by	by	ADP
gsrj-19	26	87	yang	yang	PROPN
gsrj-19	26	88	et	et	PROPN
gsrj-19	26	89	al	al	PROPN
gsrj-19	26	90	.	.	PROPN
gsrj-19	26	91	,	,	PUNCT
gsrj-19	26	92	demonstrated	demonstrate	VERB
gsrj-19	26	93	the	the	DET
gsrj-19	26	94	distribution	distribution	NOUN
gsrj-19	26	95	and	and	CCONJ
gsrj-19	26	96	expression	expression	NOUN
gsrj-19	26	97	levels	level	NOUN
gsrj-19	26	98	of	of	ADP
gsrj-19	26	99	gpr40	gpr40	PROPN
gsrj-19	26	100	in	in	ADP
gsrj-19	26	101	both	both	CCONJ
gsrj-19	26	102	normal	normal	ADJ
gsrj-19	26	103	and	and	CCONJ
gsrj-19	26	104	epileptic	epileptic	ADJ
gsrj-19	26	105	rodent	rodent	ADJ
gsrj-19	26	106	brains	brain	NOUN
gsrj-19	26	107	through	through	ADP
gsrj-19	26	108	immunofluorescence	immunofluorescence	NOUN
gsrj-19	26	109	staining.3	staining.3	PROPN
gsrj-19	26	110	this	this	DET
gsrj-19	26	111	methodology	methodology	NOUN
gsrj-19	26	112	revealed	reveal	VERB
gsrj-19	26	113	that	that	SCONJ
gsrj-19	26	114	gpr40	gpr40	PROPN
gsrj-19	26	115	was	be	AUX
gsrj-19	26	116	highly	highly	ADV
gsrj-19	26	117	expressed	express	VERB
gsrj-19	26	118	in	in	ADP
gsrj-19	26	119	the	the	DET
gsrj-19	26	120	lacunosum	lacunosum	ADJ
gsrj-19	26	121	moleculare	moleculare	NOUN
gsrj-19	26	122	layer	layer	NOUN
gsrj-19	26	123	and	and	CCONJ
gsrj-19	26	124	the	the	DET
gsrj-19	26	125	pyramidal	pyramidal	ADJ
gsrj-19	26	126	cell	cell	NOUN
gsrj-19	26	127	layer	layer	NOUN
gsrj-19	26	128	of	of	ADP
gsrj-19	26	129	the	the	DET
gsrj-19	26	130	hippocampus	hippocampus	NOUN
gsrj-19	26	131	,	,	PUNCT
gsrj-19	26	132	while	while	SCONJ
gsrj-19	26	133	it	it	PRON
gsrj-19	26	134	was	be	AUX
gsrj-19	26	135	not	not	PART
gsrj-19	26	136	highly	highly	ADV
gsrj-19	26	137	expressed	express	VERB
gsrj-19	26	138	in	in	ADP
gsrj-19	26	139	the	the	DET
gsrj-19	26	140	dentate	dentate	ADJ
gsrj-19	26	141	gyrus	gyrus	NOUN
gsrj-19	26	142	.	.	PUNCT
gsrj-19	27	1	the	the	DET
gsrj-19	27	2	study	study	NOUN
gsrj-19	27	3	further	far	ADV
gsrj-19	27	4	evaluated	evaluate	VERB
gsrj-19	27	5	the	the	DET
gsrj-19	27	6	cellular	cellular	ADJ
gsrj-19	27	7	level	level	NOUN
gsrj-19	27	8	localization	localization	NOUN
gsrj-19	27	9	of	of	ADP
gsrj-19	27	10	gpr40	gpr40	PROPN
gsrj-19	27	11	from	from	ADP
gsrj-19	27	12	a	a	DET
gsrj-19	27	13	kainic	kainic	ADJ
gsrj-19	27	14	acid	acid	NOUN
gsrj-19	27	15	(	(	PUNCT
gsrj-19	27	16	ka	ka	NOUN
gsrj-19	27	17	)	)	PUNCT
gsrj-19	27	18	induced	induce	VERB
gsrj-19	27	19	temporal	temporal	ADJ
gsrj-19	27	20	lobe	lobe	NOUN
gsrj-19	27	21	epilepsy	epilepsy	NOUN
gsrj-19	27	22	(	(	PUNCT
gsrj-19	27	23	tle	tle	NOUN
gsrj-19	27	24	)	)	PUNCT
gsrj-19	27	25	model	model	NOUN
gsrj-19	27	26	and	and	CCONJ
gsrj-19	27	27	normal	normal	ADJ
gsrj-19	27	28	control	control	NOUN
gsrj-19	27	29	brain	brain	NOUN
gsrj-19	27	30	.	.	PUNCT
gsrj-19	28	1	gpr40	gpr40	PROPN
gsrj-19	28	2	was	be	AUX
gsrj-19	28	3	colocalized	colocalize	VERB
gsrj-19	28	4	with	with	ADP
gsrj-19	28	5	microtubuleassociated	microtubuleassociate	VERB
gsrj-19	28	6	protein	protein	NOUN
gsrj-19	28	7	2	2	NUM
gsrj-19	28	8	(	(	PUNCT
gsrj-19	28	9	map2	map2	PROPN
gsrj-19	28	10	;	;	PUNCT
gsrj-19	28	11	a	a	DET
gsrj-19	28	12	marker	marker	NOUN
gsrj-19	28	13	of	of	ADP
gsrj-19	28	14	dendrites	dendrite	NOUN
gsrj-19	28	15	)	)	PUNCT
gsrj-19	28	16	and	and	CCONJ
gsrj-19	28	17	postsynaptic	postsynaptic	ADJ
gsrj-19	28	18	density-95	density-95	PROPN
gsrj-19	28	19	(	(	PUNCT
gsrj-19	28	20	psd95	psd95	NOUN
gsrj-19	28	21	;	;	PUNCT
gsrj-19	28	22	a	a	DET
gsrj-19	28	23	postsynaptic	postsynaptic	ADJ
gsrj-19	28	24	marker	marker	NOUN
gsrj-19	28	25	)	)	PUNCT
gsrj-19	28	26	but	but	CCONJ
gsrj-19	28	27	not	not	PART
gsrj-19	28	28	with	with	ADP
gsrj-19	28	29	glial	glial	ADJ
gsrj-19	28	30	fibrillary	fibrillary	ADJ
gsrj-19	28	31	acidic	acidic	ADJ
gsrj-19	28	32	protein	protein	NOUN
gsrj-19	28	33	(	(	PUNCT
gsrj-19	28	34	gfap	gfap	ADJ
gsrj-19	28	35	;	;	PUNCT
gsrj-19	28	36	an	an	DET
gsrj-19	28	37	astrocyte	astrocyte	NOUN
gsrj-19	28	38	marker	marker	NOUN
gsrj-19	28	39	)	)	PUNCT
gsrj-19	28	40	in	in	ADP
gsrj-19	28	41	the	the	DET
gsrj-19	28	42	hippocampus	hippocampus	NOUN
gsrj-19	28	43	of	of	ADP
gsrj-19	28	44	both	both	CCONJ
gsrj-19	28	45	the	the	DET
gsrj-19	28	46	epileptic	epileptic	ADJ
gsrj-19	28	47	brain	brain	NOUN
gsrj-19	28	48	and	and	CCONJ
gsrj-19	28	49	normal	normal	ADJ
gsrj-19	28	50	control	control	NOUN
gsrj-19	28	51	brain.3	brain.3	PROPN
gsrj-19	28	52	these	these	DET
gsrj-19	28	53	results	result	NOUN
gsrj-19	28	54	suggested	suggest	VERB
gsrj-19	28	55	that	that	SCONJ
gsrj-19	28	56	gpr40	gpr40	PROPN
gsrj-19	28	57	is	be	AUX
gsrj-19	28	58	mostly	mostly	ADV
gsrj-19	28	59	expressed	express	VERB
gsrj-19	28	60	in	in	ADP
gsrj-19	28	61	postsynaptic	postsynaptic	ADJ
gsrj-19	28	62	excitatory	excitatory	NOUN
gsrj-19	28	63	neurons	neuron	NOUN
gsrj-19	28	64	but	but	CCONJ
gsrj-19	28	65	not	not	PART
gsrj-19	28	66	in	in	ADP
gsrj-19	28	67	astrocytes.3	astrocytes.3	NOUN
gsrj-19	28	68	expression	expression	NOUN
gsrj-19	28	69	levels	level	NOUN
gsrj-19	28	70	of	of	ADP
gsrj-19	28	71	gpr40	gpr40	PROPN
gsrj-19	28	72	in	in	ADP
gsrj-19	28	73	the	the	DET
gsrj-19	28	74	hippocampus	hippocampus	NOUN
gsrj-19	28	75	of	of	ADP
gsrj-19	28	76	epileptic	epileptic	ADJ
gsrj-19	28	77	and	and	CCONJ
gsrj-19	28	78	nonepileptic	nonepileptic	ADJ
gsrj-19	28	79	tissues	tissue	NOUN
gsrj-19	28	80	were	be	AUX
gsrj-19	28	81	compared	compare	VERB
gsrj-19	28	82	to	to	PART
gsrj-19	28	83	validate	validate	VERB
gsrj-19	28	84	that	that	SCONJ
gsrj-19	28	85	grp40	grp40	PROPN
gsrj-19	28	86	expression	expression	NOUN
gsrj-19	28	87	is	be	AUX
gsrj-19	28	88	meaningfully	meaningfully	ADV
gsrj-19	28	89	correlated	correlate	VERB
gsrj-19	28	90	with	with	ADP
gsrj-19	28	91	epilepsy	epilepsy	NOUN
gsrj-19	28	92	.	.	PUNCT
gsrj-19	29	1	immunofluorescence	immunofluorescence	NOUN
gsrj-19	29	2	signals	signal	NOUN
gsrj-19	29	3	of	of	ADP
gsrj-19	29	4	gpr40	gpr40	PROPN
gsrj-19	29	5	were	be	AUX
gsrj-19	29	6	significantly	significantly	ADV
gsrj-19	29	7	increased	increase	VERB
gsrj-19	29	8	in	in	ADP
gsrj-19	29	9	the	the	DET
gsrj-19	29	10	ca1	ca1	PROPN
gsrj-19	29	11	hippocampal	hippocampal	PROPN
gsrj-19	29	12	region	region	NOUN
gsrj-19	29	13	of	of	ADP
gsrj-19	29	14	the	the	DET
gsrj-19	29	15	epileptic	epileptic	ADJ
gsrj-19	29	16	rodent	rodent	ADJ
gsrj-19	29	17	brain	brain	NOUN
gsrj-19	29	18	model	model	NOUN
gsrj-19	29	19	compared	compare	VERB
gsrj-19	29	20	to	to	ADP
gsrj-19	29	21	those	those	PRON
gsrj-19	29	22	of	of	ADP
gsrj-19	29	23	the	the	DET
gsrj-19	29	24	nonepileptic	nonepileptic	ADJ
gsrj-19	29	25	control	control	NOUN
gsrj-19	29	26	mice	mouse	NOUN
gsrj-19	29	27	.	.	PUNCT
gsrj-19	30	1	consistent	consistent	ADJ
gsrj-19	30	2	with	with	ADP
gsrj-19	30	3	this	this	DET
gsrj-19	30	4	mouse	mouse	NOUN
gsrj-19	30	5	model	model	NOUN
gsrj-19	30	6	,	,	PUNCT
gsrj-19	30	7	high	high	ADJ
gsrj-19	30	8	gpr40	gpr40	PROPN
gsrj-19	30	9	expression	expression	NOUN
gsrj-19	30	10	was	be	AUX
gsrj-19	30	11	observed	observe	VERB
gsrj-19	30	12	in	in	ADP
gsrj-19	30	13	the	the	DET
gsrj-19	30	14	human	human	ADJ
gsrj-19	30	15	neocortex	neocortex	NOUN
gsrj-19	30	16	of	of	ADP
gsrj-19	30	17	tle	tle	NOUN
gsrj-19	30	18	patients	patient	NOUN
gsrj-19	30	19	.	.	PUNCT
gsrj-19	31	1	in	in	ADP
gsrj-19	31	2	the	the	DET
gsrj-19	31	3	study	study	NOUN
gsrj-19	31	4	,	,	PUNCT
gsrj-19	31	5	the	the	DET
gsrj-19	31	6	team	team	NOUN
gsrj-19	31	7	conducted	conduct	VERB
gsrj-19	31	8	a	a	DET
gsrj-19	31	9	western	western	ADJ
gsrj-19	31	10	blot	blot	NOUN
gsrj-19	31	11	experiment	experiment	NOUN
gsrj-19	31	12	to	to	PART
gsrj-19	31	13	further	far	ADV
gsrj-19	31	14	validate	validate	VERB
gsrj-19	31	15	that	that	SCONJ
gsrj-19	31	16	gpr40	gpr40	ADJ
gsrj-19	31	17	protein	protein	NOUN
gsrj-19	31	18	expression	expression	NOUN
gsrj-19	31	19	increased	increase	VERB
gsrj-19	31	20	in	in	ADP
gsrj-19	31	21	epileptic	epileptic	ADJ
gsrj-19	31	22	rodent	rodent	ADJ
gsrj-19	31	23	brain	brain	NOUN
gsrj-19	31	24	models	model	NOUN
gsrj-19	31	25	compared	compare	VERB
gsrj-19	31	26	to	to	ADP
gsrj-19	31	27	normal	normal	ADJ
gsrj-19	31	28	control	control	NOUN
gsrj-19	31	29	brains	brain	NOUN
gsrj-19	31	30	.	.	PUNCT
gsrj-19	32	1	congruent	congruent	ADJ
gsrj-19	32	2	with	with	ADP
gsrj-19	32	3	the	the	DET
gsrj-19	32	4	previous	previous	ADJ
gsrj-19	32	5	results	result	NOUN
gsrj-19	32	6	,	,	PUNCT
gsrj-19	32	7	the	the	DET
gsrj-19	32	8	epileptic	epileptic	ADJ
gsrj-19	32	9	brain	brain	NOUN
gsrj-19	32	10	models	model	NOUN
gsrj-19	32	11	showed	show	VERB
gsrj-19	32	12	significantly	significantly	ADV
gsrj-19	32	13	higher	high	ADJ
gsrj-19	32	14	gpr40	gpr40	ADJ
gsrj-19	32	15	expression	expression	NOUN
gsrj-19	32	16	in	in	ADP
gsrj-19	32	17	the	the	DET
gsrj-19	32	18	cortex	cortex	NOUN
gsrj-19	32	19	and	and	CCONJ
gsrj-19	32	20	hippocampus	hippocampus	NOUN
gsrj-19	32	21	compared	compare	VERB
gsrj-19	32	22	to	to	ADP
gsrj-19	32	23	the	the	DET
gsrj-19	32	24	control.3	control.3	NOUN
gsrj-19	32	25	elevated	elevate	VERB
gsrj-19	32	26	gpr40	gpr40	PROPN
gsrj-19	32	27	levels	level	NOUN
gsrj-19	32	28	in	in	ADP
gsrj-19	32	29	epileptic	epileptic	ADJ
gsrj-19	32	30	brains	brain	NOUN
gsrj-19	32	31	suggest	suggest	VERB
gsrj-19	32	32	a	a	DET
gsrj-19	32	33	possible	possible	ADJ
gsrj-19	32	34	role	role	NOUN
gsrj-19	32	35	of	of	ADP
gsrj-19	32	36	gpr40	gpr40	PROPN
gsrj-19	32	37	in	in	ADP
gsrj-19	32	38	modulating	modulate	VERB
gsrj-19	32	39	epilepsy	epilepsy	NOUN
gsrj-19	32	40	.	.	PUNCT
gsrj-19	33	1	therefore	therefore	ADV
gsrj-19	33	2	,	,	PUNCT
gsrj-19	33	3	the	the	DET
gsrj-19	33	4	experiments	experiment	NOUN
gsrj-19	33	5	suggest	suggest	VERB
gsrj-19	33	6	that	that	SCONJ
gsrj-19	33	7	gpr40	gpr40	PROPN
gsrj-19	33	8	may	may	AUX
gsrj-19	33	9	be	be	AUX
gsrj-19	33	10	involved	involve	VERB
gsrj-19	33	11	in	in	ADP
gsrj-19	33	12	epilepsy	epilepsy	NOUN
gsrj-19	33	13	.	.	PUNCT
gsrj-19	34	1	however	however	ADV
gsrj-19	34	2	,	,	PUNCT
gsrj-19	34	3	further	further	ADJ
gsrj-19	34	4	experiments	experiment	NOUN
gsrj-19	34	5	must	must	AUX
gsrj-19	34	6	be	be	AUX
gsrj-19	34	7	conducted	conduct	VERB
gsrj-19	34	8	in	in	ADP
gsrj-19	34	9	order	order	NOUN
gsrj-19	34	10	to	to	PART
gsrj-19	34	11	discover	discover	VERB
gsrj-19	34	12	the	the	DET
gsrj-19	34	13	direct	direct	ADJ
gsrj-19	34	14	relationship	relationship	NOUN
gsrj-19	34	15	between	between	ADP
gsrj-19	34	16	gpr40	gpr40	PROPN
gsrj-19	34	17	and	and	CCONJ
gsrj-19	34	18	epilepsy	epilepsy	NOUN
gsrj-19	34	19	.	.	PUNCT
gsrj-19	35	1	if	if	SCONJ
gsrj-19	35	2	gpr40	gpr40	PROPN
gsrj-19	35	3	directly	directly	ADV
gsrj-19	35	4	downregulates	downregulate	VERB
gsrj-19	35	5	or	or	CCONJ
gsrj-19	35	6	upregulates	upregulate	VERB
gsrj-19	35	7	epileptic	epileptic	ADJ
gsrj-19	35	8	seizures	seizure	NOUN
gsrj-19	35	9	,	,	PUNCT
gsrj-19	35	10	then	then	ADV
gsrj-19	35	11	it	it	PRON
gsrj-19	35	12	is	be	AUX
gsrj-19	35	13	crucial	crucial	ADJ
gsrj-19	35	14	to	to	PART
gsrj-19	35	15	further	far	ADV
gsrj-19	35	16	study	study	VERB
gsrj-19	35	17	its	its	PRON
gsrj-19	35	18	regulatory	regulatory	ADJ
gsrj-19	35	19	mechanisms	mechanism	NOUN
gsrj-19	35	20	and	and	CCONJ
gsrj-19	35	21	signaling	signal	VERB
gsrj-19	35	22	pathway	pathway	NOUN
gsrj-19	35	23	.	.	PUNCT
gsrj-19	36	1	3	3	X
gsrj-19	36	2	.	.	X
gsrj-19	36	3	nmdar	nmdar	ADV
gsrj-19	36	4	-	-	PUNCT
gsrj-19	36	5	mediated	mediate	VERB
gsrj-19	36	6	gpr40	gpr40	ADJ
gsrj-19	36	7	signaling	signal	VERB
gsrj-19	36	8	modulates	modulate	NOUN
gsrj-19	36	9	epileptic	epileptic	ADJ
gsrj-19	36	10	seizures	seizure	NOUN
gsrj-19	36	11	also	also	ADV
gsrj-19	36	12	known	know	VERB
gsrj-19	36	13	as	as	ADP
gsrj-19	36	14	the	the	DET
gsrj-19	36	15	free	free	ADJ
gsrj-19	36	16	fatty	fatty	NOUN
gsrj-19	36	17	acid	acid	NOUN
gsrj-19	36	18	receptor	receptor	NOUN
gsrj-19	36	19	1	1	NUM
gsrj-19	36	20	,	,	PUNCT
gsrj-19	36	21	gpr40	gpr40	PROPN
gsrj-19	36	22	is	be	AUX
gsrj-19	36	23	bound	bind	VERB
gsrj-19	36	24	and	and	CCONJ
gsrj-19	36	25	activated	activate	VERB
gsrj-19	36	26	by	by	ADP
gsrj-19	36	27	long	long	ADJ
gsrj-19	36	28	,	,	PUNCT
gsrj-19	36	29	unsaturated	unsaturated	ADJ
gsrj-19	36	30	fatty	fatty	NOUN
gsrj-19	36	31	acids	acid	NOUN
gsrj-19	36	32	called	call	VERB
gsrj-19	36	33	pufas	pufas	NOUN
gsrj-19	36	34	.	.	PUNCT
gsrj-19	37	1	the	the	DET
gsrj-19	37	2	existing	exist	VERB
gsrj-19	37	3	literature	literature	NOUN
gsrj-19	37	4	has	have	AUX
gsrj-19	37	5	argued	argue	VERB
gsrj-19	37	6	that	that	SCONJ
gsrj-19	37	7	pufas	pufas	NOUN
gsrj-19	37	8	may	may	AUX
gsrj-19	37	9	have	have	VERB
gsrj-19	37	10	differential	differential	ADJ
gsrj-19	37	11	effects	effect	NOUN
gsrj-19	37	12	in	in	ADP
gsrj-19	37	13	the	the	DET
gsrj-19	37	14	cns.10	cns.10	NOUN
gsrj-19	37	15	,	,	PUNCT
gsrj-19	37	16	11	11	NUM
gsrj-19	37	17	in	in	ADP
gsrj-19	37	18	fact	fact	NOUN
gsrj-19	37	19	,	,	PUNCT
gsrj-19	37	20	one	one	NUM
gsrj-19	37	21	group	group	NOUN
gsrj-19	37	22	in	in	ADP
gsrj-19	37	23	particular	particular	ADJ
gsrj-19	37	24	,	,	PUNCT
gsrj-19	37	25	omega-3	omega-3	ADJ
gsrj-19	37	26	pufas	pufas	NOUN
gsrj-19	37	27	,	,	PUNCT
gsrj-19	37	28	has	have	AUX
gsrj-19	37	29	been	be	AUX
gsrj-19	37	30	shown	show	VERB
gsrj-19	37	31	to	to	PART
gsrj-19	37	32	have	have	VERB
gsrj-19	37	33	anticonvulsant	anticonvulsant	ADJ
gsrj-19	37	34	effects	effect	NOUN
gsrj-19	37	35	.	.	PUNCT
gsrj-19	38	1	a	a	DET
gsrj-19	38	2	study	study	NOUN
gsrj-19	38	3	by	by	ADP
gsrj-19	38	4	the	the	DET
gsrj-19	38	5	university	university	PROPN
gsrj-19	38	6	of	of	ADP
gsrj-19	38	7	toronto	toronto	PROPN
gsrj-19	38	8	's	's	PART
gsrj-19	38	9	epilepsy	epilepsy	PROPN
gsrj-19	38	10	research	research	NOUN
gsrj-19	38	11	program	program	NOUN
gsrj-19	38	12	found	find	VERB
gsrj-19	38	13	that	that	SCONJ
gsrj-19	38	14	various	various	ADJ
gsrj-19	38	15	fatty	fatty	NOUN
gsrj-19	38	16	acid	acid	NOUN
gsrj-19	38	17	chains	chain	NOUN
gsrj-19	38	18	,	,	PUNCT
gsrj-19	38	19	including	include	VERB
gsrj-19	38	20	ala	ala	PROPN
gsrj-19	38	21	,	,	PUNCT
gsrj-19	38	22	epa	epa	PROPN
gsrj-19	38	23	,	,	PUNCT
gsrj-19	38	24	and	and	CCONJ
gsrj-19	38	25	dha	dha	PROPN
gsrj-19	38	26	,	,	PUNCT
gsrj-19	38	27	reduced	reduce	VERB
gsrj-19	38	28	the	the	DET
gsrj-19	38	29	frequency	frequency	NOUN
gsrj-19	38	30	of	of	ADP
gsrj-19	38	31	action	action	NOUN
gsrj-19	38	32	potentials	potential	NOUN
gsrj-19	38	33	and	and	CCONJ
gsrj-19	38	34	excitatory	excitatory	NOUN
gsrj-19	38	35	signaling	signal	VERB
gsrj-19	38	36	in	in	ADP
gsrj-19	38	37	vitro.10	vitro.10	NOUN
gsrj-19	38	38	however	however	ADV
gsrj-19	38	39	,	,	PUNCT
gsrj-19	38	40	they	they	PRON
gsrj-19	38	41	posited	posit	VERB
gsrj-19	38	42	that	that	SCONJ
gsrj-19	38	43	the	the	DET
gsrj-19	38	44	observed	observed	ADJ
gsrj-19	38	45	effects	effect	NOUN
gsrj-19	38	46	were	be	AUX
gsrj-19	38	47	modulated	modulate	VERB
gsrj-19	38	48	through	through	ADP
gsrj-19	38	49	voltagegated	voltagegate	VERB
gsrj-19	38	50	na+	na+	NOUN
gsrj-19	38	51	and	and	CCONJ
gsrj-19	38	52	ca2	ca2	PROPN
gsrj-19	38	53	+	+	PROPN
gsrj-19	38	54	channels	channel	NOUN
gsrj-19	38	55	,	,	PUNCT
gsrj-19	38	56	further	far	ADV
gsrj-19	38	57	supporting	support	VERB
gsrj-19	38	58	that	that	SCONJ
gsrj-19	38	59	seizure	seizure	NOUN
gsrj-19	38	60	-	-	PUNCT
gsrj-19	38	61	like	like	ADJ
gsrj-19	38	62	activity	activity	NOUN
gsrj-19	38	63	is	be	AUX
gsrj-19	38	64	dependent	dependent	ADJ
gsrj-19	38	65	on	on	ADP
gsrj-19	38	66	a	a	DET
gsrj-19	38	67	plethora	plethora	NOUN
gsrj-19	38	68	of	of	ADP
gsrj-19	38	69	signaling	signal	VERB
gsrj-19	38	70	pathways	pathway	NOUN
gsrj-19	38	71	and	and	CCONJ
gsrj-19	38	72	factors	factor	NOUN
gsrj-19	38	73	.	.	PUNCT
gsrj-19	39	1	in	in	ADP
gsrj-19	39	2	contrast	contrast	NOUN
gsrj-19	39	3	,	,	PUNCT
gsrj-19	39	4	other	other	ADJ
gsrj-19	39	5	studies	study	NOUN
gsrj-19	39	6	present	present	ADJ
gsrj-19	39	7	confounding	confound	VERB
gsrj-19	39	8	results	result	NOUN
gsrj-19	39	9	,	,	PUNCT
gsrj-19	39	10	showing	show	VERB
gsrj-19	39	11	that	that	SCONJ
gsrj-19	39	12	low	low	ADJ
gsrj-19	39	13	doses	dose	NOUN
gsrj-19	39	14	of	of	ADP
gsrj-19	39	15	certain	certain	ADJ
gsrj-19	39	16	pufas	pufas	NOUN
gsrj-19	39	17	reduce	reduce	VERB
gsrj-19	39	18	seizure	seizure	NOUN
gsrj-19	39	19	frequency	frequency	NOUN
gsrj-19	39	20	whereas	whereas	SCONJ
gsrj-19	39	21	increased	increase	VERB
gsrj-19	39	22	doses	dose	NOUN
gsrj-19	39	23	have	have	VERB
gsrj-19	39	24	no	no	DET
gsrj-19	39	25	significant	significant	ADJ
gsrj-19	39	26	effects	effect	NOUN
gsrj-19	39	27	on	on	ADP
gsrj-19	39	28	seizure	seizure	NOUN
gsrj-19	39	29	frequency.11	frequency.11	ADJ
gsrj-19	39	30	pufas	pufas	NOUN
gsrj-19	39	31	may	may	AUX
gsrj-19	39	32	therefore	therefore	ADV
gsrj-19	39	33	act	act	VERB
gsrj-19	39	34	on	on	ADP
gsrj-19	39	35	many	many	ADJ
gsrj-19	39	36	target	target	NOUN
gsrj-19	39	37	locations	location	NOUN
gsrj-19	39	38	,	,	PUNCT
gsrj-19	39	39	either	either	CCONJ
gsrj-19	39	40	reducing	reduce	VERB
gsrj-19	39	41	or	or	CCONJ
gsrj-19	39	42	increasing	increase	VERB
gsrj-19	39	43	seizure	seizure	NOUN
gsrj-19	39	44	-	-	PUNCT
gsrj-19	39	45	like	like	ADJ
gsrj-19	39	46	activity	activity	NOUN
gsrj-19	39	47	.	.	PUNCT
gsrj-19	40	1	these	these	DET
gsrj-19	40	2	conflicting	conflicting	ADJ
gsrj-19	40	3	results	result	NOUN
gsrj-19	40	4	reveal	reveal	VERB
gsrj-19	40	5	the	the	DET
gsrj-19	40	6	need	need	NOUN
gsrj-19	40	7	for	for	ADP
gsrj-19	40	8	further	further	ADJ
gsrj-19	40	9	research	research	NOUN
gsrj-19	40	10	to	to	PART
gsrj-19	40	11	fully	fully	ADV
gsrj-19	40	12	understand	understand	VERB
gsrj-19	40	13	the	the	DET
gsrj-19	40	14	various	various	ADJ
gsrj-19	40	15	,	,	PUNCT
gsrj-19	40	16	complex	complex	ADJ
gsrj-19	40	17	factors	factor	NOUN
gsrj-19	40	18	that	that	PRON
gsrj-19	40	19	modulate	modulate	VERB
gsrj-19	40	20	epileptic	epileptic	ADJ
gsrj-19	40	21	activity	activity	NOUN
gsrj-19	40	22	.	.	PUNCT
gsrj-19	41	1	22	22	NUM
gsrj-19	41	2	georgetown	georgetown	PROPN
gsrj-19	41	3	scientific	scientific	PROPN
gsrj-19	41	4	research	research	PROPN
gsrj-19	41	5	journal	journal	NOUN
gsrj-19	41	6	figure	figure	NOUN
gsrj-19	41	7	1	1	NUM
gsrj-19	41	8	:	:	PUNCT
gsrj-19	41	9	activation	activation	NOUN
gsrj-19	41	10	of	of	ADP
gsrj-19	41	11	gpr40	gpr40	PROPN
gsrj-19	41	12	via	via	ADP
gsrj-19	41	13	ka	ka	ADV
gsrj-19	41	14	-	-	PUNCT
gsrj-19	41	15	induced	induced	ADJ
gsrj-19	41	16	and	and	CCONJ
gsrj-19	41	17	ptz	ptz	PROPN
gsrj-19	41	18	kindling	kindling	NOUN
gsrj-19	41	19	models	model	NOUN
gsrj-19	41	20	yields	yield	VERB
gsrj-19	41	21	highest	high	ADJ
gsrj-19	41	22	survival	survival	NOUN
gsrj-19	41	23	rates	rate	NOUN
gsrj-19	41	24	.	.	PUNCT
gsrj-19	42	1	a	a	DET
gsrj-19	42	2	)	)	PUNCT
gsrj-19	42	3	representation	representation	NOUN
gsrj-19	42	4	of	of	ADP
gsrj-19	42	5	ka	ka	NOUN
gsrj-19	42	6	-	-	PUNCT
gsrj-19	42	7	induced	induce	VERB
gsrj-19	42	8	experimental	experimental	ADJ
gsrj-19	42	9	timeline	timeline	NOUN
gsrj-19	42	10	.	.	PUNCT
gsrj-19	43	1	after	after	ADP
gsrj-19	43	2	ka	ka	PROPN
gsrj-19	43	3	injection	injection	PROPN
gsrj-19	43	4	,	,	PUNCT
gsrj-19	43	5	mice	mouse	NOUN
gsrj-19	43	6	were	be	AUX
gsrj-19	43	7	treated	treat	VERB
gsrj-19	43	8	with	with	ADP
gsrj-19	43	9	dmso	dmso	NOUN
gsrj-19	43	10	,	,	PUNCT
gsrj-19	43	11	gw9508	gw9508	PROPN
gsrj-19	43	12	,	,	PUNCT
gsrj-19	43	13	or	or	CCONJ
gsrj-19	43	14	gw1100	gw1100	NOUN
gsrj-19	43	15	(	(	PUNCT
gsrj-19	43	16	n=6	n=6	NOUN
gsrj-19	43	17	in	in	ADP
gsrj-19	43	18	each	each	DET
gsrj-19	43	19	group	group	NOUN
gsrj-19	43	20	)	)	PUNCT
gsrj-19	43	21	.	.	PUNCT
gsrj-19	44	1	b	b	X
gsrj-19	44	2	)	)	PUNCT
gsrj-19	44	3	lfp	lfp	NOUN
gsrj-19	44	4	recordings	recording	NOUN
gsrj-19	44	5	from	from	ADP
gsrj-19	44	6	each	each	DET
gsrj-19	44	7	treatment	treatment	NOUN
gsrj-19	44	8	group	group	NOUN
gsrj-19	44	9	over	over	ADP
gsrj-19	44	10	5	5	NUM
gsrj-19	44	11	minutes	minute	NOUN
gsrj-19	44	12	and	and	CCONJ
gsrj-19	44	13	zoomed	zoom	VERB
gsrj-19	44	14	in	in	ADP
gsrj-19	44	15	of	of	ADP
gsrj-19	44	16	2	2	NUM
gsrj-19	44	17	s.	s.	PROPN
gsrj-19	44	18	c	c	NOUN
gsrj-19	44	19	)	)	PUNCT
gsrj-19	44	20	corresponding	correspond	VERB
gsrj-19	44	21	frequency	frequency	NOUN
gsrj-19	44	22	recordings	recording	NOUN
gsrj-19	44	23	of	of	ADP
gsrj-19	44	24	lfp	lfp	PROPN
gsrj-19	44	25	.	.	PUNCT
gsrj-19	45	1	d	d	X
gsrj-19	45	2	-	-	PUNCT
gsrj-19	45	3	f	f	NOUN
gsrj-19	45	4	)	)	PUNCT
gsrj-19	45	5	comparing	compare	VERB
gsrj-19	45	6	three	three	NUM
gsrj-19	45	7	groups	group	NOUN
gsrj-19	45	8	in	in	ADP
gsrj-19	45	9	number	number	NOUN
gsrj-19	45	10	,	,	PUNCT
gsrj-19	45	11	duration	duration	NOUN
gsrj-19	45	12	,	,	PUNCT
gsrj-19	45	13	and	and	CCONJ
gsrj-19	45	14	time	time	NOUN
gsrj-19	45	15	spent	spend	VERB
gsrj-19	45	16	in	in	ADP
gsrj-19	45	17	sles	sle	NOUN
gsrj-19	45	18	.	.	PUNCT
gsrj-19	46	1	g	g	NOUN
gsrj-19	46	2	)	)	PUNCT
gsrj-19	46	3	using	use	VERB
gsrj-19	46	4	the	the	DET
gsrj-19	46	5	ptz	ptz	PROPN
gsrj-19	46	6	model	model	NOUN
gsrj-19	46	7	,	,	PUNCT
gsrj-19	46	8	seizure	seizure	NOUN
gsrj-19	46	9	activity	activity	NOUN
gsrj-19	46	10	was	be	AUX
gsrj-19	46	11	heightened	heighten	VERB
gsrj-19	46	12	in	in	ADP
gsrj-19	46	13	gw1100	gw1100	NOUN
gsrj-19	46	14	and	and	CCONJ
gsrj-19	46	15	reduced	reduce	VERB
gsrj-19	46	16	in	in	ADP
gsrj-19	46	17	gw9508	gw9508	NOUN
gsrj-19	46	18	groups	group	NOUN
gsrj-19	46	19	.	.	PUNCT
gsrj-19	47	1	h	h	X
gsrj-19	47	2	)	)	PUNCT
gsrj-19	47	3	highest	high	ADJ
gsrj-19	47	4	survival	survival	NOUN
gsrj-19	47	5	amongst	amongst	ADP
gsrj-19	47	6	gw9508	gw9508	PROPN
gsrj-19	47	7	group	group	NOUN
gsrj-19	47	8	and	and	CCONJ
gsrj-19	47	9	lowest	low	ADJ
gsrj-19	47	10	survival	survival	NOUN
gsrj-19	47	11	amongst	amongst	ADP
gsrj-19	47	12	gw1100	gw1100	PROPN
gsrj-19	47	13	group	group	NOUN
gsrj-19	47	14	(	(	PUNCT
gsrj-19	47	15	figure	figure	NOUN
gsrj-19	47	16	taken	take	VERB
gsrj-19	47	17	from	from	ADP
gsrj-19	47	18	yang	yang	PROPN
gsrj-19	47	19	et	et	PROPN
gsrj-19	47	20	al	al	PROPN
gsrj-19	47	21	.	.	PROPN
gsrj-19	47	22	,	,	PUNCT
gsrj-19	47	23	2018	2018	NUM
gsrj-19	47	24	)	)	PUNCT
gsrj-19	47	25	.	.	PUNCT
gsrj-19	48	1	yang	yang	PROPN
gsrj-19	48	2	et	et	PROPN
gsrj-19	48	3	al	al	PROPN
gsrj-19	48	4	.	.	PROPN
gsrj-19	48	5	discovered	discover	VERB
gsrj-19	48	6	that	that	SCONJ
gsrj-19	48	7	gpr40	gpr40	PROPN
gsrj-19	48	8	activation	activation	NOUN
gsrj-19	48	9	results	result	VERB
gsrj-19	48	10	in	in	ADP
gsrj-19	48	11	a	a	DET
gsrj-19	48	12	layered	layered	ADJ
gsrj-19	48	13	cascade	cascade	NOUN
gsrj-19	48	14	of	of	ADP
gsrj-19	48	15	signaling	signal	VERB
gsrj-19	48	16	events	event	NOUN
gsrj-19	48	17	.	.	PUNCT
gsrj-19	49	1	overall	overall	ADJ
gsrj-19	49	2	,	,	PUNCT
gsrj-19	49	3	gpr40	gpr40	PROPN
gsrj-19	49	4	affected	affect	VERB
gsrj-19	49	5	nmda	nmda	ADJ
gsrj-19	49	6	receptor	receptor	NOUN
gsrj-19	49	7	endocytosis	endocytosis	NOUN
gsrj-19	49	8	by	by	ADP
gsrj-19	49	9	binding	bind	VERB
gsrj-19	49	10	to	to	ADP
gsrj-19	49	11	nr2a	nr2a	VERB
gsrj-19	49	12	and	and	CCONJ
gsrj-19	49	13	nr2b	nr2b	NUM
gsrj-19	49	14	subunits	subunit	NOUN
gsrj-19	49	15	found	find	VERB
gsrj-19	49	16	on	on	ADP
gsrj-19	49	17	neuronal	neuronal	ADJ
gsrj-19	49	18	membranes	membrane	NOUN
gsrj-19	49	19	.	.	PUNCT
gsrj-19	50	1	to	to	PART
gsrj-19	50	2	elaborate	elaborate	VERB
gsrj-19	50	3	,	,	PUNCT
gsrj-19	50	4	the	the	DET
gsrj-19	50	5	research	research	NOUN
gsrj-19	50	6	team	team	NOUN
gsrj-19	50	7	needed	need	VERB
gsrj-19	50	8	to	to	PART
gsrj-19	50	9	confirm	confirm	VERB
gsrj-19	50	10	that	that	SCONJ
gsrj-19	50	11	gpr40	gpr40	PROPN
gsrj-19	50	12	played	play	VERB
gsrj-19	50	13	a	a	DET
gsrj-19	50	14	direct	direct	ADJ
gsrj-19	50	15	,	,	PUNCT
gsrj-19	50	16	causal	causal	ADJ
gsrj-19	50	17	role	role	NOUN
gsrj-19	50	18	in	in	ADP
gsrj-19	50	19	modulating	modulate	VERB
gsrj-19	50	20	epileptic	epileptic	ADJ
gsrj-19	50	21	seizures	seizure	NOUN
gsrj-19	50	22	.	.	PUNCT
gsrj-19	51	1	in	in	ADP
gsrj-19	51	2	order	order	NOUN
gsrj-19	51	3	to	to	PART
gsrj-19	51	4	accomplish	accomplish	VERB
gsrj-19	51	5	this	this	DET
gsrj-19	51	6	initial	initial	ADJ
gsrj-19	51	7	goal	goal	NOUN
gsrj-19	51	8	,	,	PUNCT
gsrj-19	51	9	they	they	PRON
gsrj-19	51	10	utilized	utilize	VERB
gsrj-19	51	11	an	an	DET
gsrj-19	51	12	intrahippocampal	intrahippocampal	ADJ
gsrj-19	51	13	ka	ka	VERB
gsrj-19	51	14	-	-	PUNCT
gsrj-19	51	15	induced	induce	VERB
gsrj-19	51	16	tle	tle	NOUN
gsrj-19	51	17	model	model	NOUN
gsrj-19	51	18	,	,	PUNCT
gsrj-19	51	19	meaning	mean	VERB
gsrj-19	51	20	that	that	SCONJ
gsrj-19	51	21	ka	ka	PROPN
gsrj-19	51	22	was	be	AUX
gsrj-19	51	23	injected	inject	VERB
gsrj-19	51	24	into	into	ADP
gsrj-19	51	25	mice	mouse	NOUN
gsrj-19	51	26	’s	’s	PART
gsrj-19	51	27	hippocampi	hippocampi	ADJ
gsrj-19	51	28	unilaterally	unilaterally	ADV
gsrj-19	51	29	to	to	PART
gsrj-19	51	30	induce	induce	VERB
gsrj-19	51	31	seizures	seizure	NOUN
gsrj-19	51	32	(	(	PUNCT
gsrj-19	51	33	figure	figure	NOUN
gsrj-19	51	34	1a	1a	NOUN
gsrj-19	51	35	)	)	PUNCT
gsrj-19	51	36	.	.	PUNCT
gsrj-19	52	1	previous	previous	ADJ
gsrj-19	52	2	studies	study	NOUN
gsrj-19	52	3	have	have	AUX
gsrj-19	52	4	shown	show	VERB
gsrj-19	52	5	that	that	SCONJ
gsrj-19	52	6	ka	ka	PROPN
gsrj-19	52	7	,	,	PUNCT
gsrj-19	52	8	an	an	DET
gsrj-19	52	9	excitatory	excitatory	ADJ
gsrj-19	52	10	amino	amino	NOUN
gsrj-19	52	11	acid	acid	NOUN
gsrj-19	52	12	,	,	PUNCT
gsrj-19	52	13	is	be	AUX
gsrj-19	52	14	a	a	DET
gsrj-19	52	15	useful	useful	ADJ
gsrj-19	52	16	tool	tool	NOUN
gsrj-19	52	17	for	for	ADP
gsrj-19	52	18	seizureinduction	seizureinduction	NOUN
gsrj-19	52	19	because	because	SCONJ
gsrj-19	52	20	it	it	PRON
gsrj-19	52	21	induces	induce	VERB
gsrj-19	52	22	certain	certain	ADJ
gsrj-19	52	23	seizures	seizure	NOUN
gsrj-19	52	24	that	that	PRON
gsrj-19	52	25	are	be	AUX
gsrj-19	52	26	commonly	commonly	ADV
gsrj-19	52	27	experienced	experience	VERB
gsrj-19	52	28	by	by	ADP
gsrj-19	52	29	patients	patient	NOUN
gsrj-19	52	30	with	with	ADP
gsrj-19	52	31	temporal	temporal	ADJ
gsrj-19	52	32	lobe	lobe	NOUN
gsrj-19	52	33	epilepsy.12	epilepsy.12	NOUN
gsrj-19	52	34	three	three	NUM
gsrj-19	52	35	days	day	NOUN
gsrj-19	52	36	after	after	ADP
gsrj-19	52	37	the	the	DET
gsrj-19	52	38	induction	induction	NOUN
gsrj-19	52	39	of	of	ADP
gsrj-19	52	40	epileptic	epileptic	ADJ
gsrj-19	52	41	activity	activity	NOUN
gsrj-19	52	42	,	,	PUNCT
gsrj-19	52	43	additional	additional	ADJ
gsrj-19	52	44	compounds	compound	NOUN
gsrj-19	52	45	were	be	AUX
gsrj-19	52	46	injected	inject	VERB
gsrj-19	52	47	daily	daily	ADV
gsrj-19	52	48	for	for	ADP
gsrj-19	52	49	one	one	NUM
gsrj-19	52	50	week	week	NOUN
gsrj-19	52	51	.	.	PUNCT
gsrj-19	53	1	these	these	DET
gsrj-19	53	2	treatments	treatment	NOUN
gsrj-19	53	3	included	include	VERB
gsrj-19	53	4	a	a	DET
gsrj-19	53	5	dmso	dmso	ADJ
gsrj-19	53	6	control	control	NOUN
gsrj-19	53	7	,	,	PUNCT
gsrj-19	53	8	gw9508	gw9508	NOUN
gsrj-19	53	9	agonist	agonist	NOUN
gsrj-19	53	10	,	,	PUNCT
gsrj-19	53	11	or	or	CCONJ
gsrj-19	53	12	gw1100	gw1100	NOUN
gsrj-19	53	13	antagonist	antagonist	NOUN
gsrj-19	53	14	of	of	ADP
gsrj-19	53	15	the	the	DET
gsrj-19	53	16	target	target	NOUN
gsrj-19	53	17	gpr40	gpr40	PROPN
gsrj-19	53	18	receptor	receptor	NOUN
gsrj-19	53	19	.	.	PUNCT
gsrj-19	54	1	after	after	ADP
gsrj-19	54	2	one	one	NUM
gsrj-19	54	3	-	-	PUNCT
gsrj-19	54	4	month	month	NOUN
gsrj-19	54	5	,	,	PUNCT
gsrj-19	54	6	local	local	ADJ
gsrj-19	54	7	field	field	NOUN
gsrj-19	54	8	potentials	potential	NOUN
gsrj-19	54	9	,	,	PUNCT
gsrj-19	54	10	which	which	PRON
gsrj-19	54	11	were	be	AUX
gsrj-19	54	12	characterized	characterize	VERB
gsrj-19	54	13	as	as	ADP
gsrj-19	54	14	strong	strong	ADJ
gsrj-19	54	15	electrical	electrical	ADJ
gsrj-19	54	16	signals	signal	NOUN
gsrj-19	54	17	between	between	ADP
gsrj-19	54	18	neurons	neuron	NOUN
gsrj-19	54	19	,	,	PUNCT
gsrj-19	54	20	were	be	AUX
gsrj-19	54	21	measured	measure	VERB
gsrj-19	54	22	(	(	PUNCT
gsrj-19	54	23	figure	figure	NOUN
gsrj-19	54	24	1b	1b	NUM
gsrj-19	54	25	)	)	PUNCT
gsrj-19	54	26	.	.	PUNCT
gsrj-19	55	1	these	these	DET
gsrj-19	55	2	measurements	measurement	NOUN
gsrj-19	55	3	reflected	reflect	VERB
gsrj-19	55	4	both	both	CCONJ
gsrj-19	55	5	the	the	DET
gsrj-19	55	6	frequency	frequency	NOUN
gsrj-19	55	7	and	and	CCONJ
gsrj-19	55	8	duration	duration	NOUN
gsrj-19	55	9	of	of	ADP
gsrj-19	55	10	any	any	DET
gsrj-19	55	11	seizure	seizure	NOUN
gsrj-19	55	12	-	-	PUNCT
gsrj-19	55	13	like	like	ADJ
gsrj-19	55	14	events	event	NOUN
gsrj-19	55	15	(	(	PUNCT
gsrj-19	55	16	sle	sle	PROPN
gsrj-19	55	17	’s	’s	PART
gsrj-19	55	18	)	)	PUNCT
gsrj-19	55	19	experienced	experience	VERB
gsrj-19	55	20	by	by	ADP
gsrj-19	55	21	the	the	DET
gsrj-19	55	22	mice	mouse	NOUN
gsrj-19	55	23	.	.	PUNCT
gsrj-19	56	1	the	the	DET
gsrj-19	56	2	compiled	compile	VERB
gsrj-19	56	3	data	datum	NOUN
gsrj-19	56	4	revealed	reveal	VERB
gsrj-19	56	5	that	that	SCONJ
gsrj-19	56	6	mice	mouse	NOUN
gsrj-19	56	7	injected	inject	VERB
gsrj-19	56	8	with	with	ADP
gsrj-19	56	9	the	the	DET
gsrj-19	56	10	gw1100	gw1100	NOUN
gsrj-19	56	11	antagonist	antagonist	NOUN
gsrj-19	56	12	experienced	experience	VERB
gsrj-19	56	13	more	more	ADV
gsrj-19	56	14	seizurelike	seizurelike	ADJ
gsrj-19	56	15	events	event	NOUN
gsrj-19	56	16	that	that	PRON
gsrj-19	56	17	lasted	last	VERB
gsrj-19	56	18	longer	long	ADV
gsrj-19	56	19	compared	compare	VERB
gsrj-19	56	20	to	to	ADP
gsrj-19	56	21	the	the	DET
gsrj-19	56	22	control	control	NOUN
gsrj-19	56	23	(	(	PUNCT
gsrj-19	56	24	figure	figure	NOUN
gsrj-19	56	25	1d	1d	NUM
gsrj-19	56	26	,	,	PUNCT
gsrj-19	56	27	f	f	NOUN
gsrj-19	56	28	)	)	PUNCT
gsrj-19	56	29	.	.	PUNCT
gsrj-19	57	1	in	in	ADP
gsrj-19	57	2	contrast	contrast	NOUN
gsrj-19	57	3	,	,	PUNCT
gsrj-19	57	4	mice	mouse	NOUN
gsrj-19	57	5	injected	inject	VERB
gsrj-19	57	6	with	with	ADP
gsrj-19	57	7	the	the	DET
gsrj-19	57	8	gw9508	gw9508	PROPN
gsrj-19	57	9	agonist	agonist	NOUN
gsrj-19	57	10	experienced	experience	VERB
gsrj-19	57	11	fewer	few	ADJ
gsrj-19	57	12	seizure	seizure	NOUN
gsrj-19	57	13	-	-	PUNCT
gsrj-19	57	14	like	like	ADJ
gsrj-19	57	15	events	event	NOUN
gsrj-19	57	16	that	that	PRON
gsrj-19	57	17	lasted	last	VERB
gsrj-19	57	18	a	a	DET
gsrj-19	57	19	significantly	significantly	ADV
gsrj-19	57	20	shorter	short	ADJ
gsrj-19	57	21	time	time	NOUN
gsrj-19	57	22	compared	compare	VERB
gsrj-19	57	23	to	to	ADP
gsrj-19	57	24	the	the	DET
gsrj-19	57	25	control	control	NOUN
gsrj-19	57	26	(	(	PUNCT
gsrj-19	57	27	figure	figure	NOUN
gsrj-19	57	28	1d	1d	NUM
gsrj-19	57	29	,	,	PUNCT
gsrj-19	57	30	f).3	f).3	PROPN
gsrj-19	57	31	to	to	PART
gsrj-19	57	32	confirm	confirm	VERB
gsrj-19	57	33	their	their	PRON
gsrj-19	57	34	findings	finding	NOUN
gsrj-19	57	35	,	,	PUNCT
gsrj-19	57	36	the	the	DET
gsrj-19	57	37	researchers	researcher	NOUN
gsrj-19	57	38	repeated	repeat	VERB
gsrj-19	57	39	their	their	PRON
gsrj-19	57	40	experiment	experiment	NOUN
gsrj-19	57	41	with	with	ADP
gsrj-19	57	42	a	a	DET
gsrj-19	57	43	pentylenetetrazol	pentylenetetrazol	NOUN
gsrj-19	57	44	(	(	PUNCT
gsrj-19	57	45	ptz	ptz	PROPN
gsrj-19	57	46	)	)	PUNCT
gsrj-19	57	47	kindling	kindle	VERB
gsrj-19	57	48	model	model	NOUN
gsrj-19	57	49	.	.	PUNCT
gsrj-19	58	1	like	like	ADP
gsrj-19	58	2	kainic	kainic	ADJ
gsrj-19	58	3	acid	acid	NOUN
gsrj-19	58	4	,	,	PUNCT
gsrj-19	58	5	pentylenetetrazol	pentylenetetrazol	NOUN
gsrj-19	58	6	,	,	PUNCT
gsrj-19	58	7	a	a	DET
gsrj-19	58	8	gaba	gaba	NOUN
gsrj-19	58	9	a	a	DET
gsrj-19	58	10	receptor	receptor	NOUN
gsrj-19	58	11	antagonist	antagonist	NOUN
gsrj-19	58	12	,	,	PUNCT
gsrj-19	58	13	was	be	AUX
gsrj-19	58	14	used	use	VERB
gsrj-19	58	15	to	to	PART
gsrj-19	58	16	induce	induce	VERB
gsrj-19	58	17	convulsive	convulsive	ADJ
gsrj-19	58	18	activity	activity	NOUN
gsrj-19	58	19	in	in	ADP
gsrj-19	58	20	the	the	DET
gsrj-19	58	21	mice13	mice13	NOUN
gsrj-19	58	22	;	;	PUNCT
gsrj-19	58	23	this	this	DET
gsrj-19	58	24	model	model	NOUN
gsrj-19	58	25	therefore	therefore	ADV
gsrj-19	58	26	represents	represent	VERB
gsrj-19	58	27	the	the	DET
gsrj-19	58	28	seizure	seizure	NOUN
gsrj-19	58	29	-	-	PUNCT
gsrj-19	58	30	like	like	ADJ
gsrj-19	58	31	symptoms	symptom	NOUN
gsrj-19	58	32	experienced	experience	VERB
gsrj-19	58	33	by	by	ADP
gsrj-19	58	34	many	many	ADJ
gsrj-19	58	35	patients	patient	NOUN
gsrj-19	58	36	suffering	suffer	VERB
gsrj-19	58	37	with	with	ADP
gsrj-19	58	38	epilepsy	epilepsy	NOUN
gsrj-19	58	39	.	.	PUNCT
gsrj-19	59	1	like	like	ADP
gsrj-19	59	2	the	the	DET
gsrj-19	59	3	previous	previous	ADJ
gsrj-19	59	4	model	model	NOUN
gsrj-19	59	5	,	,	PUNCT
gsrj-19	59	6	the	the	DET
gsrj-19	59	7	mice	mouse	NOUN
gsrj-19	59	8	received	receive	VERB
gsrj-19	59	9	intracerebroventricular	intracerebroventricular	ADJ
gsrj-19	59	10	injections	injection	NOUN
gsrj-19	59	11	of	of	ADP
gsrj-19	59	12	one	one	NUM
gsrj-19	59	13	of	of	ADP
gsrj-19	59	14	three	three	NUM
gsrj-19	59	15	treatments	treatment	NOUN
gsrj-19	59	16	:	:	PUNCT
gsrj-19	59	17	the	the	DET
gsrj-19	59	18	dmso	dmso	ADJ
gsrj-19	59	19	control	control	PROPN
gsrj-19	59	20	,	,	PUNCT
gsrj-19	59	21	the	the	DET
gsrj-19	59	22	gw9508	gw9508	NOUN
gsrj-19	59	23	agonist	agonist	NOUN
gsrj-19	59	24	,	,	PUNCT
gsrj-19	59	25	or	or	CCONJ
gsrj-19	59	26	the	the	DET
gsrj-19	59	27	gw1100	gw1100	NOUN
gsrj-19	59	28	antagonist	antagonist	NOUN
gsrj-19	59	29	.	.	PUNCT
gsrj-19	60	1	while	while	SCONJ
gsrj-19	60	2	all	all	DET
gsrj-19	60	3	three	three	NUM
gsrj-19	60	4	mice	mouse	NOUN
gsrj-19	60	5	groups	group	NOUN
gsrj-19	60	6	showed	show	VERB
gsrj-19	60	7	increased	increase	VERB
gsrj-19	60	8	seizure	seizure	NOUN
gsrj-19	60	9	scores	score	NOUN
gsrj-19	60	10	after	after	ADP
gsrj-19	60	11	ptz	ptz	PROPN
gsrj-19	60	12	treatment	treatment	NOUN
gsrj-19	60	13	,	,	PUNCT
gsrj-19	60	14	the	the	DET
gsrj-19	60	15	mice	mouse	NOUN
gsrj-19	60	16	treated	treat	VERB
gsrj-19	60	17	with	with	ADP
gsrj-19	60	18	gpr40	gpr40	PROPN
gsrj-19	60	19	selective	selective	ADJ
gsrj-19	60	20	agonist	agonist	NOUN
gsrj-19	60	21	exhibited	exhibit	VERB
gsrj-19	60	22	significantly	significantly	ADV
gsrj-19	60	23	lower	lower	ADV
gsrj-19	60	24	seizure	seizure	NOUN
gsrj-19	60	25	scores	score	NOUN
gsrj-19	60	26	compared	compare	VERB
gsrj-19	60	27	to	to	ADP
gsrj-19	60	28	those	those	PRON
gsrj-19	60	29	treated	treat	VERB
gsrj-19	60	30	with	with	ADP
gsrj-19	60	31	gpr40	gpr40	PROPN
gsrj-19	60	32	antagonist	antagonist	NOUN
gsrj-19	60	33	.	.	PUNCT
gsrj-19	61	1	as	as	SCONJ
gsrj-19	61	2	ptz	ptz	PROPN
gsrj-19	61	3	injections	injection	NOUN
gsrj-19	61	4	continued	continue	VERB
gsrj-19	61	5	to	to	PART
gsrj-19	61	6	be	be	AUX
gsrj-19	61	7	administered	administer	VERB
gsrj-19	61	8	,	,	PUNCT
gsrj-19	61	9	the	the	DET
gsrj-19	61	10	mice	mouse	NOUN
gsrj-19	61	11	treated	treat	VERB
gsrj-19	61	12	with	with	ADP
gsrj-19	61	13	the	the	DET
gsrj-19	61	14	agonist	agonist	NOUN
gsrj-19	61	15	had	have	VERB
gsrj-19	61	16	the	the	DET
gsrj-19	61	17	highest	high	ADJ
gsrj-19	61	18	survival	survival	NOUN
gsrj-19	61	19	rate	rate	NOUN
gsrj-19	61	20	,	,	PUNCT
gsrj-19	61	21	while	while	SCONJ
gsrj-19	61	22	the	the	DET
gsrj-19	61	23	mice	mouse	NOUN
gsrj-19	61	24	treated	treat	VERB
gsrj-19	61	25	with	with	ADP
gsrj-19	61	26	the	the	DET
gsrj-19	61	27	antagonist	antagonist	NOUN
gsrj-19	61	28	had	have	VERB
gsrj-19	61	29	the	the	DET
gsrj-19	61	30	lowest	low	ADJ
gsrj-19	61	31	survival	survival	NOUN
gsrj-19	61	32	rate	rate	NOUN
gsrj-19	61	33	and	and	CCONJ
gsrj-19	61	34	were	be	AUX
gsrj-19	61	35	most	most	ADV
gsrj-19	61	36	prone	prone	ADJ
gsrj-19	61	37	to	to	ADP
gsrj-19	61	38	generalized	generalized	ADJ
gsrj-19	61	39	tonic	tonic	NOUN
gsrj-19	61	40	-	-	PUNCT
gsrj-19	61	41	clonic	clonic	NOUN
gsrj-19	61	42	seizure	seizure	NOUN
gsrj-19	61	43	(	(	PUNCT
gsrj-19	61	44	gtcs	gtcs	NOUN
gsrj-19	61	45	)	)	PUNCT
gsrj-19	61	46	related	related	ADJ
gsrj-19	61	47	death	death	NOUN
gsrj-19	61	48	(	(	PUNCT
gsrj-19	61	49	figure	figure	NOUN
gsrj-19	61	50	1	1	NUM
gsrj-19	61	51	g	g	NOUN
gsrj-19	61	52	,	,	PUNCT
gsrj-19	61	53	h	h	NOUN
gsrj-19	61	54	)	)	PUNCT
gsrj-19	61	55	.	.	PUNCT
gsrj-19	62	1	these	these	DET
gsrj-19	62	2	findings	finding	NOUN
gsrj-19	62	3	served	serve	VERB
gsrj-19	62	4	as	as	ADP
gsrj-19	62	5	a	a	DET
gsrj-19	62	6	key	key	ADJ
gsrj-19	62	7	indication	indication	NOUN
gsrj-19	62	8	that	that	SCONJ
gsrj-19	62	9	activating	activate	VERB
gsrj-19	62	10	or	or	CCONJ
gsrj-19	62	11	inhibiting	inhibit	VERB
gsrj-19	62	12	gpr40	gpr40	NOUN
gsrj-19	62	13	receptors	receptor	NOUN
gsrj-19	62	14	directly	directly	ADV
gsrj-19	62	15	affects	affect	VERB
gsrj-19	62	16	epileptic	epileptic	ADJ
gsrj-19	62	17	seizure	seizure	NOUN
gsrj-19	62	18	activity	activity	NOUN
gsrj-19	62	19	;	;	PUNCT
gsrj-19	62	20	specifically	specifically	ADV
gsrj-19	62	21	,	,	PUNCT
gsrj-19	62	22	activating	activate	VERB
gsrj-19	62	23	the	the	DET
gsrj-19	62	24	receptor	receptor	NOUN
gsrj-19	62	25	resulted	result	VERB
gsrj-19	62	26	in	in	ADP
gsrj-19	62	27	reduced	reduced	ADJ
gsrj-19	62	28	epileptic	epileptic	ADJ
gsrj-19	62	29	activity	activity	NOUN
gsrj-19	62	30	and	and	CCONJ
gsrj-19	62	31	an	an	DET
gsrj-19	62	32	increased	increase	VERB
gsrj-19	62	33	chance	chance	NOUN
gsrj-19	62	34	23	23	NUM
gsrj-19	62	35	georgetown	georgetown	PROPN
gsrj-19	62	36	scientific	scientific	PROPN
gsrj-19	62	37	research	research	NOUN
gsrj-19	62	38	journal	journal	PROPN
gsrj-19	62	39	for	for	ADP
gsrj-19	62	40	survival	survival	NOUN
gsrj-19	62	41	,	,	PUNCT
gsrj-19	62	42	while	while	SCONJ
gsrj-19	62	43	inhibiting	inhibit	VERB
gsrj-19	62	44	the	the	DET
gsrj-19	62	45	receptor	receptor	NOUN
gsrj-19	62	46	led	lead	VERB
gsrj-19	62	47	to	to	ADP
gsrj-19	62	48	opposite	opposite	ADJ
gsrj-19	62	49	observed	observed	ADJ
gsrj-19	62	50	effects.3	effects.3	NOUN
gsrj-19	62	51	figure	figure	NOUN
gsrj-19	62	52	2	2	NUM
gsrj-19	62	53	:	:	PUNCT
gsrj-19	62	54	changes	change	NOUN
gsrj-19	62	55	in	in	ADP
gsrj-19	62	56	cell	cell	NOUN
gsrj-19	62	57	surface	surface	NOUN
gsrj-19	62	58	nr2a	nr2a	NOUN
gsrj-19	62	59	and	and	CCONJ
gsrj-19	62	60	nr2b	nr2b	NUM
gsrj-19	62	61	subunit	subunit	NOUN
gsrj-19	62	62	expression	expression	NOUN
gsrj-19	62	63	in	in	ADP
gsrj-19	62	64	hippocampal	hippocampal	ADJ
gsrj-19	62	65	tissue	tissue	NOUN
gsrj-19	62	66	samples	sample	NOUN
gsrj-19	62	67	in	in	ADP
gsrj-19	62	68	gpr40	gpr40	NOUN
gsrj-19	62	69	-	-	PUNCT
gsrj-19	62	70	treated	treat	VERB
gsrj-19	62	71	mice	mouse	NOUN
gsrj-19	62	72	during	during	ADP
gsrj-19	62	73	epilepsy	epilepsy	NOUN
gsrj-19	62	74	.	.	PUNCT
gsrj-19	63	1	after	after	ADP
gsrj-19	63	2	ka	ka	PROPN
gsrj-19	63	3	injection	injection	NOUN
gsrj-19	63	4	or	or	CCONJ
gsrj-19	63	5	ptz	ptz	PROPN
gsrj-19	63	6	treatment	treatment	NOUN
gsrj-19	63	7	,	,	PUNCT
gsrj-19	63	8	mice	mouse	NOUN
gsrj-19	63	9	were	be	AUX
gsrj-19	63	10	treated	treat	VERB
gsrj-19	63	11	with	with	ADP
gsrj-19	63	12	dmso	dmso	NOUN
gsrj-19	63	13	,	,	PUNCT
gsrj-19	63	14	gw9508	gw9508	PROPN
gsrj-19	63	15	,	,	PUNCT
gsrj-19	63	16	or	or	CCONJ
gsrj-19	63	17	gw1100	gw1100	NOUN
gsrj-19	63	18	(	(	PUNCT
gsrj-19	63	19	n=5	n=5	PROPN
gsrj-19	63	20	in	in	ADP
gsrj-19	63	21	each	each	DET
gsrj-19	63	22	group	group	NOUN
gsrj-19	63	23	)	)	PUNCT
gsrj-19	63	24	.	.	PUNCT
gsrj-19	64	1	a	a	X
gsrj-19	64	2	-	-	PUNCT
gsrj-19	64	3	b	b	NOUN
gsrj-19	64	4	)	)	PUNCT
gsrj-19	64	5	ka	ka	PROPN
gsrj-19	64	6	model	model	PROPN
gsrj-19	64	7	:	:	PUNCT
gsrj-19	64	8	cell	cell	NOUN
gsrj-19	64	9	surface	surface	NOUN
gsrj-19	64	10	and	and	CCONJ
gsrj-19	64	11	total	total	ADJ
gsrj-19	64	12	n2ra	n2ra	NOUN
gsrj-19	64	13	and	and	CCONJ
gsrj-19	64	14	nr2b	nr2b	NUM
gsrj-19	64	15	expression	expression	NOUN
gsrj-19	64	16	was	be	AUX
gsrj-19	64	17	quantified	quantify	VERB
gsrj-19	64	18	via	via	ADP
gsrj-19	64	19	western	western	ADJ
gsrj-19	64	20	blot	blot	NOUN
gsrj-19	64	21	.	.	PUNCT
gsrj-19	65	1	c	c	X
gsrj-19	65	2	-	-	PUNCT
gsrj-19	65	3	d	d	NOUN
gsrj-19	65	4	)	)	PUNCT
gsrj-19	65	5	ptz	ptz	PROPN
gsrj-19	65	6	model	model	NOUN
gsrj-19	65	7	:	:	PUNCT
gsrj-19	65	8	cell	cell	NOUN
gsrj-19	65	9	surface	surface	NOUN
gsrj-19	65	10	and	and	CCONJ
gsrj-19	65	11	total	total	ADJ
gsrj-19	65	12	nr2a	nr2a	NOUN
gsrj-19	65	13	and	and	CCONJ
gsrj-19	65	14	nr2b	nr2b	NUM
gsrj-19	65	15	expression	expression	NOUN
gsrj-19	65	16	was	be	AUX
gsrj-19	65	17	quantified	quantify	VERB
gsrj-19	65	18	via	via	ADP
gsrj-19	65	19	western	western	ADJ
gsrj-19	65	20	blot	blot	NOUN
gsrj-19	65	21	.	.	PUNCT
gsrj-19	66	1	significant	significant	ADJ
gsrj-19	66	2	differences	difference	NOUN
gsrj-19	66	3	were	be	AUX
gsrj-19	66	4	observed	observe	VERB
gsrj-19	66	5	in	in	ADP
gsrj-19	66	6	both	both	DET
gsrj-19	66	7	treatment	treatment	NOUN
gsrj-19	66	8	models	model	NOUN
gsrj-19	66	9	between	between	ADP
gsrj-19	66	10	antagonist	antagonist	NOUN
gsrj-19	66	11	and	and	CCONJ
gsrj-19	66	12	agonist	agonist	NOUN
gsrj-19	66	13	groups	group	NOUN
gsrj-19	66	14	.	.	PUNCT
gsrj-19	67	1	one	one	NUM
gsrj-19	67	2	-	-	PUNCT
gsrj-19	67	3	way	way	NOUN
gsrj-19	67	4	anova	anova	PROPN
gsrj-19	67	5	and	and	CCONJ
gsrj-19	67	6	tukey	tukey	PROPN
gsrj-19	67	7	’s	’s	PART
gsrj-19	67	8	test	test	NOUN
gsrj-19	67	9	(	(	PUNCT
gsrj-19	67	10	figure	figure	NOUN
gsrj-19	67	11	taken	take	VERB
gsrj-19	67	12	from	from	ADP
gsrj-19	67	13	yang	yang	PROPN
gsrj-19	67	14	et	et	PROPN
gsrj-19	67	15	al	al	PROPN
gsrj-19	67	16	.	.	PROPN
gsrj-19	67	17	,	,	PUNCT
gsrj-19	67	18	2018	2018	NUM
gsrj-19	67	19	)	)	PUNCT
gsrj-19	67	20	.	.	PUNCT
gsrj-19	68	1	the	the	DET
gsrj-19	68	2	next	next	ADJ
gsrj-19	68	3	aim	aim	NOUN
gsrj-19	68	4	was	be	AUX
gsrj-19	68	5	to	to	PART
gsrj-19	68	6	determine	determine	VERB
gsrj-19	68	7	how	how	SCONJ
gsrj-19	68	8	gpr40	gpr40	PROPN
gsrj-19	68	9	regulated	regulate	VERB
gsrj-19	68	10	seizure	seizure	NOUN
gsrj-19	68	11	-	-	PUNCT
gsrj-19	68	12	like	like	ADJ
gsrj-19	68	13	activity	activity	NOUN
gsrj-19	68	14	.	.	PUNCT
gsrj-19	69	1	they	they	PRON
gsrj-19	69	2	found	find	VERB
gsrj-19	69	3	that	that	SCONJ
gsrj-19	69	4	gpr40	gpr40	PROPN
gsrj-19	69	5	regulated	regulate	VERB
gsrj-19	69	6	the	the	DET
gsrj-19	69	7	functions	function	NOUN
gsrj-19	69	8	of	of	ADP
gsrj-19	69	9	nr2a	nr2a	NOUN
gsrj-19	69	10	and	and	CCONJ
gsrj-19	69	11	nr2b	nr2b	NOUN
gsrj-19	69	12	as	as	ADV
gsrj-19	69	13	well	well	ADV
gsrj-19	69	14	as	as	ADP
gsrj-19	69	15	nmdar	nmdar	ADV
gsrj-19	69	16	-	-	PUNCT
gsrj-19	69	17	mediated	mediate	VERB
gsrj-19	69	18	synaptic	synaptic	ADJ
gsrj-19	69	19	responses	response	NOUN
gsrj-19	69	20	.	.	PUNCT
gsrj-19	70	1	interestingly	interestingly	ADV
gsrj-19	70	2	,	,	PUNCT
gsrj-19	70	3	the	the	DET
gsrj-19	70	4	different	different	ADJ
gsrj-19	70	5	subunits	subunit	NOUN
gsrj-19	70	6	of	of	ADP
gsrj-19	70	7	the	the	DET
gsrj-19	70	8	nmda	nmda	ADJ
gsrj-19	70	9	receptor	receptor	NOUN
gsrj-19	70	10	are	be	AUX
gsrj-19	70	11	referred	refer	VERB
gsrj-19	70	12	to	to	ADP
gsrj-19	70	13	as	as	ADP
gsrj-19	70	14	a	a	DET
gsrj-19	70	15	heterotetrameric	heterotetrameric	ADJ
gsrj-19	70	16	assembly	assembly	NOUN
gsrj-19	70	17	.	.	PUNCT
gsrj-19	71	1	specifically	specifically	ADV
gsrj-19	71	2	,	,	PUNCT
gsrj-19	71	3	the	the	DET
gsrj-19	71	4	role	role	NOUN
gsrj-19	71	5	of	of	ADP
gsrj-19	71	6	the	the	DET
gsrj-19	71	7	nr2	nr2	NOUN
gsrj-19	71	8	subunit	subunit	NOUN
gsrj-19	71	9	in	in	ADP
gsrj-19	71	10	epilepsy	epilepsy	NOUN
gsrj-19	71	11	was	be	AUX
gsrj-19	71	12	evaluated	evaluate	VERB
gsrj-19	71	13	by	by	ADP
gsrj-19	71	14	determining	determine	VERB
gsrj-19	71	15	the	the	DET
gsrj-19	71	16	impact	impact	NOUN
gsrj-19	71	17	of	of	ADP
gsrj-19	71	18	gpr40	gpr40	PROPN
gsrj-19	71	19	on	on	ADP
gsrj-19	71	20	nmdar	nmdar	PROPN
gsrj-19	71	21	regulation	regulation	NOUN
gsrj-19	71	22	(	(	PUNCT
gsrj-19	71	23	figure	figure	NOUN
gsrj-19	71	24	2	2	NUM
gsrj-19	71	25	)	)	PUNCT
gsrj-19	71	26	.	.	PUNCT
gsrj-19	72	1	in	in	ADP
gsrj-19	72	2	order	order	NOUN
gsrj-19	72	3	to	to	PART
gsrj-19	72	4	study	study	VERB
gsrj-19	72	5	the	the	DET
gsrj-19	72	6	regulation	regulation	NOUN
gsrj-19	72	7	and	and	CCONJ
gsrj-19	72	8	cell	cell	NOUN
gsrj-19	72	9	surface	surface	NOUN
gsrj-19	72	10	expression	expression	NOUN
gsrj-19	72	11	of	of	ADP
gsrj-19	72	12	nr2	nr2	PROPN
gsrj-19	72	13	subunits	subunit	NOUN
gsrj-19	72	14	,	,	PUNCT
gsrj-19	72	15	the	the	DET
gsrj-19	72	16	experimenters	experimenter	NOUN
gsrj-19	72	17	treated	treat	VERB
gsrj-19	72	18	mice	mouse	NOUN
gsrj-19	72	19	with	with	ADP
gsrj-19	72	20	ka	ka	PROPN
gsrj-19	72	21	and	and	CCONJ
gsrj-19	72	22	ptz	ptz	PROPN
gsrj-19	72	23	,	,	PUNCT
gsrj-19	72	24	then	then	ADV
gsrj-19	72	25	harnessed	harness	VERB
gsrj-19	72	26	hippocampal	hippocampal	ADJ
gsrj-19	72	27	slices	slice	NOUN
gsrj-19	72	28	from	from	ADP
gsrj-19	72	29	these	these	DET
gsrj-19	72	30	mouse	mouse	NOUN
gsrj-19	72	31	models	model	NOUN
gsrj-19	72	32	.	.	PUNCT
gsrj-19	73	1	they	they	PRON
gsrj-19	73	2	quantified	quantify	VERB
gsrj-19	73	3	total	total	ADJ
gsrj-19	73	4	expression	expression	NOUN
gsrj-19	73	5	and	and	CCONJ
gsrj-19	73	6	cell	cell	NOUN
gsrj-19	73	7	surface	surface	NOUN
gsrj-19	73	8	expression	expression	NOUN
gsrj-19	73	9	of	of	ADP
gsrj-19	73	10	both	both	CCONJ
gsrj-19	73	11	nr2a	nr2a	PROPN
gsrj-19	73	12	and	and	CCONJ
gsrj-19	73	13	nr2b	nr2b	NOUN
gsrj-19	73	14	subunits	subunit	NOUN
gsrj-19	73	15	for	for	ADP
gsrj-19	73	16	the	the	DET
gsrj-19	73	17	gw9508	gw9508	NOUN
gsrj-19	73	18	,	,	PUNCT
gsrj-19	73	19	gw1100	gw1100	NOUN
gsrj-19	73	20	,	,	PUNCT
gsrj-19	73	21	and	and	CCONJ
gsrj-19	73	22	dmso	dmso	ADJ
gsrj-19	73	23	groups	group	NOUN
gsrj-19	73	24	and	and	CCONJ
gsrj-19	73	25	compared	compare	VERB
gsrj-19	73	26	them	they	PRON
gsrj-19	73	27	against	against	ADP
gsrj-19	73	28	a	a	DET
gsrj-19	73	29	standard	standard	ADJ
gsrj-19	73	30	control	control	NOUN
gsrj-19	73	31	of	of	ADP
gsrj-19	73	32	bactin	bactin	NOUN
gsrj-19	73	33	.	.	PUNCT
gsrj-19	74	1	it	it	PRON
gsrj-19	74	2	was	be	AUX
gsrj-19	74	3	found	find	VERB
gsrj-19	74	4	that	that	SCONJ
gsrj-19	74	5	when	when	SCONJ
gsrj-19	74	6	compared	compare	VERB
gsrj-19	74	7	to	to	ADP
gsrj-19	74	8	the	the	DET
gsrj-19	74	9	dmso	dmso	ADJ
gsrj-19	74	10	group	group	NOUN
gsrj-19	74	11	,	,	PUNCT
gsrj-19	74	12	nr2a	nr2a	PROPN
gsrj-19	74	13	/	/	SYM
gsrj-19	74	14	b	b	NOUN
gsrj-19	74	15	showed	show	VERB
gsrj-19	74	16	no	no	DET
gsrj-19	74	17	significant	significant	ADJ
gsrj-19	74	18	change	change	NOUN
gsrj-19	74	19	in	in	ADP
gsrj-19	74	20	total	total	ADJ
gsrj-19	74	21	expression	expression	NOUN
gsrj-19	74	22	for	for	ADP
gsrj-19	74	23	both	both	CCONJ
gsrj-19	74	24	the	the	DET
gsrj-19	74	25	gw9508	gw9508	PROPN
gsrj-19	74	26	and	and	CCONJ
gsrj-19	74	27	gw1100	gw1100	NOUN
gsrj-19	74	28	models	model	NOUN
gsrj-19	74	29	(	(	PUNCT
gsrj-19	74	30	figure	figure	NOUN
gsrj-19	74	31	2	2	NUM
gsrj-19	74	32	)	)	PUNCT
gsrj-19	74	33	.	.	PUNCT
gsrj-19	75	1	however	however	ADV
gsrj-19	75	2	,	,	PUNCT
gsrj-19	75	3	the	the	DET
gsrj-19	75	4	ratio	ratio	NOUN
gsrj-19	75	5	of	of	ADP
gsrj-19	75	6	surface	surface	NOUN
gsrj-19	75	7	to	to	AUX
gsrj-19	75	8	total	total	ADJ
gsrj-19	75	9	expression	expression	NOUN
gsrj-19	75	10	of	of	ADP
gsrj-19	75	11	both	both	CCONJ
gsrj-19	75	12	nr2a	nr2a	PROPN
gsrj-19	75	13	and	and	CCONJ
gsrj-19	75	14	nr2b	nr2b	PROPN
gsrj-19	75	15	was	be	AUX
gsrj-19	75	16	significantly	significantly	ADV
gsrj-19	75	17	reduced	reduce	VERB
gsrj-19	75	18	for	for	ADP
gsrj-19	75	19	the	the	DET
gsrj-19	75	20	gw9508	gw9508	PROPN
gsrj-19	75	21	agonist	agonist	NOUN
gsrj-19	75	22	treatment	treatment	NOUN
gsrj-19	75	23	group	group	NOUN
gsrj-19	75	24	whereas	whereas	SCONJ
gsrj-19	75	25	the	the	DET
gsrj-19	75	26	opposite	opposite	ADJ
gsrj-19	75	27	results	result	NOUN
gsrj-19	75	28	were	be	AUX
gsrj-19	75	29	observed	observe	VERB
gsrj-19	75	30	for	for	ADP
gsrj-19	75	31	the	the	DET
gsrj-19	75	32	gw1100	gw1100	PROPN
gsrj-19	75	33	antagonist	antagonist	NOUN
gsrj-19	75	34	treatment	treatment	NOUN
gsrj-19	75	35	group	group	NOUN
gsrj-19	75	36	.	.	PUNCT
gsrj-19	76	1	(	(	PUNCT
gsrj-19	76	2	figure	figure	NOUN
gsrj-19	76	3	2	2	NUM
gsrj-19	76	4	)	)	PUNCT
gsrj-19	76	5	.	.	PUNCT
gsrj-19	77	1	these	these	DET
gsrj-19	77	2	results	result	NOUN
gsrj-19	77	3	suggest	suggest	VERB
gsrj-19	77	4	that	that	SCONJ
gsrj-19	77	5	gpr40	gpr40	PROPN
gsrj-19	77	6	impacted	impact	VERB
gsrj-19	77	7	the	the	DET
gsrj-19	77	8	cell	cell	NOUN
gsrj-19	77	9	surface	surface	NOUN
gsrj-19	77	10	expression	expression	NOUN
gsrj-19	77	11	of	of	ADP
gsrj-19	77	12	both	both	DET
gsrj-19	77	13	nmda	nmda	ADJ
gsrj-19	77	14	subunits	subunit	NOUN
gsrj-19	77	15	in	in	ADP
gsrj-19	77	16	the	the	DET
gsrj-19	77	17	hippocampal	hippocampal	ADJ
gsrj-19	77	18	tissues	tissue	NOUN
gsrj-19	77	19	.	.	PUNCT
gsrj-19	78	1	figure	figure	VERB
gsrj-19	78	2	3	3	NUM
gsrj-19	78	3	.	.	PUNCT
gsrj-19	79	1	gpr40	gpr40	PROPN
gsrj-19	79	2	regulates	regulate	VERB
gsrj-19	79	3	nr2a	nr2a	PROPN
gsrj-19	79	4	and	and	CCONJ
gsrj-19	79	5	nr2b	nr2b	NUM
gsrj-19	79	6	endocytosis	endocytosis	NOUN
gsrj-19	79	7	,	,	PUNCT
gsrj-19	79	8	thereby	thereby	ADV
gsrj-19	79	9	affecting	affect	VERB
gsrj-19	79	10	nmda	nmda	ADJ
gsrj-19	79	11	-	-	PUNCT
gsrj-19	79	12	mediated	mediate	VERB
gsrj-19	79	13	postsynaptic	postsynaptic	ADJ
gsrj-19	79	14	currents	current	NOUN
gsrj-19	79	15	.	.	PUNCT
gsrj-19	80	1	ca1	ca1	PROPN
gsrj-19	80	2	hippocampal	hippocampal	PROPN
gsrj-19	80	3	neurons	neuron	NOUN
gsrj-19	80	4	were	be	AUX
gsrj-19	80	5	isolated	isolate	VERB
gsrj-19	80	6	from	from	ADP
gsrj-19	80	7	brain	brain	NOUN
gsrj-19	80	8	tissue	tissue	NOUN
gsrj-19	80	9	treated	treat	VERB
gsrj-19	80	10	with	with	ADP
gsrj-19	80	11	endocytosis	endocytosis	NOUN
gsrj-19	80	12	and	and	CCONJ
gsrj-19	80	13	exocytosis	exocytosis	NOUN
gsrj-19	80	14	blockers	blocker	NOUN
gsrj-19	80	15	.	.	PUNCT
gsrj-19	81	1	a	a	X
gsrj-19	81	2	-	-	PUNCT
gsrj-19	81	3	d	d	NOUN
gsrj-19	81	4	)	)	PUNCT
gsrj-19	81	5	measured	measure	VERB
gsrj-19	81	6	nmdarepscs	nmdarepsc	NOUN
gsrj-19	81	7	after	after	ADP
gsrj-19	81	8	treatment	treatment	NOUN
gsrj-19	81	9	with	with	ADP
gsrj-19	81	10	0.1	0.1	NUM
gsrj-19	81	11	m	m	NOUN
gsrj-19	81	12	tetx	tetx	NOUN
gsrj-19	81	13	or	or	CCONJ
gsrj-19	81	14	80	80	NUM
gsrj-19	81	15	mm	mm	NOUN
gsrj-19	81	16	dynasore	dynasore	NOUN
gsrj-19	81	17	(	(	PUNCT
gsrj-19	81	18	n=5	n=5	PROPN
gsrj-19	81	19	in	in	ADP
gsrj-19	81	20	each	each	DET
gsrj-19	81	21	group	group	NOUN
gsrj-19	81	22	)	)	PUNCT
gsrj-19	81	23	.	.	PUNCT
gsrj-19	82	1	significant	significant	ADJ
gsrj-19	82	2	difference	difference	NOUN
gsrj-19	82	3	(	(	PUNCT
gsrj-19	82	4	*	*	PUNCT
gsrj-19	82	5	p	p	X
gsrj-19	82	6	<	<	X
gsrj-19	82	7	0.05	0.05	NUM
gsrj-19	82	8	)	)	PUNCT
gsrj-19	82	9	observed	observe	VERB
gsrj-19	82	10	between	between	ADP
gsrj-19	82	11	control	control	NOUN
gsrj-19	82	12	and	and	CCONJ
gsrj-19	82	13	treatment	treatment	NOUN
gsrj-19	82	14	groups	group	NOUN
gsrj-19	82	15	when	when	SCONJ
gsrj-19	82	16	treated	treat	VERB
gsrj-19	82	17	with	with	ADP
gsrj-19	82	18	tetx	tetx	NOUN
gsrj-19	82	19	.	.	PUNCT
gsrj-19	83	1	one	one	NUM
gsrj-19	83	2	-	-	PUNCT
gsrj-19	83	3	way	way	NOUN
gsrj-19	83	4	anova	anova	PROPN
gsrj-19	83	5	and	and	CCONJ
gsrj-19	83	6	tukey	tukey	PROPN
gsrj-19	83	7	’s	’s	PART
gsrj-19	83	8	test	test	NOUN
gsrj-19	83	9	.	.	PUNCT
gsrj-19	84	1	e	e	X
gsrj-19	84	2	-	-	NOUN
gsrj-19	84	3	f	f	ADJ
gsrj-19	84	4	)	)	PUNCT
gsrj-19	84	5	confocal	confocal	ADJ
gsrj-19	84	6	image	image	NOUN
gsrj-19	84	7	and	and	CCONJ
gsrj-19	84	8	analysis	analysis	NOUN
gsrj-19	84	9	showing	show	VERB
gsrj-19	84	10	differences	difference	NOUN
gsrj-19	84	11	in	in	ADP
gsrj-19	84	12	alexa	alexa	ADJ
gsrj-19	84	13	594	594	NUM
gsrj-19	84	14	-	-	PUNCT
gsrj-19	84	15	transferrin	transferrin	NOUN
gsrj-19	84	16	uptake	uptake	NOUN
gsrj-19	84	17	between	between	ADP
gsrj-19	84	18	20	20	NUM
gsrj-19	84	19	m	m	NOUN
gsrj-19	84	20	gw9508	gw9508	NOUN
gsrj-19	84	21	and	and	CCONJ
gsrj-19	84	22	dmso	dmso	ADJ
gsrj-19	84	23	treatment	treatment	NOUN
gsrj-19	84	24	groups	group	NOUN
gsrj-19	84	25	.	.	PUNCT
gsrj-19	85	1	g	g	NOUN
gsrj-19	85	2	-	-	PUNCT
gsrj-19	85	3	h	h	NOUN
gsrj-19	85	4	)	)	PUNCT
gsrj-19	85	5	confocal	confocal	ADJ
gsrj-19	85	6	image	image	NOUN
gsrj-19	85	7	and	and	CCONJ
gsrj-19	85	8	analysis	analysis	NOUN
gsrj-19	85	9	showing	show	VERB
gsrj-19	85	10	differences	difference	NOUN
gsrj-19	85	11	in	in	ADP
gsrj-19	85	12	alexa	alexa	ADJ
gsrj-19	85	13	594	594	NUM
gsrj-19	85	14	-	-	PUNCT
gsrj-19	85	15	transferrin	transferrin	NOUN
gsrj-19	85	16	uptake	uptake	NOUN
gsrj-19	85	17	between	between	ADP
gsrj-19	85	18	20	20	NUM
gsrj-19	85	19	m	m	NOUN
gsrj-19	85	20	gw1100	gw1100	NOUN
gsrj-19	85	21	and	and	CCONJ
gsrj-19	85	22	dmso	dmso	ADJ
gsrj-19	85	23	treatment	treatment	NOUN
gsrj-19	85	24	groups	group	NOUN
gsrj-19	85	25	(	(	PUNCT
gsrj-19	85	26	figure	figure	NOUN
gsrj-19	85	27	taken	take	VERB
gsrj-19	85	28	from	from	ADP
gsrj-19	85	29	yang	yang	PROPN
gsrj-19	85	30	et	et	PROPN
gsrj-19	85	31	al	al	PROPN
gsrj-19	85	32	.	.	PROPN
gsrj-19	85	33	,	,	PUNCT
gsrj-19	85	34	2018	2018	NUM
gsrj-19	85	35	)	)	PUNCT
gsrj-19	85	36	.	.	PUNCT
gsrj-19	86	1	24	24	NUM
gsrj-19	86	2	georgetown	georgetown	PROPN
gsrj-19	86	3	scientific	scientific	PROPN
gsrj-19	86	4	research	research	NOUN
gsrj-19	86	5	journal	journal	NOUN
gsrj-19	86	6	this	this	DET
gsrj-19	86	7	finding	finding	NOUN
gsrj-19	86	8	was	be	AUX
gsrj-19	86	9	further	far	ADV
gsrj-19	86	10	analyzed	analyze	VERB
gsrj-19	86	11	,	,	PUNCT
gsrj-19	86	12	shedding	shed	VERB
gsrj-19	86	13	light	light	NOUN
gsrj-19	86	14	on	on	ADP
gsrj-19	86	15	the	the	DET
gsrj-19	86	16	regulation	regulation	NOUN
gsrj-19	86	17	of	of	ADP
gsrj-19	86	18	gpr40	gpr40	PROPN
gsrj-19	86	19	on	on	ADP
gsrj-19	86	20	the	the	DET
gsrj-19	86	21	surface	surface	NOUN
gsrj-19	86	22	level	level	NOUN
gsrj-19	86	23	expression	expression	NOUN
gsrj-19	86	24	of	of	ADP
gsrj-19	86	25	nmdars	nmdar	NOUN
gsrj-19	86	26	.	.	PUNCT
gsrj-19	87	1	this	this	PRON
gsrj-19	87	2	was	be	AUX
gsrj-19	87	3	done	do	VERB
gsrj-19	87	4	through	through	ADP
gsrj-19	87	5	the	the	DET
gsrj-19	87	6	examination	examination	NOUN
gsrj-19	87	7	of	of	ADP
gsrj-19	87	8	nmda	nmda	ADJ
gsrj-19	87	9	-	-	PUNCT
gsrj-19	87	10	epscs	epsc	NOUN
gsrj-19	87	11	(	(	PUNCT
gsrj-19	87	12	nmda	nmda	ADJ
gsrj-19	87	13	-	-	PUNCT
gsrj-19	87	14	excitatory	excitatory	ADJ
gsrj-19	87	15	postsynaptic	postsynaptic	ADJ
gsrj-19	87	16	currents	current	NOUN
gsrj-19	87	17	)	)	PUNCT
gsrj-19	87	18	on	on	ADP
gsrj-19	87	19	specific	specific	ADJ
gsrj-19	87	20	ca1	ca1	PROPN
gsrj-19	87	21	hippocampal	hippocampal	ADJ
gsrj-19	87	22	neurons	neuron	NOUN
gsrj-19	87	23	that	that	PRON
gsrj-19	87	24	were	be	AUX
gsrj-19	87	25	obtained	obtain	VERB
gsrj-19	87	26	from	from	ADP
gsrj-19	87	27	brain	brain	NOUN
gsrj-19	87	28	tissue	tissue	NOUN
gsrj-19	87	29	slices	slice	NOUN
gsrj-19	87	30	treated	treat	VERB
gsrj-19	87	31	with	with	ADP
gsrj-19	87	32	endocytosis	endocytosis	NOUN
gsrj-19	87	33	and	and	CCONJ
gsrj-19	87	34	exocytosis	exocytosis	NOUN
gsrj-19	87	35	blockers	blocker	NOUN
gsrj-19	87	36	.	.	PUNCT
gsrj-19	88	1	interestingly	interestingly	ADV
gsrj-19	88	2	,	,	PUNCT
gsrj-19	88	3	nmda	nmda	ADJ
gsrj-19	88	4	-	-	PUNCT
gsrj-19	88	5	epscs	epsc	NOUN
gsrj-19	88	6	amplitudes	amplitude	NOUN
gsrj-19	88	7	were	be	AUX
gsrj-19	88	8	decreased	decrease	VERB
gsrj-19	88	9	in	in	ADP
gsrj-19	88	10	gw9508	gw9508	PROPN
gsrj-19	88	11	but	but	CCONJ
gsrj-19	88	12	increased	increase	VERB
gsrj-19	88	13	in	in	ADP
gsrj-19	88	14	gw1100	gw1100	PROPN
gsrj-19	88	15	(	(	PUNCT
gsrj-19	88	16	figure	figure	NOUN
gsrj-19	88	17	3b	3b	NUM
gsrj-19	88	18	)	)	PUNCT
gsrj-19	88	19	.	.	PUNCT
gsrj-19	89	1	however	however	ADV
gsrj-19	89	2	,	,	PUNCT
gsrj-19	89	3	this	this	DET
gsrj-19	89	4	effect	effect	NOUN
gsrj-19	89	5	was	be	AUX
gsrj-19	89	6	not	not	PART
gsrj-19	89	7	seen	see	VERB
gsrj-19	89	8	in	in	ADP
gsrj-19	89	9	the	the	DET
gsrj-19	89	10	presence	presence	NOUN
gsrj-19	89	11	of	of	ADP
gsrj-19	89	12	the	the	DET
gsrj-19	89	13	endocytosis	endocytosis	NOUN
gsrj-19	89	14	blocker	blocker	NOUN
gsrj-19	89	15	dynasore	dynasore	NOUN
gsrj-19	89	16	,	,	PUNCT
gsrj-19	89	17	suggesting	suggest	VERB
gsrj-19	89	18	that	that	SCONJ
gsrj-19	89	19	gpr40	gpr40	PROPN
gsrj-19	89	20	regulates	regulate	VERB
gsrj-19	89	21	mnda	mnda	NOUN
gsrj-19	89	22	transmission	transmission	NOUN
gsrj-19	89	23	through	through	ADP
gsrj-19	89	24	endocytic	endocytic	ADJ
gsrj-19	89	25	mechanism	mechanism	NOUN
gsrj-19	89	26	(	(	PUNCT
gsrj-19	89	27	figure	figure	NOUN
gsrj-19	89	28	3b	3b	NUM
gsrj-19	89	29	,	,	PUNCT
gsrj-19	89	30	d	d	NOUN
gsrj-19	89	31	)	)	PUNCT
gsrj-19	89	32	.	.	PUNCT
gsrj-19	90	1	in	in	SCONJ
gsrj-19	90	2	order	order	NOUN
gsrj-19	90	3	to	to	PART
gsrj-19	90	4	quantify	quantify	VERB
gsrj-19	90	5	the	the	DET
gsrj-19	90	6	effect	effect	NOUN
gsrj-19	90	7	of	of	ADP
gsrj-19	90	8	grp40	grp40	PROPN
gsrj-19	90	9	on	on	ADP
gsrj-19	90	10	endocytosis	endocytosis	NOUN
gsrj-19	90	11	,	,	PUNCT
gsrj-19	90	12	an	an	DET
gsrj-19	90	13	alexa-594	alexa-594	NOUN
gsrj-19	90	14	-	-	PUNCT
gsrj-19	90	15	transferrin	transferrin	NOUN
gsrj-19	90	16	uptake	uptake	ADJ
gsrj-19	90	17	assay	assay	NOUN
gsrj-19	90	18	of	of	ADP
gsrj-19	90	19	cultured	cultured	ADJ
gsrj-19	90	20	neurons	neuron	NOUN
gsrj-19	90	21	that	that	PRON
gsrj-19	90	22	had	have	AUX
gsrj-19	90	23	been	be	AUX
gsrj-19	90	24	previously	previously	ADV
gsrj-19	90	25	treated	treat	VERB
gsrj-19	90	26	with	with	ADP
gsrj-19	90	27	gw9508	gw9508	PROPN
gsrj-19	90	28	and	and	CCONJ
gsrj-19	90	29	gw1100	gw1100	NOUN
gsrj-19	90	30	was	be	AUX
gsrj-19	90	31	used	use	VERB
gsrj-19	90	32	.	.	PUNCT
gsrj-19	91	1	gw9508	gw9508	PROPN
gsrj-19	91	2	showed	show	VERB
gsrj-19	91	3	an	an	DET
gsrj-19	91	4	increase	increase	NOUN
gsrj-19	91	5	in	in	ADP
gsrj-19	91	6	comparison	comparison	NOUN
gsrj-19	91	7	to	to	ADP
gsrj-19	91	8	dmso	dmso	NOUN
gsrj-19	91	9	whereas	whereas	SCONJ
gsrj-19	91	10	gw1100	gw1100	PROPN
gsrj-19	91	11	showed	show	VERB
gsrj-19	91	12	a	a	DET
gsrj-19	91	13	decrease	decrease	NOUN
gsrj-19	91	14	in	in	ADP
gsrj-19	91	15	comparison	comparison	NOUN
gsrj-19	91	16	to	to	ADP
gsrj-19	91	17	dmso	dmso	NOUN
gsrj-19	91	18	,	,	PUNCT
gsrj-19	91	19	which	which	PRON
gsrj-19	91	20	was	be	AUX
gsrj-19	91	21	seen	see	VERB
gsrj-19	91	22	via	via	ADP
gsrj-19	91	23	the	the	DET
gsrj-19	91	24	levels	level	NOUN
gsrj-19	91	25	of	of	ADP
gsrj-19	91	26	uptake	uptake	ADJ
gsrj-19	91	27	/	/	SYM
gsrj-19	91	28	intensity	intensity	NOUN
gsrj-19	91	29	of	of	ADP
gsrj-19	91	30	the	the	DET
gsrj-19	91	31	fluorescently	fluorescently	ADV
gsrj-19	91	32	conjugated	conjugate	VERB
gsrj-19	91	33	alexa	alexa	PROPN
gsrj-19	91	34	594	594	NUM
gsrj-19	91	35	-	-	PUNCT
gsrj-19	91	36	transferrin	transferrin	NOUN
gsrj-19	91	37	(	(	PUNCT
gsrj-19	91	38	figure	figure	NOUN
gsrj-19	91	39	3f	3f	PROPN
gsrj-19	91	40	,	,	PUNCT
gsrj-19	91	41	h	h	NOUN
gsrj-19	91	42	)	)	PUNCT
gsrj-19	91	43	.	.	PUNCT
gsrj-19	92	1	thus	thus	ADV
gsrj-19	92	2	,	,	PUNCT
gsrj-19	92	3	this	this	PRON
gsrj-19	92	4	confirmed	confirm	VERB
gsrj-19	92	5	that	that	SCONJ
gsrj-19	92	6	gpr40	gpr40	PROPN
gsrj-19	92	7	in	in	ADP
gsrj-19	92	8	fact	fact	NOUN
gsrj-19	92	9	has	have	VERB
gsrj-19	92	10	an	an	DET
gsrj-19	92	11	important	important	ADJ
gsrj-19	92	12	role	role	NOUN
gsrj-19	92	13	in	in	ADP
gsrj-19	92	14	the	the	DET
gsrj-19	92	15	regulation	regulation	NOUN
gsrj-19	92	16	of	of	ADP
gsrj-19	92	17	nmdar	nmdar	NOUN
gsrj-19	92	18	endocytosis	endocytosis	NOUN
gsrj-19	92	19	.	.	PUNCT
gsrj-19	93	1	the	the	DET
gsrj-19	93	2	molecular	molecular	ADJ
gsrj-19	93	3	mechanism	mechanism	NOUN
gsrj-19	93	4	regarding	regard	VERB
gsrj-19	93	5	gpr40	gpr40	PROPN
gsrj-19	93	6	regulation	regulation	NOUN
gsrj-19	93	7	of	of	ADP
gsrj-19	93	8	nmdar	nmdar	ADV
gsrj-19	93	9	-	-	PUNCT
gsrj-19	93	10	mediated	mediate	VERB
gsrj-19	93	11	excitatory	excitatory	ADJ
gsrj-19	93	12	synaptic	synaptic	ADJ
gsrj-19	93	13	transmission	transmission	NOUN
gsrj-19	93	14	has	have	VERB
gsrj-19	93	15	yet	yet	ADV
gsrj-19	93	16	to	to	PART
gsrj-19	93	17	be	be	AUX
gsrj-19	93	18	uncovered	uncover	VERB
gsrj-19	93	19	,	,	PUNCT
gsrj-19	93	20	however	however	ADV
gsrj-19	93	21	,	,	PUNCT
gsrj-19	93	22	this	this	DET
gsrj-19	93	23	study	study	NOUN
gsrj-19	93	24	provided	provide	VERB
gsrj-19	93	25	some	some	DET
gsrj-19	93	26	preliminary	preliminary	ADJ
gsrj-19	93	27	support	support	NOUN
gsrj-19	93	28	for	for	ADP
gsrj-19	93	29	gpr40	gpr40	PROPN
gsrj-19	93	30	and	and	CCONJ
gsrj-19	93	31	nmda	nmda	ADJ
gsrj-19	93	32	receptor	receptor	NOUN
gsrj-19	93	33	interaction	interaction	NOUN
gsrj-19	93	34	.	.	PUNCT
gsrj-19	94	1	the	the	DET
gsrj-19	94	2	surface	surface	NOUN
gsrj-19	94	3	expression	expression	NOUN
gsrj-19	94	4	of	of	ADP
gsrj-19	94	5	nmdars	nmdar	NOUN
gsrj-19	94	6	was	be	AUX
gsrj-19	94	7	shown	show	VERB
gsrj-19	94	8	to	to	PART
gsrj-19	94	9	have	have	VERB
gsrj-19	94	10	a	a	DET
gsrj-19	94	11	critical	critical	ADJ
gsrj-19	94	12	role	role	NOUN
gsrj-19	94	13	in	in	ADP
gsrj-19	94	14	nmdarmediated	nmdarmediate	VERB
gsrj-19	94	15	postsynaptic	postsynaptic	ADJ
gsrj-19	94	16	responses	response	NOUN
gsrj-19	94	17	,	,	PUNCT
gsrj-19	94	18	and	and	CCONJ
gsrj-19	94	19	their	their	PRON
gsrj-19	94	20	mislocalization	mislocalization	NOUN
gsrj-19	94	21	would	would	AUX
gsrj-19	94	22	therefore	therefore	ADV
gsrj-19	94	23	explain	explain	VERB
gsrj-19	94	24	the	the	DET
gsrj-19	94	25	possible	possible	ADJ
gsrj-19	94	26	pathological	pathological	ADJ
gsrj-19	94	27	impact	impact	NOUN
gsrj-19	94	28	on	on	ADP
gsrj-19	94	29	epilepsy	epilepsy	NOUN
gsrj-19	94	30	.	.	PUNCT
gsrj-19	95	1	an	an	DET
gsrj-19	95	2	interesting	interesting	ADJ
gsrj-19	95	3	implication	implication	NOUN
gsrj-19	95	4	from	from	ADP
gsrj-19	95	5	this	this	DET
gsrj-19	95	6	paper	paper	NOUN
gsrj-19	95	7	is	be	AUX
gsrj-19	95	8	the	the	DET
gsrj-19	95	9	role	role	NOUN
gsrj-19	95	10	that	that	PRON
gsrj-19	95	11	interactions	interaction	NOUN
gsrj-19	95	12	between	between	ADP
gsrj-19	95	13	proteins	protein	NOUN
gsrj-19	95	14	had	have	VERB
gsrj-19	95	15	on	on	ADP
gsrj-19	95	16	the	the	DET
gsrj-19	95	17	surface	surface	NOUN
gsrj-19	95	18	cell	cell	NOUN
gsrj-19	95	19	expression	expression	NOUN
gsrj-19	95	20	of	of	ADP
gsrj-19	95	21	nmdars	nmdar	NOUN
gsrj-19	95	22	.	.	PUNCT
gsrj-19	96	1	more	more	ADV
gsrj-19	96	2	specifically	specifically	ADV
gsrj-19	96	3	,	,	PUNCT
gsrj-19	96	4	the	the	DET
gsrj-19	96	5	reciprocal	reciprocal	ADJ
gsrj-19	96	6	co	co	NOUN
gsrj-19	96	7	immunoprecipitation	immunoprecipitation	NOUN
gsrj-19	96	8	,	,	PUNCT
gsrj-19	96	9	a	a	DET
gsrj-19	96	10	technique	technique	NOUN
gsrj-19	96	11	that	that	PRON
gsrj-19	96	12	serves	serve	VERB
gsrj-19	96	13	to	to	PART
gsrj-19	96	14	precipitate	precipitate	VERB
gsrj-19	96	15	a	a	DET
gsrj-19	96	16	protein	protein	NOUN
gsrj-19	96	17	antigen	antigen	ADJ
gsrj-19	96	18	out	out	ADP
gsrj-19	96	19	of	of	ADP
gsrj-19	96	20	a	a	DET
gsrj-19	96	21	solution	solution	NOUN
gsrj-19	96	22	via	via	ADP
gsrj-19	96	23	the	the	DET
gsrj-19	96	24	use	use	NOUN
gsrj-19	96	25	of	of	ADP
gsrj-19	96	26	a	a	DET
gsrj-19	96	27	specific	specific	ADJ
gsrj-19	96	28	protein	protein	NOUN
gsrj-19	96	29	binding	bind	VERB
gsrj-19	96	30	antibody	antibody	NOUN
gsrj-19	96	31	,	,	PUNCT
gsrj-19	96	32	showed	show	VERB
gsrj-19	96	33	that	that	SCONJ
gsrj-19	96	34	gpr40	gpr40	PROPN
gsrj-19	96	35	directly	directly	ADV
gsrj-19	96	36	interacts	interact	VERB
gsrj-19	96	37	with	with	ADP
gsrj-19	96	38	nr2a	nr2a	PROPN
gsrj-19	96	39	and	and	CCONJ
gsrj-19	96	40	nr2b	nr2b	NOUN
gsrj-19	96	41	.	.	PUNCT
gsrj-19	97	1	additionally	additionally	ADV
gsrj-19	97	2	,	,	PUNCT
gsrj-19	97	3	the	the	DET
gsrj-19	97	4	activation	activation	NOUN
gsrj-19	97	5	of	of	ADP
gsrj-19	97	6	gpr40	gpr40	PROPN
gsrj-19	97	7	led	lead	VERB
gsrj-19	97	8	to	to	PART
gsrj-19	97	9	decreased	decrease	VERB
gsrj-19	97	10	binding	bind	VERB
gsrj-19	97	11	with	with	ADP
gsrj-19	97	12	nr2a	nr2a	NOUN
gsrj-19	97	13	/	/	SYM
gsrj-19	97	14	b	b	NOUN
gsrj-19	97	15	,	,	PUNCT
gsrj-19	97	16	while	while	SCONJ
gsrj-19	97	17	the	the	DET
gsrj-19	97	18	inhibition	inhibition	NOUN
gsrj-19	97	19	of	of	ADP
gsrj-19	97	20	gpr40	gpr40	PROPN
gsrj-19	97	21	led	lead	VERB
gsrj-19	97	22	to	to	ADP
gsrj-19	97	23	increased	increase	VERB
gsrj-19	97	24	binding	bind	VERB
gsrj-19	97	25	.	.	PUNCT
gsrj-19	98	1	this	this	PRON
gsrj-19	98	2	supports	support	VERB
gsrj-19	98	3	the	the	DET
gsrj-19	98	4	idea	idea	NOUN
gsrj-19	98	5	that	that	SCONJ
gsrj-19	98	6	gpr40	gpr40	PROPN
gsrj-19	98	7	is	be	AUX
gsrj-19	98	8	therefore	therefore	ADV
gsrj-19	98	9	involved	involve	VERB
gsrj-19	98	10	in	in	ADP
gsrj-19	98	11	the	the	DET
gsrj-19	98	12	regulation	regulation	NOUN
gsrj-19	98	13	of	of	ADP
gsrj-19	98	14	both	both	PRON
gsrj-19	98	15	neuronal	neuronal	ADJ
gsrj-19	98	16	excitability	excitability	NOUN
gsrj-19	98	17	and	and	CCONJ
gsrj-19	98	18	epileptic	epileptic	ADJ
gsrj-19	98	19	activity	activity	NOUN
gsrj-19	98	20	.	.	PUNCT
gsrj-19	99	1	the	the	DET
gsrj-19	99	2	activation	activation	NOUN
gsrj-19	99	3	of	of	ADP
gsrj-19	99	4	gpr40	gpr40	PROPN
gsrj-19	99	5	is	be	AUX
gsrj-19	99	6	thus	thus	ADV
gsrj-19	99	7	thought	think	VERB
gsrj-19	99	8	to	to	PART
gsrj-19	99	9	decrease	decrease	VERB
gsrj-19	99	10	epileptic	epileptic	ADJ
gsrj-19	99	11	seizures	seizure	NOUN
gsrj-19	99	12	in	in	ADP
gsrj-19	99	13	animal	animal	NOUN
gsrj-19	99	14	models	model	NOUN
gsrj-19	99	15	,	,	PUNCT
gsrj-19	99	16	as	as	ADV
gsrj-19	99	17	well	well	ADV
gsrj-19	99	18	as	as	ADP
gsrj-19	99	19	nmdarmediated	nmdarmediate	VERB
gsrj-19	99	20	postsynaptic	postsynaptic	ADJ
gsrj-19	99	21	transmission	transmission	NOUN
gsrj-19	99	22	,	,	PUNCT
gsrj-19	99	23	which	which	PRON
gsrj-19	99	24	allowed	allow	VERB
gsrj-19	99	25	for	for	ADP
gsrj-19	99	26	a	a	DET
gsrj-19	99	27	new	new	ADJ
gsrj-19	99	28	antiepileptic	antiepileptic	ADJ
gsrj-19	99	29	target	target	NOUN
gsrj-19	99	30	to	to	PART
gsrj-19	99	31	be	be	AUX
gsrj-19	99	32	established.3	established.3	NOUN
gsrj-19	99	33	overall	overall	ADV
gsrj-19	99	34	,	,	PUNCT
gsrj-19	99	35	these	these	DET
gsrj-19	99	36	results	result	NOUN
gsrj-19	99	37	demonstrate	demonstrate	VERB
gsrj-19	99	38	that	that	SCONJ
gsrj-19	99	39	gpr40	gpr40	PROPN
gsrj-19	99	40	activation	activation	NOUN
gsrj-19	99	41	decreases	decrease	VERB
gsrj-19	99	42	epileptic	epileptic	ADJ
gsrj-19	99	43	seizures	seizure	NOUN
gsrj-19	99	44	through	through	ADP
gsrj-19	99	45	binding	bind	VERB
gsrj-19	99	46	to	to	ADP
gsrj-19	99	47	nr2a	nr2a	NOUN
gsrj-19	99	48	/	/	SYM
gsrj-19	99	49	nr2b	nr2b	NOUN
gsrj-19	99	50	,	,	PUNCT
gsrj-19	99	51	inducing	induce	VERB
gsrj-19	99	52	increased	increased	ADJ
gsrj-19	99	53	endocytosis	endocytosis	NOUN
gsrj-19	99	54	of	of	ADP
gsrj-19	99	55	nmda	nmda	ADJ
gsrj-19	99	56	receptors	receptor	NOUN
gsrj-19	99	57	,	,	PUNCT
gsrj-19	99	58	and	and	CCONJ
gsrj-19	99	59	therefore	therefore	ADV
gsrj-19	99	60	affecting	affect	VERB
gsrj-19	99	61	nmdar	nmdar	ADV
gsrj-19	99	62	-	-	PUNCT
gsrj-19	99	63	mediated	mediate	VERB
gsrj-19	99	64	postsynaptic	postsynaptic	ADJ
gsrj-19	99	65	transmission	transmission	NOUN
gsrj-19	99	66	and	and	CCONJ
gsrj-19	99	67	excitability	excitability	NOUN
gsrj-19	99	68	.	.	PUNCT
gsrj-19	100	1	4	4	X
gsrj-19	100	2	.	.	NOUN
gsrj-19	100	3	conclusion	conclusion	NOUN
gsrj-19	100	4	and	and	CCONJ
gsrj-19	100	5	future	future	ADJ
gsrj-19	100	6	directions	direction	NOUN
gsrj-19	100	7	overall	overall	ADV
gsrj-19	100	8	,	,	PUNCT
gsrj-19	100	9	more	more	ADJ
gsrj-19	100	10	research	research	NOUN
gsrj-19	100	11	is	be	AUX
gsrj-19	100	12	needed	need	VERB
gsrj-19	100	13	to	to	PART
gsrj-19	100	14	understand	understand	VERB
gsrj-19	100	15	the	the	DET
gsrj-19	100	16	complex	complex	ADJ
gsrj-19	100	17	interaction	interaction	NOUN
gsrj-19	100	18	between	between	ADP
gsrj-19	100	19	sleep	sleep	NOUN
gsrj-19	100	20	and	and	CCONJ
gsrj-19	100	21	epilepsy	epilepsy	NOUN
gsrj-19	100	22	.	.	PUNCT
gsrj-19	101	1	sleep	sleep	NOUN
gsrj-19	101	2	is	be	AUX
gsrj-19	101	3	a	a	DET
gsrj-19	101	4	very	very	ADV
gsrj-19	101	5	important	important	ADJ
gsrj-19	101	6	factor	factor	NOUN
gsrj-19	101	7	to	to	PART
gsrj-19	101	8	consider	consider	VERB
gsrj-19	101	9	in	in	ADP
gsrj-19	101	10	epilepsy	epilepsy	NOUN
gsrj-19	101	11	patients	patient	NOUN
gsrj-19	101	12	and	and	CCONJ
gsrj-19	101	13	epileptic	epileptic	ADJ
gsrj-19	101	14	patients	patient	NOUN
gsrj-19	101	15	need	need	VERB
gsrj-19	101	16	to	to	PART
gsrj-19	101	17	make	make	VERB
gsrj-19	101	18	sure	sure	ADJ
gsrj-19	101	19	they	they	PRON
gsrj-19	101	20	have	have	VERB
gsrj-19	101	21	a	a	DET
gsrj-19	101	22	consistent	consistent	ADJ
gsrj-19	101	23	sleep	sleep	NOUN
gsrj-19	101	24	schedule	schedule	NOUN
gsrj-19	101	25	.	.	PUNCT
gsrj-19	102	1	in	in	ADP
gsrj-19	102	2	summary	summary	NOUN
gsrj-19	102	3	,	,	PUNCT
gsrj-19	102	4	yang	yang	PROPN
gsrj-19	102	5	et	et	PROPN
gsrj-19	102	6	al	al	PROPN
gsrj-19	102	7	.	.	PROPN
gsrj-19	102	8	found	find	VERB
gsrj-19	102	9	that	that	SCONJ
gsrj-19	102	10	increased	increase	VERB
gsrj-19	102	11	gpr40	gpr40	PROPN
gsrj-19	102	12	expression	expression	NOUN
gsrj-19	102	13	resulted	result	VERB
gsrj-19	102	14	in	in	ADP
gsrj-19	102	15	decreased	decrease	VERB
gsrj-19	102	16	binding	bind	VERB
gsrj-19	102	17	to	to	ADP
gsrj-19	102	18	the	the	DET
gsrj-19	102	19	nmda	nmda	ADJ
gsrj-19	102	20	receptor	receptor	NOUN
gsrj-19	102	21	subunit	subunit	NOUN
gsrj-19	102	22	nr2b	nr2b	NOUN
gsrj-19	102	23	which	which	PRON
gsrj-19	102	24	resulted	result	VERB
gsrj-19	102	25	in	in	ADP
gsrj-19	102	26	neuroprotective	neuroprotective	ADJ
gsrj-19	102	27	effects	effect	NOUN
gsrj-19	102	28	.	.	PUNCT
gsrj-19	103	1	one	one	NUM
gsrj-19	103	2	potential	potential	ADJ
gsrj-19	103	3	area	area	NOUN
gsrj-19	103	4	of	of	ADP
gsrj-19	103	5	future	future	ADJ
gsrj-19	103	6	research	research	NOUN
gsrj-19	103	7	includes	include	VERB
gsrj-19	103	8	the	the	DET
gsrj-19	103	9	downstream	downstream	ADJ
gsrj-19	103	10	signaling	signal	VERB
gsrj-19	103	11	interactions	interaction	NOUN
gsrj-19	103	12	,	,	PUNCT
gsrj-19	103	13	as	as	SCONJ
gsrj-19	103	14	they	they	PRON
gsrj-19	103	15	can	can	AUX
gsrj-19	103	16	provide	provide	VERB
gsrj-19	103	17	insight	insight	NOUN
gsrj-19	103	18	in	in	ADP
gsrj-19	103	19	the	the	DET
gsrj-19	103	20	development	development	NOUN
gsrj-19	103	21	of	of	ADP
gsrj-19	103	22	treatments.3	treatments.3	PROPN
gsrj-19	103	23	in	in	ADP
gsrj-19	103	24	a	a	DET
gsrj-19	103	25	previous	previous	ADJ
gsrj-19	103	26	study	study	NOUN
gsrj-19	103	27	by	by	ADP
gsrj-19	103	28	frasca	frasca	PROPN
gsrj-19	103	29	et	et	PROPN
gsrj-19	103	30	al	al	PROPN
gsrj-19	103	31	.	.	PROPN
gsrj-19	103	32	,	,	PUNCT
gsrj-19	103	33	nr2b	nr2b	NOUN
gsrj-19	103	34	was	be	AUX
gsrj-19	103	35	studied	study	VERB
gsrj-19	103	36	by	by	ADP
gsrj-19	103	37	pharmacologically	pharmacologically	ADV
gsrj-19	103	38	blocking	block	VERB
gsrj-19	103	39	nmda	nmda	ADJ
gsrj-19	103	40	receptors	receptor	NOUN
gsrj-19	103	41	with	with	ADP
gsrj-19	103	42	ifenprodil.23	ifenprodil.23	NOUN
gsrj-19	103	43	their	their	PRON
gsrj-19	103	44	data	datum	NOUN
gsrj-19	103	45	suggests	suggest	VERB
gsrj-19	103	46	that	that	SCONJ
gsrj-19	103	47	the	the	DET
gsrj-19	103	48	reduction	reduction	NOUN
gsrj-19	103	49	of	of	ADP
gsrj-19	103	50	neurodegeneration	neurodegeneration	NOUN
gsrj-19	103	51	during	during	ADP
gsrj-19	103	52	epileptogenesis	epileptogenesis	NOUN
gsrj-19	103	53	was	be	AUX
gsrj-19	103	54	due	due	ADJ
gsrj-19	103	55	to	to	ADP
gsrj-19	103	56	the	the	DET
gsrj-19	103	57	block	block	NOUN
gsrj-19	103	58	of	of	ADP
gsrj-19	103	59	excitotoxicity.23	excitotoxicity.23	NOUN
gsrj-19	103	60	the	the	DET
gsrj-19	103	61	findings	finding	NOUN
gsrj-19	103	62	of	of	ADP
gsrj-19	103	63	frasca	frasca	PROPN
gsrj-19	103	64	et	et	PROPN
gsrj-19	103	65	al.23	al.23	NOUN
gsrj-19	103	66	apply	apply	VERB
gsrj-19	103	67	to	to	ADP
gsrj-19	103	68	the	the	DET
gsrj-19	103	69	research	research	NOUN
gsrj-19	103	70	discussed	discuss	VERB
gsrj-19	103	71	by	by	ADP
gsrj-19	103	72	yang	yang	PROPN
gsrj-19	103	73	et	et	PROPN
gsrj-19	103	74	al.3	al.3	PROPN
gsrj-19	103	75	,	,	PUNCT
gsrj-19	103	76	particularly	particularly	ADV
gsrj-19	103	77	in	in	ADP
gsrj-19	103	78	reference	reference	NOUN
gsrj-19	103	79	to	to	ADP
gsrj-19	103	80	the	the	DET
gsrj-19	103	81	nr2b	nr2b	NOUN
gsrj-19	103	82	subunit	subunit	NOUN
gsrj-19	103	83	.	.	PUNCT
gsrj-19	104	1	while	while	SCONJ
gsrj-19	104	2	the	the	DET
gsrj-19	104	3	yang	yang	PROPN
gsrj-19	104	4	study	study	PROPN
gsrj-19	104	5	observed	observe	VERB
gsrj-19	104	6	the	the	DET
gsrj-19	104	7	binding	binding	NOUN
gsrj-19	104	8	of	of	ADP
gsrj-19	104	9	gpr40	gpr40	PROPN
gsrj-19	104	10	to	to	ADP
gsrj-19	104	11	nr2b	nr2b	NOUN
gsrj-19	104	12	to	to	PART
gsrj-19	104	13	be	be	AUX
gsrj-19	104	14	a	a	DET
gsrj-19	104	15	method	method	NOUN
gsrj-19	104	16	of	of	ADP
gsrj-19	104	17	nmda	nmda	ADJ
gsrj-19	104	18	receptor	receptor	NOUN
gsrj-19	104	19	regulation	regulation	NOUN
gsrj-19	104	20	,	,	PUNCT
gsrj-19	104	21	the	the	DET
gsrj-19	104	22	frasca	frasca	PROPN
gsrj-19	104	23	study	study	NOUN
gsrj-19	104	24	specifically	specifically	ADV
gsrj-19	104	25	examined	examine	VERB
gsrj-19	104	26	the	the	DET
gsrj-19	104	27	role	role	NOUN
gsrj-19	104	28	of	of	ADP
gsrj-19	104	29	phosphorylation	phosphorylation	NOUN
gsrj-19	104	30	as	as	ADP
gsrj-19	104	31	a	a	DET
gsrj-19	104	32	form	form	NOUN
gsrj-19	104	33	of	of	ADP
gsrj-19	104	34	nr2b	nr2b	NOUN
gsrj-19	104	35	and	and	CCONJ
gsrj-19	104	36	nmda	nmda	ADJ
gsrj-19	104	37	receptor	receptor	NOUN
gsrj-19	104	38	regulation	regulation	NOUN
gsrj-19	104	39	.	.	PUNCT
gsrj-19	105	1	these	these	DET
gsrj-19	105	2	two	two	NUM
gsrj-19	105	3	different	different	ADJ
gsrj-19	105	4	approaches	approach	NOUN
gsrj-19	105	5	towards	towards	ADP
gsrj-19	105	6	nmda	nmda	ADJ
gsrj-19	105	7	receptor	receptor	NOUN
gsrj-19	105	8	regulation	regulation	NOUN
gsrj-19	105	9	could	could	AUX
gsrj-19	105	10	influence	influence	VERB
gsrj-19	105	11	future	future	ADJ
gsrj-19	105	12	treatment	treatment	NOUN
gsrj-19	105	13	development	development	NOUN
gsrj-19	105	14	.	.	PUNCT
gsrj-19	106	1	the	the	DET
gsrj-19	106	2	gpr40	gpr40	PROPN
gsrj-19	106	3	and	and	CCONJ
gsrj-19	106	4	nmda	nmda	ADJ
gsrj-19	106	5	receptor	receptor	NOUN
gsrj-19	106	6	interactions	interaction	NOUN
gsrj-19	106	7	studied	study	VERB
gsrj-19	106	8	by	by	ADP
gsrj-19	106	9	yang	yang	PROPN
gsrj-19	106	10	et	et	PROPN
gsrj-19	106	11	al	al	PROPN
gsrj-19	106	12	.	.	PROPN
gsrj-19	106	13	showed	show	VERB
gsrj-19	106	14	an	an	DET
gsrj-19	106	15	25	25	NUM
gsrj-19	106	16	georgetown	georgetown	NOUN
gsrj-19	106	17	scientific	scientific	ADJ
gsrj-19	106	18	research	research	NOUN
gsrj-19	106	19	journal	journal	NOUN
gsrj-19	106	20	increase	increase	NOUN
gsrj-19	106	21	in	in	ADP
gsrj-19	106	22	gpr40	gpr40	PROPN
gsrj-19	106	23	expression	expression	NOUN
gsrj-19	106	24	.	.	PUNCT
gsrj-19	107	1	the	the	DET
gsrj-19	107	2	phosphorylation	phosphorylation	NOUN
gsrj-19	107	3	of	of	ADP
gsrj-19	107	4	the	the	DET
gsrj-19	107	5	nr2	nr2	NOUN
gsrj-19	107	6	subunit	subunit	NOUN
gsrj-19	107	7	of	of	ADP
gsrj-19	107	8	nmda	nmda	ADJ
gsrj-19	107	9	receptors	receptor	NOUN
gsrj-19	107	10	shown	show	VERB
gsrj-19	107	11	by	by	ADP
gsrj-19	107	12	frasca	frasca	PROPN
gsrj-19	107	13	et	et	PROPN
gsrj-19	107	14	al	al	PROPN
gsrj-19	107	15	.	.	PROPN
gsrj-19	107	16	resulted	result	VERB
gsrj-19	107	17	in	in	ADP
gsrj-19	107	18	reduced	reduced	ADJ
gsrj-19	107	19	cell	cell	NOUN
gsrj-19	107	20	death	death	NOUN
gsrj-19	107	21	;	;	PUNCT
gsrj-19	107	22	perhaps	perhaps	ADV
gsrj-19	107	23	an	an	DET
gsrj-19	107	24	increase	increase	NOUN
gsrj-19	107	25	in	in	ADP
gsrj-19	107	26	gpr40	gpr40	PROPN
gsrj-19	107	27	could	could	AUX
gsrj-19	107	28	induce	induce	VERB
gsrj-19	107	29	the	the	DET
gsrj-19	107	30	same	same	ADJ
gsrj-19	107	31	effects.3	effects.3	NOUN
gsrj-19	107	32	,	,	PUNCT
gsrj-19	107	33	14	14	NUM
gsrj-19	107	34	more	more	ADJ
gsrj-19	107	35	research	research	NOUN
gsrj-19	107	36	is	be	AUX
gsrj-19	107	37	required	require	VERB
gsrj-19	107	38	to	to	PART
gsrj-19	107	39	determine	determine	VERB
gsrj-19	107	40	if	if	SCONJ
gsrj-19	107	41	gpr40	gpr40	PROPN
gsrj-19	107	42	is	be	AUX
gsrj-19	107	43	indeed	indeed	ADV
gsrj-19	107	44	a	a	DET
gsrj-19	107	45	therapeutic	therapeutic	ADJ
gsrj-19	107	46	target	target	NOUN
gsrj-19	107	47	and	and	CCONJ
gsrj-19	107	48	can	can	AUX
gsrj-19	107	49	mediate	mediate	VERB
gsrj-19	107	50	the	the	DET
gsrj-19	107	51	effects	effect	NOUN
gsrj-19	107	52	of	of	ADP
gsrj-19	107	53	epilepsy	epilepsy	NOUN
gsrj-19	107	54	.	.	PUNCT
gsrj-19	108	1	yang	yang	PROPN
gsrj-19	108	2	et	et	PROPN
gsrj-19	108	3	al	al	PROPN
gsrj-19	108	4	.	.	PROPN
gsrj-19	108	5	established	establish	VERB
gsrj-19	108	6	a	a	DET
gsrj-19	108	7	connection	connection	NOUN
gsrj-19	108	8	between	between	ADP
gsrj-19	108	9	gpr40	gpr40	PROPN
gsrj-19	108	10	and	and	CCONJ
gsrj-19	108	11	nmda	nmda	ADJ
gsrj-19	108	12	receptors	receptor	NOUN
gsrj-19	108	13	,	,	PUNCT
gsrj-19	108	14	which	which	PRON
gsrj-19	108	15	is	be	AUX
gsrj-19	108	16	a	a	DET
gsrj-19	108	17	first	first	ADJ
gsrj-19	108	18	and	and	CCONJ
gsrj-19	108	19	necessary	necessary	ADJ
gsrj-19	108	20	step	step	NOUN
gsrj-19	108	21	in	in	ADP
gsrj-19	108	22	studying	study	VERB
gsrj-19	108	23	this	this	DET
gsrj-19	108	24	pathway	pathway	NOUN
gsrj-19	108	25	further	far	ADV
gsrj-19	108	26	.	.	PUNCT
gsrj-19	109	1	on	on	ADP
gsrj-19	109	2	a	a	DET
gsrj-19	109	3	gross	gross	ADJ
gsrj-19	109	4	anatomy	anatomy	NOUN
gsrj-19	109	5	scale	scale	NOUN
gsrj-19	109	6	,	,	PUNCT
gsrj-19	109	7	expression	expression	NOUN
gsrj-19	109	8	of	of	ADP
gsrj-19	109	9	gpr40	gpr40	PROPN
gsrj-19	109	10	is	be	AUX
gsrj-19	109	11	localized	localize	VERB
gsrj-19	109	12	to	to	ADP
gsrj-19	109	13	the	the	DET
gsrj-19	109	14	hippocampus	hippocampus	NOUN
gsrj-19	109	15	and	and	CCONJ
gsrj-19	109	16	cortex	cortex	NOUN
gsrj-19	109	17	.	.	PUNCT
gsrj-19	110	1	additionally	additionally	ADV
gsrj-19	110	2	,	,	PUNCT
gsrj-19	110	3	they	they	PRON
gsrj-19	110	4	found	find	VERB
gsrj-19	110	5	that	that	SCONJ
gsrj-19	110	6	gpr40	gpr40	PROPN
gsrj-19	110	7	expression	expression	NOUN
gsrj-19	110	8	increased	increase	VERB
gsrj-19	110	9	in	in	ADP
gsrj-19	110	10	epileptic	epileptic	ADJ
gsrj-19	110	11	brains	brain	NOUN
gsrj-19	110	12	compared	compare	VERB
gsrj-19	110	13	to	to	ADP
gsrj-19	110	14	nonepileptic	nonepileptic	ADJ
gsrj-19	110	15	brains	brain	NOUN
gsrj-19	110	16	.	.	PUNCT
gsrj-19	111	1	these	these	DET
gsrj-19	111	2	findings	finding	NOUN
gsrj-19	111	3	shed	shed	VERB
gsrj-19	111	4	light	light	NOUN
gsrj-19	111	5	on	on	ADP
gsrj-19	111	6	the	the	DET
gsrj-19	111	7	effects	effect	NOUN
gsrj-19	111	8	of	of	ADP
gsrj-19	111	9	gpr40	gpr40	PROPN
gsrj-19	111	10	on	on	ADP
gsrj-19	111	11	spine	spine	ADJ
gsrj-19	111	12	density	density	NOUN
gsrj-19	111	13	and	and	CCONJ
gsrj-19	111	14	nmda	nmda	ADJ
gsrj-19	111	15	signaling	signal	VERB
gsrj-19	111	16	amplitude.3	amplitude.3	NOUN
gsrj-19	111	17	all	all	PRON
gsrj-19	111	18	of	of	ADP
gsrj-19	111	19	this	this	DET
gsrj-19	111	20	further	further	ADJ
gsrj-19	111	21	research	research	NOUN
gsrj-19	111	22	can	can	AUX
gsrj-19	111	23	significantly	significantly	ADV
gsrj-19	111	24	contribute	contribute	VERB
gsrj-19	111	25	to	to	ADP
gsrj-19	111	26	the	the	DET
gsrj-19	111	27	current	current	ADJ
gsrj-19	111	28	understanding	understanding	NOUN
gsrj-19	111	29	of	of	ADP
gsrj-19	111	30	epilepsy	epilepsy	NOUN
gsrj-19	111	31	.	.	PUNCT
gsrj-19	112	1	this	this	DET
gsrj-19	112	2	disease	disease	NOUN
gsrj-19	112	3	,	,	PUNCT
gsrj-19	112	4	characterized	characterize	VERB
gsrj-19	112	5	by	by	ADP
gsrj-19	112	6	the	the	DET
gsrj-19	112	7	spontaneous	spontaneous	ADJ
gsrj-19	112	8	recurrence	recurrence	NOUN
gsrj-19	112	9	of	of	ADP
gsrj-19	112	10	unprovoked	unprovoked	ADJ
gsrj-19	112	11	seizures	seizure	NOUN
gsrj-19	112	12	,	,	PUNCT
gsrj-19	112	13	significantly	significantly	ADV
gsrj-19	112	14	impacts	impact	VERB
gsrj-19	112	15	the	the	DET
gsrj-19	112	16	daily	daily	ADJ
gsrj-19	112	17	life	life	NOUN
gsrj-19	112	18	of	of	ADP
gsrj-19	112	19	those	those	PRON
gsrj-19	112	20	afflicted	afflict	VERB
gsrj-19	112	21	with	with	ADP
gsrj-19	112	22	the	the	DET
gsrj-19	112	23	condition.1	condition.1	PROPN
gsrj-19	112	24	furthermore	furthermore	ADV
gsrj-19	112	25	,	,	PUNCT
gsrj-19	112	26	advancements	advancement	NOUN
gsrj-19	112	27	in	in	ADP
gsrj-19	112	28	the	the	DET
gsrj-19	112	29	understanding	understanding	NOUN
gsrj-19	112	30	of	of	ADP
gsrj-19	112	31	epilepsy	epilepsy	NOUN
gsrj-19	112	32	can	can	AUX
gsrj-19	112	33	potentially	potentially	ADV
gsrj-19	112	34	shed	shed	VERB
gsrj-19	112	35	light	light	NOUN
gsrj-19	112	36	on	on	ADP
gsrj-19	112	37	the	the	DET
gsrj-19	112	38	causes	cause	NOUN
gsrj-19	112	39	of	of	ADP
gsrj-19	112	40	other	other	ADJ
gsrj-19	112	41	symptoms	symptom	NOUN
gsrj-19	112	42	of	of	ADP
gsrj-19	112	43	the	the	DET
gsrj-19	112	44	condition	condition	NOUN
gsrj-19	112	45	at	at	ADP
gsrj-19	112	46	a	a	DET
gsrj-19	112	47	molecular	molecular	ADJ
gsrj-19	112	48	level	level	NOUN
gsrj-19	112	49	,	,	PUNCT
gsrj-19	112	50	such	such	ADJ
gsrj-19	112	51	as	as	ADP
gsrj-19	112	52	confusion	confusion	NOUN
gsrj-19	112	53	,	,	PUNCT
gsrj-19	112	54	anxiety	anxiety	NOUN
gsrj-19	112	55	,	,	PUNCT
gsrj-19	112	56	and	and	CCONJ
gsrj-19	112	57	deja	deja	PROPN
gsrj-19	112	58	vu.1	vu.1	PROPN
gsrj-19	112	59	hopefully	hopefully	ADV
gsrj-19	112	60	,	,	PUNCT
gsrj-19	112	61	the	the	DET
gsrj-19	112	62	findings	finding	NOUN
gsrj-19	112	63	from	from	ADP
gsrj-19	112	64	yang	yang	PROPN
gsrj-19	112	65	et	et	PROPN
gsrj-19	112	66	al	al	PROPN
gsrj-19	112	67	.	.	PROPN
gsrj-19	112	68	,	,	PUNCT
gsrj-19	112	69	along	along	ADP
gsrj-19	112	70	with	with	ADP
gsrj-19	112	71	future	future	ADJ
gsrj-19	112	72	research	research	NOUN
gsrj-19	112	73	on	on	ADP
gsrj-19	112	74	synaptic	synaptic	ADJ
gsrj-19	112	75	transmission	transmission	NOUN
gsrj-19	112	76	in	in	ADP
gsrj-19	112	77	this	this	DET
gsrj-19	112	78	field	field	NOUN
gsrj-19	112	79	,	,	PUNCT
gsrj-19	112	80	can	can	AUX
gsrj-19	112	81	help	help	VERB
gsrj-19	112	82	push	push	VERB
gsrj-19	112	83	the	the	DET
gsrj-19	112	84	scientific	scientific	ADJ
gsrj-19	112	85	community	community	NOUN
gsrj-19	112	86	one	one	NUM
gsrj-19	112	87	step	step	NOUN
gsrj-19	112	88	closer	close	ADV
gsrj-19	112	89	to	to	ADP
gsrj-19	112	90	finding	find	VERB
gsrj-19	112	91	a	a	DET
gsrj-19	112	92	treatment	treatment	NOUN
gsrj-19	112	93	for	for	ADP
gsrj-19	112	94	this	this	DET
gsrj-19	112	95	disorder	disorder	NOUN
gsrj-19	112	96	.	.	PUNCT
gsrj-19	113	1	acknowledgements	acknowledgement	NOUN
gsrj-19	113	2	we	we	PRON
gsrj-19	113	3	would	would	AUX
gsrj-19	113	4	like	like	VERB
gsrj-19	113	5	to	to	PART
gsrj-19	113	6	thank	thank	VERB
gsrj-19	113	7	dr	dr	PROPN
gsrj-19	113	8	.	.	PROPN
gsrj-19	113	9	katherine	katherine	PROPN
gsrj-19	113	10	maguire	maguire	PROPN
gsrj-19	113	11	-	-	PUNCT
gsrj-19	113	12	zeiss	zeiss	PROPN
gsrj-19	113	13	for	for	ADP
gsrj-19	113	14	leading	lead	VERB
gsrj-19	113	15	our	our	PRON
gsrj-19	113	16	synaptic	synaptic	ADJ
gsrj-19	113	17	transmission	transmission	NOUN
gsrj-19	113	18	course	course	NOUN
gsrj-19	113	19	and	and	CCONJ
gsrj-19	113	20	this	this	DET
gsrj-19	113	21	paper	paper	NOUN
gsrj-19	113	22	project	project	NOUN
gsrj-19	113	23	in	in	ADP
gsrj-19	113	24	the	the	DET
gsrj-19	113	25	fall	fall	NOUN
gsrj-19	113	26	of	of	ADP
gsrj-19	113	27	2020	2020	NUM
gsrj-19	113	28	as	as	ADV
gsrj-19	113	29	well	well	ADV
gsrj-19	113	30	as	as	ADP
gsrj-19	113	31	the	the	DET
gsrj-19	113	32	georgetown	georgetown	PROPN
gsrj-19	113	33	biology	biology	NOUN
gsrj-19	113	34	department	department	PROPN
gsrj-19	113	35	.	.	PUNCT
gsrj-19	114	1	references	reference	NOUN
gsrj-19	114	2	1	1	NUM
gsrj-19	114	3	.	.	PUNCT
gsrj-19	115	1	shneker	shneker	PROPN
gsrj-19	115	2	,	,	PUNCT
gsrj-19	115	3	b.	b.	PROPN
gsrj-19	115	4	f.	f.	PROPN
gsrj-19	115	5	,	,	PUNCT
gsrj-19	115	6	&	&	CCONJ
gsrj-19	115	7	fountain	fountain	NOUN
gsrj-19	115	8	,	,	PUNCT
gsrj-19	115	9	n.	n.	PROPN
gsrj-19	115	10	b.	b.	PROPN
gsrj-19	115	11	(	(	PUNCT
gsrj-19	115	12	2003	2003	NUM
gsrj-19	115	13	)	)	PUNCT
gsrj-19	115	14	.	.	PUNCT
gsrj-19	116	1	epilepsy	epilepsy	PROPN
gsrj-19	116	2	.	.	PUNCT
gsrj-19	117	1	dis	dis	PROPN
gsrj-19	117	2	mon	mon	PROPN
gsrj-19	117	3	,	,	PUNCT
gsrj-19	117	4	49(7	49(7	PROPN
gsrj-19	117	5	)	)	PUNCT
gsrj-19	117	6	,	,	PUNCT
gsrj-19	117	7	426	426	NUM
gsrj-19	117	8	-	-	SYM
gsrj-19	117	9	78	78	NUM
gsrj-19	117	10	.	.	PUNCT
gsrj-19	118	1	http://doi.org/10.1016/s0011-5029(03)00065-8	http://doi.org/10.1016/s0011-5029(03)00065-8	NOUN
gsrj-19	118	2	2	2	NUM
gsrj-19	118	3	.	.	PUNCT
gsrj-19	118	4	epilepsy	epilepsy	PROPN
gsrj-19	118	5	.	.	PUNCT
gsrj-19	119	1	(	(	PUNCT
gsrj-19	119	2	2020	2020	NUM
gsrj-19	119	3	,	,	PUNCT
gsrj-19	119	4	may	may	AUX
gsrj-19	119	5	05	05	NUM
gsrj-19	119	6	)	)	PUNCT
gsrj-19	119	7	.	.	PUNCT
gsrj-19	120	1	retrieved	retrieve	VERB
gsrj-19	120	2	november	november	PROPN
gsrj-19	120	3	18	18	NUM
gsrj-19	120	4	,	,	PUNCT
gsrj-19	120	5	2020	2020	NUM
gsrj-19	120	6	,	,	PUNCT
gsrj-19	120	7	from	from	ADP
gsrj-19	120	8	https://www.mayoclinic.org/diseasesconditions/epilepsy/symptoms-causes/syc20350093	https://www.mayoclinic.org/diseasesconditions/epilepsy/symptoms-causes/syc20350093	NUM
gsrj-19	120	9	3	3	NUM
gsrj-19	120	10	.	.	X
gsrj-19	120	11	yang	yang	PROPN
gsrj-19	120	12	,	,	PUNCT
gsrj-19	120	13	y.	y.	PROPN
gsrj-19	120	14	,	,	PUNCT
gsrj-19	120	15	tian	tian	PROPN
gsrj-19	120	16	,	,	PUNCT
gsrj-19	120	17	x.	x.	PROPN
gsrj-19	120	18	,	,	PUNCT
gsrj-19	120	19	xu	xu	PROPN
gsrj-19	120	20	,	,	PUNCT
gsrj-19	120	21	d.	d.	PROPN
gsrj-19	120	22	,	,	PUNCT
gsrj-19	120	23	zheng	zheng	PROPN
gsrj-19	120	24	,	,	PUNCT
gsrj-19	120	25	f.	f.	PROPN
gsrj-19	120	26	,	,	PUNCT
gsrj-19	120	27	lu	lu	PROPN
gsrj-19	120	28	,	,	PUNCT
gsrj-19	120	29	x.	x.	PROPN
gsrj-19	120	30	,	,	PUNCT
gsrj-19	120	31	zhang	zhang	PROPN
gsrj-19	120	32	,	,	PUNCT
gsrj-19	120	33	y.	y.	PROPN
gsrj-19	120	34	,	,	PUNCT
gsrj-19	120	35	ma	ma	PROPN
gsrj-19	120	36	,	,	PUNCT
gsrj-19	120	37	y.	y.	PROPN
gsrj-19	120	38	,	,	PUNCT
gsrj-19	120	39	li	li	PROPN
gsrj-19	120	40	,	,	PUNCT
gsrj-19	120	41	y.	y.	PROPN
gsrj-19	120	42	,	,	PUNCT
gsrj-19	120	43	xu	xu	PROPN
gsrj-19	120	44	,	,	PUNCT
gsrj-19	120	45	x.	x.	PROPN
gsrj-19	120	46	,	,	PUNCT
gsrj-19	120	47	zhu	zhu	PROPN
gsrj-19	120	48	,	,	PUNCT
gsrj-19	120	49	b.	b.	PROPN
gsrj-19	120	50	,	,	PUNCT
gsrj-19	120	51	&	&	CCONJ
gsrj-19	120	52	wang	wang	PROPN
gsrj-19	120	53	,	,	PUNCT
gsrj-19	120	54	x.	x.	NOUN
gsrj-19	120	55	(	(	PUNCT
gsrj-19	120	56	2018	2018	NUM
gsrj-19	120	57	)	)	PUNCT
gsrj-19	120	58	.	.	PUNCT
gsrj-19	121	1	gpr40	gpr40	PROPN
gsrj-19	121	2	modulates	modulate	NOUN
gsrj-19	121	3	epileptic	epileptic	ADJ
gsrj-19	121	4	seizure	seizure	NOUN
gsrj-19	121	5	and	and	CCONJ
gsrj-19	121	6	nmda	nmda	ADJ
gsrj-19	121	7	receptor	receptor	NOUN
gsrj-19	121	8	function	function	NOUN
gsrj-19	121	9	.	.	PUNCT
gsrj-19	122	1	science	science	NOUN
gsrj-19	122	2	advances	advance	NOUN
gsrj-19	122	3	,	,	PUNCT
gsrj-19	122	4	4(10	4(10	NUM
gsrj-19	122	5	)	)	PUNCT
gsrj-19	122	6	.	.	PUNCT
gsrj-19	123	1	4	4	X
gsrj-19	123	2	.	.	X
gsrj-19	123	3	vasilenko	vasilenko	PROPN
gsrj-19	123	4	,	,	PUNCT
gsrj-19	123	5	a.	a.	NOUN
gsrj-19	123	6	v.	v.	PROPN
gsrj-19	123	7	,	,	PUNCT
gsrj-19	123	8	onishchenko	onishchenko	PROPN
gsrj-19	123	9	,	,	PUNCT
gsrj-19	123	10	l.	l.	PROPN
gsrj-19	123	11	s.	s.	PROPN
gsrj-19	123	12	,	,	PUNCT
gsrj-19	123	13	zhivolupov	zhivolupov	PROPN
gsrj-19	123	14	,	,	PUNCT
gsrj-19	123	15	s.	s.	PROPN
gsrj-19	123	16	a.	a.	PROPN
gsrj-19	123	17	,	,	PUNCT
gsrj-19	123	18	lobzin	lobzin	PROPN
gsrj-19	123	19	,	,	PUNCT
gsrj-19	123	20	s.	s.	PROPN
gsrj-19	123	21	v.	v.	PROPN
gsrj-19	123	22	,	,	PUNCT
gsrj-19	123	23	zabolotskii	zabolotskii	PROPN
gsrj-19	123	24	,	,	PUNCT
gsrj-19	123	25	n.	n.	PROPN
gsrj-19	123	26	n.	n.	PROPN
gsrj-19	123	27	,	,	PUNCT
gsrj-19	123	28	&	&	CCONJ
gsrj-19	123	29	bodrova	bodrova	PROPN
gsrj-19	123	30	,	,	PUNCT
gsrj-19	123	31	t.	t.	PROPN
gsrj-19	123	32	v.	v.	PROPN
gsrj-19	123	33	(	(	PUNCT
gsrj-19	123	34	2017	2017	NUM
gsrj-19	123	35	)	)	PUNCT
gsrj-19	123	36	.	.	PUNCT
gsrj-19	124	1	the	the	DET
gsrj-19	124	2	significance	significance	NOUN
gsrj-19	124	3	of	of	ADP
gsrj-19	124	4	sleep	sleep	NOUN
gsrj-19	124	5	deprivation	deprivation	NOUN
gsrj-19	124	6	in	in	ADP
gsrj-19	124	7	the	the	DET
gsrj-19	124	8	development	development	NOUN
gsrj-19	124	9	of	of	ADP
gsrj-19	124	10	local	local	ADJ
gsrj-19	124	11	epilepsy	epilepsy	NOUN
gsrj-19	124	12	from	from	ADP
gsrj-19	124	13	the	the	DET
gsrj-19	124	14	point	point	NOUN
gsrj-19	124	15	of	of	ADP
gsrj-19	124	16	view	view	NOUN
gsrj-19	124	17	of	of	ADP
gsrj-19	124	18	neuroplasticity	neuroplasticity	NOUN
gsrj-19	124	19	.	.	PUNCT
gsrj-19	125	1	neuroscience	neuroscience	NOUN
gsrj-19	125	2	and	and	CCONJ
gsrj-19	125	3	behavioral	behavioral	ADJ
gsrj-19	125	4	physiology	physiology	NOUN
gsrj-19	125	5	,	,	PUNCT
gsrj-19	125	6	47(9	47(9	NOUN
gsrj-19	125	7	)	)	PUNCT
gsrj-19	125	8	,	,	PUNCT
gsrj-19	125	9	11021108	11021108	NUM
gsrj-19	125	10	.	.	PUNCT
gsrj-19	126	1	http://doi.org/10.1007/s11055-017-0518-8	http://doi.org/10.1007/s11055-017-0518-8	PRON
gsrj-19	126	2	5	5	NUM
gsrj-19	126	3	.	.	PUNCT
gsrj-19	126	4	slater	slater	PROPN
gsrj-19	126	5	,	,	PUNCT
gsrj-19	126	6	j.	j.	PROPN
gsrj-19	126	7	,	,	PUNCT
gsrj-19	126	8	chung	chung	PROPN
gsrj-19	126	9	,	,	PUNCT
gsrj-19	126	10	s.	s.	PROPN
gsrj-19	126	11	,	,	PUNCT
gsrj-19	126	12	huynh	huynh	PROPN
gsrj-19	126	13	,	,	PUNCT
gsrj-19	126	14	l.	l.	PROPN
gsrj-19	126	15	,	,	PUNCT
gsrj-19	126	16	duh	duh	PROPN
gsrj-19	126	17	,	,	PUNCT
gsrj-19	126	18	m.	m.	NOUN
gsrj-19	126	19	s.	s.	PROPN
gsrj-19	126	20	,	,	PUNCT
gsrj-19	126	21	gorin	gorin	PROPN
gsrj-19	126	22	,	,	PUNCT
gsrj-19	126	23	b.	b.	PROPN
gsrj-19	126	24	,	,	PUNCT
gsrj-19	126	25	mcmicken	mcmicken	VERB
gsrj-19	126	26	,	,	PUNCT
gsrj-19	126	27	c.	c.	PROPN
gsrj-19	126	28	,	,	PUNCT
gsrj-19	126	29	ziemann	ziemann	PROPN
gsrj-19	126	30	,	,	PUNCT
gsrj-19	126	31	a.	a.	PROPN
gsrj-19	126	32	,	,	PUNCT
gsrj-19	126	33	&	&	CCONJ
gsrj-19	126	34	isojarvi	isojarvi	PROPN
gsrj-19	126	35	,	,	PUNCT
gsrj-19	126	36	j.	j.	PROPN
gsrj-19	126	37	(	(	PUNCT
gsrj-19	126	38	2018	2018	NUM
gsrj-19	126	39	)	)	PUNCT
gsrj-19	126	40	.	.	PUNCT
gsrj-19	127	1	efficacy	efficacy	NOUN
gsrj-19	127	2	of	of	ADP
gsrj-19	127	3	antiepileptic	antiepileptic	ADJ
gsrj-19	127	4	drugs	drug	NOUN
gsrj-19	127	5	in	in	ADP
gsrj-19	127	6	the	the	DET
gsrj-19	127	7	adjunctive	adjunctive	ADJ
gsrj-19	127	8	treatment	treatment	NOUN
gsrj-19	127	9	of	of	ADP
gsrj-19	127	10	refractory	refractory	NOUN
gsrj-19	127	11	partial	partial	ADJ
gsrj-19	127	12	-	-	PUNCT
gsrj-19	127	13	onset	onset	ADJ
gsrj-19	127	14	seizures	seizure	NOUN
gsrj-19	127	15	:	:	PUNCT
gsrj-19	127	16	meta	meta	ADJ
gsrj-19	127	17	-	-	PUNCT
gsrj-19	127	18	analysis	analysis	NOUN
gsrj-19	127	19	of	of	ADP
gsrj-19	127	20	pivotal	pivotal	ADJ
gsrj-19	127	21	trials	trial	NOUN
gsrj-19	127	22	.	.	PUNCT
gsrj-19	128	1	epilepsy	epilepsy	PROPN
gsrj-19	128	2	research	research	NOUN
gsrj-19	128	3	,	,	PUNCT
gsrj-19	128	4	143	143	NUM
gsrj-19	128	5	,	,	PUNCT
gsrj-19	128	6	120	120	NUM
gsrj-19	128	7	-	-	SYM
gsrj-19	128	8	129	129	NUM
gsrj-19	128	9	.	.	PUNCT
gsrj-19	129	1	6	6	NUM
gsrj-19	129	2	.	.	X
gsrj-19	129	3	fukata	fukata	PROPN
gsrj-19	129	4	,	,	PUNCT
gsrj-19	129	5	y.	y.	PROPN
gsrj-19	129	6	,	,	PUNCT
gsrj-19	129	7	&	&	CCONJ
gsrj-19	129	8	fukata	fukata	ADJ
gsrj-19	129	9	,	,	PUNCT
gsrj-19	129	10	m.	m.	NOUN
gsrj-19	129	11	(	(	PUNCT
gsrj-19	129	12	2017	2017	NUM
gsrj-19	129	13	)	)	PUNCT
gsrj-19	129	14	.	.	PUNCT
gsrj-19	130	1	epilepsy	epilepsy	PROPN
gsrj-19	130	2	and	and	CCONJ
gsrj-19	130	3	synaptic	synaptic	ADJ
gsrj-19	130	4	proteins	protein	NOUN
gsrj-19	130	5	.	.	PUNCT
gsrj-19	131	1	current	current	ADJ
gsrj-19	131	2	opinion	opinion	NOUN
gsrj-19	131	3	in	in	ADP
gsrj-19	131	4	neurobiology	neurobiology	NOUN
gsrj-19	131	5	,	,	PUNCT
gsrj-19	131	6	45	45	NUM
gsrj-19	131	7	,	,	PUNCT
gsrj-19	131	8	1–8	1–8	NUM
gsrj-19	131	9	.	.	NOUN
gsrj-19	131	10	7	7	NUM
gsrj-19	131	11	.	.	NUM
gsrj-19	131	12	akyuz	akyuz	PROPN
gsrj-19	131	13	,	,	PUNCT
gsrj-19	131	14	e.	e.	PROPN
gsrj-19	131	15	,	,	PUNCT
gsrj-19	131	16	polat	polat	PROPN
gsrj-19	131	17	,	,	PUNCT
gsrj-19	131	18	a.k	a.k	PROPN
gsrj-19	131	19	.	.	PROPN
gsrj-19	131	20	,	,	PUNCT
gsrj-19	131	21	eroglu	eroglu	PROPN
gsrj-19	131	22	,	,	PUNCT
gsrj-19	131	23	e.	e.	PROPN
gsrj-19	131	24	,	,	PUNCT
gsrj-19	131	25	kullu	kullu	PROPN
gsrj-19	131	26	,	,	PUNCT
gsrj-19	131	27	i.	i.	PROPN
gsrj-19	131	28	,	,	PUNCT
gsrj-19	131	29	angelopoulou	angelopoulou	PROPN
gsrj-19	131	30	,	,	PUNCT
gsrj-19	131	31	e.	e.	PROPN
gsrj-19	131	32	,	,	PUNCT
gsrj-19	131	33	&	&	CCONJ
gsrj-19	131	34	paudel	paudel	PROPN
gsrj-19	131	35	,	,	PUNCT
gsrj-19	131	36	y.n	y.n	PROPN
gsrj-19	131	37	.	.	PROPN
gsrj-19	131	38	revisiting	revisit	VERB
gsrj-19	131	39	the	the	DET
gsrj-19	131	40	role	role	NOUN
gsrj-19	131	41	of	of	ADP
gsrj-19	131	42	neurotransmitters	neurotransmitter	NOUN
gsrj-19	131	43	in	in	ADP
gsrj-19	131	44	epilepsy	epilepsy	NOUN
gsrj-19	131	45	:	:	PUNCT
gsrj-19	131	46	an	an	DET
gsrj-19	131	47	updated	update	VERB
gsrj-19	131	48	review	review	NOUN
gsrj-19	131	49	.	.	PUNCT
gsrj-19	132	1	life	life	NOUN
gsrj-19	132	2	sciences	science	NOUN
gsrj-19	132	3	.	.	PUNCT
gsrj-19	133	1	265	265	NUM
gsrj-19	133	2	.	.	PUNCT
gsrj-19	134	1	https://doi.org/10.1016/j.lfs.2020.118826	https://doi.org/10.1016/j.lfs.2020.118826	PROPN
gsrj-19	134	2	8	8	NUM
gsrj-19	134	3	.	.	PUNCT
gsrj-19	135	1	stretton	stretton	PROPN
gsrj-19	135	2	,	,	PUNCT
gsrj-19	135	3	j.	j.	PROPN
gsrj-19	135	4	,	,	PUNCT
gsrj-19	135	5	&	&	CCONJ
gsrj-19	135	6	thompson	thompson	PROPN
gsrj-19	135	7	,	,	PUNCT
gsrj-19	135	8	p.	p.	NOUN
gsrj-19	135	9	j.	j.	PROPN
gsrj-19	135	10	(	(	PUNCT
gsrj-19	135	11	2012	2012	NUM
gsrj-19	135	12	)	)	PUNCT
gsrj-19	135	13	.	.	PUNCT
gsrj-19	136	1	frontal	frontal	ADJ
gsrj-19	136	2	lobe	lobe	NOUN
gsrj-19	136	3	function	function	NOUN
gsrj-19	136	4	in	in	ADP
gsrj-19	136	5	temporal	temporal	ADJ
gsrj-19	136	6	lobe	lobe	NOUN
gsrj-19	136	7	epilepsy	epilepsy	NOUN
gsrj-19	136	8	.	.	PUNCT
gsrj-19	137	1	epilepsy	epilepsy	PROPN
gsrj-19	137	2	research	research	NOUN
gsrj-19	137	3	,	,	PUNCT
gsrj-19	137	4	98(1	98(1	NOUN
gsrj-19	137	5	)	)	PUNCT
gsrj-19	137	6	,	,	PUNCT
gsrj-19	137	7	1–13	1–13	NOUN
gsrj-19	137	8	.	.	PUNCT
gsrj-19	138	1	9	9	NUM
gsrj-19	138	2	.	.	X
gsrj-19	138	3	zamarbide	zamarbide	NOUN
gsrj-19	138	4	,	,	PUNCT
gsrj-19	138	5	m.	m.	NOUN
gsrj-19	138	6	,	,	PUNCT
gsrj-19	138	7	etayo	etayo	NOUN
gsrj-19	138	8	-	-	PUNCT
gsrj-19	138	9	labiano	labiano	PROPN
gsrj-19	138	10	,	,	PUNCT
gsrj-19	138	11	i.	i.	PROPN
gsrj-19	138	12	,	,	PUNCT
gsrj-19	138	13	ricobaraza	ricobaraza	PROPN
gsrj-19	138	14	,	,	PUNCT
gsrj-19	138	15	a.	a.	NOUN
gsrj-19	138	16	,	,	PUNCT
gsrj-19	138	17	martínez	martínez	NOUN
gsrj-19	138	18	-	-	PUNCT
gsrj-19	138	19	pinilla	pinilla	NOUN
gsrj-19	138	20	,	,	PUNCT
gsrj-19	138	21	e.	e.	PROPN
gsrj-19	138	22	,	,	PUNCT
gsrj-19	138	23	aymerich	aymerich	PROPN
gsrj-19	138	24	,	,	PUNCT
gsrj-19	138	25	m.	m.	PROPN
gsrj-19	138	26	s.	s.	PROPN
gsrj-19	138	27	,	,	PUNCT
gsrj-19	138	28	luis	luis	PROPN
gsrj-19	138	29	lanciego	lanciego	PROPN
gsrj-19	138	30	,	,	PUNCT
gsrj-19	138	31	j.	j.	PROPN
gsrj-19	138	32	,	,	PUNCT
gsrj-19	138	33	pérez	pérez	NOUN
gsrj-19	138	34	-	-	PUNCT
gsrj-19	138	35	mediavilla	mediavilla	PROPN
gsrj-19	138	36	,	,	PUNCT
gsrj-19	138	37	a.	a.	NOUN
gsrj-19	138	38	,	,	PUNCT
gsrj-19	138	39	&	&	CCONJ
gsrj-19	138	40	franco	franco	PROPN
gsrj-19	138	41	,	,	PUNCT
gsrj-19	138	42	r.	r.	PROPN
gsrj-19	138	43	(	(	PUNCT
gsrj-19	138	44	2014	2014	NUM
gsrj-19	138	45	)	)	PUNCT
gsrj-19	138	46	.	.	PUNCT
gsrj-19	139	1	gpr40	gpr40	PROPN
gsrj-19	139	2	activation	activation	NOUN
gsrj-19	139	3	leads	lead	VERB
gsrj-19	139	4	to	to	ADP
gsrj-19	139	5	creb	creb	NOUN
gsrj-19	139	6	and	and	CCONJ
gsrj-19	139	7	erk	erk	PROPN
gsrj-19	139	8	phosphorylation	phosphorylation	NOUN
gsrj-19	139	9	in	in	ADP
gsrj-19	139	10	primary	primary	ADJ
gsrj-19	139	11	cultures	culture	NOUN
gsrj-19	139	12	of	of	ADP
gsrj-19	139	13	neurons	neuron	NOUN
gsrj-19	139	14	from	from	ADP
gsrj-19	139	15	the	the	DET
gsrj-19	139	16	mouse	mouse	NOUN
gsrj-19	139	17	cns	cns	NOUN
gsrj-19	139	18	and	and	CCONJ
gsrj-19	139	19	in	in	ADP
gsrj-19	139	20	human	human	ADJ
gsrj-19	139	21	neuroblastoma	neuroblastoma	NOUN
gsrj-19	139	22	cells	cell	NOUN
gsrj-19	139	23	.	.	PUNCT
gsrj-19	140	1	hippocampus	hippocampus	NOUN
gsrj-19	140	2	,	,	PUNCT
gsrj-19	140	3	24(7	24(7	NUM
gsrj-19	140	4	)	)	PUNCT
gsrj-19	140	5	.	.	PUNCT
gsrj-19	141	1	10	10	NUM
gsrj-19	141	2	.	.	X
gsrj-19	141	3	taha	taha	PROPN
gsrj-19	141	4	,	,	PUNCT
gsrj-19	141	5	a.y	a.y	PROPN
gsrj-19	141	6	.	.	PROPN
gsrj-19	141	7	,	,	PUNCT
gsrj-19	141	8	burnham	burnham	PROPN
gsrj-19	141	9	,	,	PUNCT
gsrj-19	141	10	w.m	w.m	PROPN
gsrj-19	141	11	.	.	PROPN
gsrj-19	141	12	,	,	PUNCT
gsrj-19	141	13	&	&	CCONJ
gsrj-19	141	14	auvin	auvin	PROPN
gsrj-19	141	15	,	,	PUNCT
gsrj-19	141	16	s.	s.	PROPN
gsrj-19	141	17	(	(	PUNCT
gsrj-19	141	18	2010	2010	NUM
gsrj-19	141	19	)	)	PUNCT
gsrj-19	141	20	,	,	PUNCT
gsrj-19	141	21	polyunsaturated	polyunsaturate	VERB
gsrj-19	141	22	fatty	fatty	NOUN
gsrj-19	141	23	acids	acid	NOUN
gsrj-19	141	24	and	and	CCONJ
gsrj-19	141	25	epilepsy	epilepsy	NOUN
gsrj-19	141	26	.	.	PUNCT
gsrj-19	142	1	epilepsia	epilepsia	NOUN
gsrj-19	142	2	,	,	PUNCT
gsrj-19	142	3	51	51	NUM
gsrj-19	142	4	,	,	PUNCT
gsrj-19	142	5	1348	1348	NUM
gsrj-19	142	6	-	-	SYM
gsrj-19	142	7	1358	1358	NUM
gsrj-19	142	8	.	.	PUNCT
gsrj-19	143	1	https://doi.org/10.1111/j.15281167.2010.02654.x	https://doi.org/10.1111/j.15281167.2010.02654.x	X
gsrj-19	144	1	11	11	NUM
gsrj-19	144	2	.	.	PUNCT
gsrj-19	144	3	degiorgio	degiorgio	NOUN
gsrj-19	144	4	,	,	PUNCT
gsrj-19	144	5	c.	c.	PROPN
gsrj-19	144	6	m.	m.	PROPN
gsrj-19	144	7	,	,	PUNCT
gsrj-19	144	8	miller	miller	PROPN
gsrj-19	144	9	,	,	PUNCT
gsrj-19	144	10	p.	p.	PROPN
gsrj-19	144	11	r.	r.	PROPN
gsrj-19	144	12	,	,	PUNCT
gsrj-19	144	13	harper	harper	PROPN
gsrj-19	144	14	,	,	PUNCT
gsrj-19	144	15	r.	r.	PROPN
gsrj-19	144	16	,	,	PUNCT
gsrj-19	144	17	gornbein	gornbein	PROPN
gsrj-19	144	18	,	,	PUNCT
gsrj-19	144	19	j.	j.	PROPN
gsrj-19	144	20	,	,	PUNCT
gsrj-19	144	21	schrader	schrader	PROPN
gsrj-19	144	22	,	,	PUNCT
gsrj-19	144	23	l.	l.	PROPN
gsrj-19	144	24	,	,	PUNCT
gsrj-19	144	25	soss	soss	PROPN
gsrj-19	144	26	,	,	PUNCT
gsrj-19	144	27	j.	j.	PROPN
gsrj-19	144	28	,	,	PUNCT
gsrj-19	144	29	&	&	CCONJ
gsrj-19	144	30	meymandi	meymandi	PROPN
gsrj-19	144	31	,	,	PUNCT
gsrj-19	144	32	s.	s.	PROPN
gsrj-19	144	33	(	(	PUNCT
gsrj-19	144	34	2015	2015	NUM
gsrj-19	144	35	)	)	PUNCT
gsrj-19	144	36	.	.	PUNCT
gsrj-19	145	1	fish	fish	NOUN
gsrj-19	145	2	oil	oil	NOUN
gsrj-19	145	3	(	(	PUNCT
gsrj-19	145	4	n-3	n-3	ADJ
gsrj-19	145	5	fatty	fatty	NOUN
gsrj-19	145	6	acids	acid	NOUN
gsrj-19	145	7	)	)	PUNCT
gsrj-19	145	8	in	in	ADP
gsrj-19	145	9	drug	drug	NOUN
gsrj-19	145	10	resistant	resistant	ADJ
gsrj-19	145	11	epilepsy	epilepsy	NOUN
gsrj-19	145	12	:	:	PUNCT
gsrj-19	145	13	a	a	DET
gsrj-19	145	14	randomised	randomised	ADJ
gsrj-19	145	15	placebo	placebo	NOUN
gsrj-19	145	16	-	-	PUNCT
gsrj-19	145	17	controlled	control	VERB
gsrj-19	145	18	crossover	crossover	NOUN
gsrj-19	145	19	study	study	NOUN
gsrj-19	145	20	.	.	PUNCT
gsrj-19	146	1	journal	journal	PROPN
gsrj-19	146	2	of	of	ADP
gsrj-19	146	3	neurology	neurology	NOUN
gsrj-19	146	4	,	,	PUNCT
gsrj-19	146	5	neurosurgery	neurosurgery	NOUN
gsrj-19	146	6	,	,	PUNCT
gsrj-19	146	7	and	and	CCONJ
gsrj-19	146	8	psychiatry	psychiatry	NOUN
gsrj-19	146	9	,	,	PUNCT
gsrj-19	146	10	(	(	PUNCT
gsrj-19	146	11	86)1	86)1	NUM
gsrj-19	146	12	,	,	PUNCT
gsrj-19	146	13	65	65	NUM
gsrj-19	146	14	-	-	SYM
gsrj-19	146	15	70	70	NUM
gsrj-19	146	16	.	.	PUNCT
gsrj-19	147	1	http://doi.org/10.1136/jnnp-2014-307749	http://doi.org/10.1136/jnnp-2014-307749	PROPN
gsrj-19	147	2	26	26	NUM
gsrj-19	147	3	georgetown	georgetown	PROPN
gsrj-19	147	4	scientific	scientific	PROPN
gsrj-19	147	5	research	research	PROPN
gsrj-19	147	6	journal	journal	PROPN
gsrj-19	147	7	12	12	NUM
gsrj-19	147	8	.	.	PUNCT
gsrj-19	148	1	farivar	farivar	PROPN
gsrj-19	148	2	,	,	PUNCT
gsrj-19	148	3	t.	t.	PROPN
gsrj-19	148	4	,	,	PUNCT
gsrj-19	148	5	nassiri	nassiri	NOUN
gsrj-19	148	6	,	,	PUNCT
gsrj-19	148	7	m.	m.	NOUN
gsrj-19	148	8	,	,	PUNCT
gsrj-19	148	9	johari	johari	PROPN
gsrj-19	148	10	,	,	PUNCT
gsrj-19	148	11	p.	p.	PROPN
gsrj-19	148	12	,	,	PUNCT
gsrj-19	148	13	najafipour	najafipour	NOUN
gsrj-19	148	14	,	,	PUNCT
gsrj-19	148	15	r.	r.	PROPN
gsrj-19	148	16	,	,	PUNCT
gsrj-19	148	17	&	&	CCONJ
gsrj-19	148	18	haijali	haijali	PROPN
gsrj-19	148	19	,	,	PUNCT
gsrj-19	148	20	f.	f.	PROPN
gsrj-19	148	21	(	(	PUNCT
gsrj-19	148	22	2016	2016	NUM
gsrj-19	148	23	)	)	PUNCT
gsrj-19	148	24	.	.	PUNCT
gsrj-19	149	1	the	the	DET
gsrj-19	149	2	effects	effect	NOUN
gsrj-19	149	3	of	of	ADP
gsrj-19	149	4	kainic	kainic	ADJ
gsrj-19	149	5	acidinduced	acidinduced	ADJ
gsrj-19	149	6	seizure	seizure	NOUN
gsrj-19	149	7	on	on	ADP
gsrj-19	149	8	gene	gene	NOUN
gsrj-19	149	9	expression	expression	NOUN
gsrj-19	149	10	of	of	ADP
gsrj-19	149	11	brain	brain	NOUN
gsrj-19	149	12	neurotransmitter	neurotransmitter	NOUN
gsrj-19	149	13	receptors	receptor	NOUN
gsrj-19	149	14	in	in	ADP
gsrj-19	149	15	mice	mouse	NOUN
gsrj-19	149	16	using	use	VERB
gsrj-19	149	17	rt2	rt2	PROPN
gsrj-19	149	18	pcr	pcr	PROPN
gsrj-19	149	19	array	array	NOUN
gsrj-19	149	20	.	.	PUNCT
gsrj-19	150	1	basic	basic	ADJ
gsrj-19	150	2	clinical	clinical	ADJ
gsrj-19	150	3	neuroscience	neuroscience	NOUN
gsrj-19	150	4	.	.	PUNCT
gsrj-19	151	1	13	13	NUM
gsrj-19	151	2	.	.	X
gsrj-19	151	3	dhir	dhir	ADJ
gsrj-19	151	4	,	,	PUNCT
gsrj-19	151	5	a.	a.	NOUN
gsrj-19	151	6	(	(	PUNCT
gsrj-19	151	7	2012	2012	NUM
gsrj-19	151	8	)	)	PUNCT
gsrj-19	151	9	.	.	PUNCT
gsrj-19	152	1	pentylenetetrazol	pentylenetetrazol	NOUN
gsrj-19	152	2	(	(	PUNCT
gsrj-19	152	3	ptz	ptz	PROPN
gsrj-19	152	4	)	)	PUNCT
gsrj-19	152	5	kindling	kindle	VERB
gsrj-19	152	6	model	model	NOUN
gsrj-19	152	7	of	of	ADP
gsrj-19	152	8	epilepsy	epilepsy	NOUN
gsrj-19	152	9	.	.	PUNCT
gsrj-19	153	1	current	current	ADJ
gsrj-19	153	2	protocols	protocol	NOUN
gsrj-19	153	3	in	in	ADP
gsrj-19	153	4	neuroscience	neuroscience	NOUN
gsrj-19	153	5	.	.	PUNCT
gsrj-19	154	1	https://doi.org/10.1002/0471142301.ns0937s58	https://doi.org/10.1002/0471142301.ns0937s58	PROPN
gsrj-19	154	2	14	14	NUM
gsrj-19	154	3	.	.	PUNCT
gsrj-19	155	1	frasca	frasca	PROPN
gsrj-19	155	2	,	,	PUNCT
gsrj-19	155	3	a.	a.	NOUN
gsrj-19	155	4	,	,	PUNCT
gsrj-19	155	5	aalbers	aalber	NOUN
gsrj-19	155	6	,	,	PUNCT
gsrj-19	155	7	m.	m.	NOUN
gsrj-19	155	8	,	,	PUNCT
gsrj-19	155	9	frigerio	frigerio	PROPN
gsrj-19	155	10	,	,	PUNCT
gsrj-19	155	11	f.	f.	PROPN
gsrj-19	155	12	,	,	PUNCT
gsrj-19	155	13	fiordaliso	fiordaliso	PROPN
gsrj-19	155	14	,	,	PUNCT
gsrj-19	155	15	f.	f.	PROPN
gsrj-19	155	16	,	,	PUNCT
gsrj-19	155	17	salio	salio	NOUN
gsrj-19	155	18	,	,	PUNCT
gsrj-19	155	19	m.	m.	NOUN
gsrj-19	155	20	,	,	PUNCT
gsrj-19	155	21	gobbi	gobbi	PROPN
gsrj-19	155	22	,	,	PUNCT
gsrj-19	155	23	m.	m.	NOUN
gsrj-19	155	24	,	,	PUNCT
gsrj-19	155	25	...	...	PUNCT
gsrj-19	155	26	&	&	CCONJ
gsrj-19	155	27	di	di	PROPN
gsrj-19	155	28	luca	luca	PROPN
gsrj-19	155	29	,	,	PUNCT
gsrj-19	155	30	m.	m.	NOUN
gsrj-19	155	31	(	(	PUNCT
gsrj-19	155	32	2011	2011	NUM
gsrj-19	155	33	)	)	PUNCT
gsrj-19	155	34	.	.	PUNCT
gsrj-19	156	1	misplaced	misplace	VERB
gsrj-19	156	2	nmda	nmda	ADJ
gsrj-19	156	3	receptors	receptor	NOUN
gsrj-19	156	4	in	in	ADP
gsrj-19	156	5	epileptogenesis	epileptogenesis	NOUN
gsrj-19	156	6	contribute	contribute	VERB
gsrj-19	156	7	to	to	ADP
gsrj-19	156	8	excitotoxicity	excitotoxicity	NOUN
gsrj-19	156	9	.	.	PUNCT
gsrj-19	157	1	neurobiology	neurobiology	NOUN
gsrj-19	157	2	of	of	ADP
gsrj-19	157	3	disease	disease	NOUN
gsrj-19	157	4	,	,	PUNCT
gsrj-19	157	5	43(2	43(2	NUM
gsrj-19	157	6	)	)	PUNCT
gsrj-19	157	7	,	,	PUNCT
gsrj-19	157	8	507	507	NUM
gsrj-19	157	9	-	-	SYM
gsrj-19	157	10	515	515	NUM
gsrj-19	157	11	.	.	NOUN
gsrj-19	157	12	27	27	NUM
gsrj-19	157	13	73	73	NUM
gsrj-19	157	14	danya	danya	PROPN
gsrj-19	157	15	adams	adams	PROPN
gsrj-19	157	16	�	�	PROPN
gsrj-19	157	17	table	table	NOUN
gsrj-19	157	18	of	of	ADP
gsrj-19	157	19	contents	content	NOUN
gsrj-19	157	20	letter	letter	NOUN
gsrj-19	157	21	from	from	ADP
gsrj-19	157	22	the	the	DET
gsrj-19	157	23	editors	editor	NOUN
gsrj-19	157	24	an	an	DET
gsrj-19	157	25	investigation	investigation	NOUN
gsrj-19	157	26	into	into	ADP
gsrj-19	157	27	the	the	DET
gsrj-19	157	28	mathematics	mathematic	NOUN
gsrj-19	157	29	of	of	ADP
gsrj-19	157	30	decryptiontechniques	decryptiontechnique	NOUN
gsrj-19	157	31	in	in	ADP
gsrj-19	157	32	rsa	rsa	NOUN
gsrj-19	157	33	encryption	encryption	NOUN
gsrj-19	157	34	,	,	PUNCT
gsrj-19	157	35	with	with	ADP
gsrj-19	157	36	an	an	DET
gsrj-19	157	37	implementation	implementation	NOUN
gsrj-19	157	38	in	in	ADP
gsrj-19	157	39	python	python	PROPN
gsrj-19	157	40	gpr40	gpr40	PROPN
gsrj-19	157	41	and	and	CCONJ
gsrj-19	157	42	postsynaptic	postsynaptic	ADJ
gsrj-19	157	43	nmda	nmda	ADJ
gsrj-19	157	44	receptors	receptor	NOUN
gsrj-19	157	45	:	:	PUNCT
gsrj-19	157	46	a	a	DET
gsrj-19	157	47	pair	pair	NOUN
gsrj-19	157	48	against	against	ADP
gsrj-19	157	49	epilepsy	epilepsy	NOUN
gsrj-19	157	50	the	the	DET
gsrj-19	157	51	burn	burn	NOUN
gsrj-19	157	52	behind	behind	ADP
gsrj-19	157	53	the	the	DET
gsrj-19	157	54	bullet	bullet	NOUN
gsrj-19	157	55	:	:	PUNCT
gsrj-19	157	56	understanding	understand	VERB
gsrj-19	157	57	black	black	ADJ
gsrj-19	157	58	mothers	mother	NOUN
gsrj-19	157	59	’	'	PUNCT
gsrj-19	157	60	experiences	experience	NOUN
gsrj-19	157	61	after	after	ADP
gsrj-19	157	62	losing	lose	VERB
gsrj-19	157	63	a	a	DET
gsrj-19	157	64	child	child	NOUN
gsrj-19	157	65	to	to	PART
gsrj-19	157	66	gun	gun	NOUN
gsrj-19	157	67	violence	violence	NOUN
gsrj-19	157	68	in	in	ADP
gsrj-19	157	69	washington	washington	PROPN
gsrj-19	157	70	,	,	PUNCT
gsrj-19	157	71	dc	dc	PROPN
gsrj-19	157	72	-	-	PUNCT
gsrj-19	157	73	baltimore	baltimore	PROPN
gsrj-19	157	74	city	city	PROPN
gsrj-19	157	75	metropolitan	metropolitan	PROPN
gsrj-19	157	76	region	region	NOUN
gsrj-19	157	77	cancer	cancer	NOUN
gsrj-19	157	78	models	model	NOUN
gsrj-19	157	79	to	to	PART
gsrj-19	157	80	defeat	defeat	VERB
gsrj-19	157	81	therapy	therapy	NOUN
gsrj-19	157	82	resistance	resistance	NOUN
gsrj-19	157	83	in	in	ADP
gsrj-19	157	84	pancreatic	pancreatic	ADJ
gsrj-19	157	85	ductal	ductal	ADJ
gsrj-19	157	86	adenocarcinoma	adenocarcinoma	NOUN
gsrj-19	157	87	about	about	ADP
gsrj-19	157	88	the	the	DET
gsrj-19	157	89	authors	author	NOUN
gsrj-19	157	90	meet	meet	VERB
gsrj-19	157	91	the	the	DET
gsrj-19	157	92	staff	staff	NOUN
gsrj-19	157	93	acknowledgements	acknowledgement	NOUN